methotrexate has been researched along with Local Neoplasm Recurrence in 1049 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 334 (31.84) | 18.7374 |
| 1990's | 235 (22.40) | 18.2507 |
| 2000's | 215 (20.50) | 29.6817 |
| 2010's | 165 (15.73) | 24.3611 |
| 2020's | 100 (9.53) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, J; Cai, Q; Fang, Y; Huang, H; Li, Z; Liu, P; Ma, S; Su, N; Tian, X; Wang, J; Xia, Y; Zhang, Y | 1 |
| Advani, R; Alharthy, H; Ayers, A; Ayers, EC; Barlow, CM; Barrett-Campbell, O; Caimi, PF; Chavez, JC; Cohen, J; David, KA; Del Prete, C; Echalier, B; Fu, T; Grover, NS; Hill, BT; Huntington, SF; Kahl, BS; Kallam, A; Kamdar, M; Karmali, R; Khan, N; Landsburg, DJ; Lansigan, F; Law, J; Lazaryan, A; Lee, J; Liu, J; Liu, Y; Major, A; Malecek, MK; McCook, AA; Nakhoda, S; Ollila, TA; Olszewski, A; Orellana-Noia, VM; Portell, CA; Raghunathan, V; Reed, DR; Rojek, AE; Romancik, J; Saeed, H; Sen, JM; Shah, H; Smith, SM; Snow, A; Sohail, MA; Spinner, MA; Spurgeon, SE; Stephens, DM; Switchenko, J; Voorhees, TJ; Watkins, M; Yellala, A | 1 |
| Fujiwara, S; Imoto, N; Ishihara, S; Ito, R; Kurahashi, S; Sakai, T; Sugiura, I; Suzuki, Y; Yamamoto, S | 1 |
| Grommes, C; Schaff, LR | 1 |
| Grommes, C; Modelevsky, L; Reiss, SN; Yerram, P | 1 |
| Chukwueke, U; Grommes, C; Nayak, L | 1 |
| Agbetiafa, K; Ahearne, M; Barlow, BR; Calimeri, T; Cheah, CY; Choquet, S; Clavert, A; Cwynarski, K; Durot, E; Ebsworth, TJ; El Galaly, TC; Elliot, J; Eyre, TA; Fernandez, R; Ferreri, AJM; Forgeard, N; Fox, CP; Gounder, P; Guidetti, A; Hamad, N; Htut, TW; Khwaja, J; Kirkwood, AA; Ku, M; Lebras, L; Lees, C; Lewis, KL; Liu, Q; Lombion, N; Lopez-Garcia, A; Manos, K; Martinez-Calle, N; McIlroy, G; McKay, P; Miall, F; Moles-Moreau, MP; Narkhede, M; O'Mahony, D; Preston, G; Renaud, L; Ricard, L; Roulin, L; Rusconi, C; Santarsieri, A; Schorb, E; Scott, H; Shah, N; Smith, J; Soussain, C; Strüßmann, T; Tchernonog, E; Vassallo, F; Wilson, MR; Wong Doo, N; Zayac, AS; Øvlisen, AK | 1 |
| Iga, N; Imamura, Y; Ishizaki, M; Kawai, H; Miyauchi, S; Mizuno, D; Nishi, H; Suemori, K; Uno, F; Yoshida, R | 1 |
| Fujioka, T; Hosoya, T; Kubota, K; Kumaki, Y; Mori, M; Nakagawa, T; Oda, G; Ogawa, A; Onishi, I; Uetake, H | 1 |
| Amaki, J; Ando, T; Asano, N; Choi, I; Ejima, Y; Fukuhara, N; Hasegawa, M; Kagami, Y; Kameoka, Y; Katayama, N; Kubota, N; Maeda, T; Maruyama, D; Masaki, Y; Matsuoka, H; Miyazaki, K; Murayama, T; Oguchi, M; Sakai, R; Sekiguchi, N; Shimada, K; Suzuki, R; Taguchi, S; Takizawa, J; Terui, Y; Tsukamoto, H; Tsukamoto, N; Uoshima, N; Utsumi, T; Wada, H; Yamaguchi, M | 1 |
| Cho, D; Cho, J; Jo, H; Kang, ES; Kim, SJ; Kim, WS; Yoon, SE | 1 |
| Fortin Ensign, SP; Gathers, D; Mrugala, MM; Wiedmeier, JE | 1 |
| Chan, JY; Chang, EWY; Chiang, J; Farid, M; Lim, ST; Poon, E; Qiu, TY; Somasundaram, N; Tan, JY; Tan, YH; Tao, M; Yang, VS | 1 |
| Jareemit, N; Kuljarusnont, S; Phianpiset, R; Ruengkhachorn, I; Udompunturak, S | 1 |
| Altınay, S; Kural, A; Özmen, A; Tural, D; Tutar, Y | 1 |
| Fukuhara, N; Furukawa, E; Harigae, H; Ichikawa, S; Ichinohasama, R; Miyazaki, M; Onishi, Y; Onodera, K; Yokoyama, H | 1 |
| Borawska, A; Dabrowska-Iwanicka, A; Domanska-Czyz, K; Druzd-Sitek, A; Konecki, R; Lampka, E; Lapinska, G; Osiadacz, W; Osowiecki, M; Ostrowska, B; Paszkiewicz-Kozik, E; Popławska, L; Romejko-Jarosinska, J; Rymkiewicz, G; Smorczewska, M; Swierkowska, M; Tajer, J; Targonski, L; Walewski, J | 1 |
| Ando, J; Ando, M; Komatsu, N; Ota, Y; Yasuda, H; Yoshida, S | 1 |
| Chen, X; Li, Z; Lin, Z; Liu, L; Xu, B; Zeng, H | 1 |
| Fujita, N; Hashimoto, K; Horikoshi, H; Horiuchi, Y; Itoh, K; Kaneko, M; Kawamura, Y; Kimata, M; Kimura, F; Makino, A; Obuchi, Y; Ono, Y; Sano, A; Tanaka, Y | 1 |
| Al-Atrash, G; Alousi, AM; Bashir, Q; Champlin, RE; Hosing, CM; Kebriaei, P; Khouri, I; Mehta, RS; Nieto, Y; Oran, B; Popat, UR; Qazilbash, MH; Ramdial, J; Rezvani, K; Rondon, G; Saliba, RM; Shpall, EJ; Srour, SA | 1 |
| Bobillo, S; Cheah, CY; Cwynarski, K; El-Galaly, TC; Evens, AM; Eyre, TA; Ferreri, AJM; Lewis, KL; Maurer, MJ; McKay, P; Savage, KJ; Villa, D; Wilson, MR | 1 |
| Kumagai, J; Mochimatsu, Y; Ohgaki, F; Paku, S; Shuto, T; Takemoto, Y; Tatezuki, J | 1 |
| Cao, A; Chen, H; Chen, L; Du, P; Geng, D; Liu, X; Shen, L; Wu, X | 1 |
| Bielack, SS; Blattmann, C; Borkhardt, A; Csóka, M; Hassenpflug, W; Hecker-Nolting, S; Kabíčková, E; Kager, L; Kessler, T; Kevric, M; Kratz, C; Kühne, T; Lehrnbecher, T; Mayer-Steinacker, R; Mettmann, V; Metzler, M; Reichardt, P; Rossig, C; Sorg, B; von Luettichau, I; Windhager, R | 1 |
| Alam, A; Chhabra, NK; Kaushal, D; Lahoria, U; Nahar, U; Singh, S | 1 |
| Gomes, CMF; Martins-Neves, SR; Sampaio-Ribeiro, G | 1 |
| Liu, B; Shi, X; Wang, Z; Xie, X; Xu, D; Zhang, N | 1 |
| Cheah, CY; Lewis, KL | 1 |
| Alvarado, Y; Ferrajoli, A; Garcia-Manero, G; Garris, R; Huang, X; Jabbour, E; Jain, N; Kadia, TM; Kantarjian, H; Konopleva, M; Macaron, W; Patel, KP; Ravandi, F; Short, NJ; Thompson, PA; Yilmaz, M | 1 |
| Curry, LD; Iragavarapu, C; Keller, P; Krem, MM; Li, N; Monohan, GP; Munker, R; Nozad, S; Pryor, P; Yan, D | 1 |
| Bobillo, S; Cwynarski, K; Ferreri, AJM; Khwaja, J | 1 |
| Bobillo, S; Cwynarski, K; Wilson, MR | 2 |
| Cushen, BF; Hancock, BW; Hills, A; Kandiah, K; Palmer, JE; Parker, VL; Singh, K; Tidy, JA; Winter, MC | 1 |
| Cheng, CL; Fang, WQ; Hou, HA; Lin, CP; Ma, WL; Tien, HF; Tsai, CH; Yeh, PT | 1 |
| Albright, BB; Davidson, BA; Ellett, T; Goins, EC; Havrilesky, LJ; Kaplan, SJ; Knochenhauer, HE; Monuszko, KA; Moss, HA; Previs, RA | 1 |
| Berkowitz, RS; Braga, A; Elias, KM; Freitas, F; Fülöp, V; Horowitz, NS; Jareemit, N; Maestá, I; Paiva, G; Ramírez, LAC; Therasakvichya, S | 1 |
| Cho, SG; Choi, BO; Jeon, YW; Kim, TY; Min, GJ; O, JH; Park, G; Park, YH | 1 |
| Bachy, E; Cartron, G; Chaubard, S; Chauchet, A; Clavert, A; Couronné, L; Damaj, G; Fornecker, LM; Gaulard, P; Ghesquières, H; Gressin, R; Hermine, O; Jaccard, A; Lavergne, D; Le Gouill, S; Lemonnier, F; Marouf, A; Michot, JM; Obéric, L; Rossignol, J; Salles, G; Sibon, D; Tournilhac, O; Vargaftig, J; Waultier-Rascalou, A | 1 |
| Assouly, P; Benichou, J; Bernard, P; Chosidow, O; de Viragh, PA; Del Marmol, V; Delaporte, E; Donnadieu, N; Dupuy, A; Grimalt, R; Houivet, E; Joly, P; Lafon, A; Machet, L; Reygagne, P; Richard, MA; Tosti, A | 1 |
| Elsea, D; Lilley, C; Lisano, J; Liu, J; Savage, KJ; Yu, KS | 1 |
| Chang, Q; Chen, X; Gu, J; Huang, X; Jiang, R; Jiang, T; Liu, S; Wang, L; Wang, Z; Xu, G; Zhang, P | 1 |
| Ando, K; Ichinose, K; Imaizumi, Y; Itonaga, H; Kato, T; Miyazaki, Y; Miyoshi, H; Ohshima, K; Sato, S; Sawayama, Y | 1 |
| Bennett, R; Berkahn, L; Christophers, M; Coomarasamy, C; Issa, S; Jackson, S; Ruskova, A; Theakston, E; Wong, S | 1 |
| Liu, R; Qin, Y; Ren, C; Wu, D; Zhang, W; Zhang, X | 1 |
| Cwynarski, K; Khwaja, J | 1 |
| Al Malki, MM; Alousi, AM; Applegate, K; Bhatt, AS; Bolaños-Meade, J; Clark, W; DiFronzo, NL; Efebera, YA; El Jurdi, N; Elmariah, H; Gooptu, M; Hall, AC; Hamadani, M; Holtan, SG; Horowitz, MM; Jamy, OH; Jones, RJ; Kean, LS; Larkin, KT; Leifer, E; Loren, AW; Martens, MJ; Perales, MA; Reshef, R; Rezvani, AR; Runaas, L; Shaffer, BC; Solh, M; Wu, J; Yao, JM | 1 |
| DeAngelis, LM; Grommes, C; Nandakumar, S; Omuro, AMP; Schaff, LR; Therkelsen, KE | 1 |
| Brunstein, C; Copelan, EA; Corrigan, D; Dean, RM; Gerds, AT; Hamilton, BK; Hanna, R; Jagadeesh, D; Kalaycio, M; Li, H; Lucas, T; Majhail, NS; Rotz, SJ; Rybicki, LA; Sauter, CS; Sobecks, R | 1 |
| Abdel-Fattah, RM; El Gammal, MM; Elhaddad, AM; Maher, MA; Mahmoud, HK; Mansour, OM; Samra, MA; Shouman, MT | 1 |
| Miyazaki, K | 1 |
| Akhtari, M; Brothers, J; Cao, H; Hino, C; Lacy, C; Mirshahidi, H; Park, K | 1 |
| Asakura, S; Tanaka, T; Ueda, Y; Yano, T | 1 |
| Bishton, MJ; Cheah, CY; Cwynarski, K; El-Galaly, TC; Eyre, TA; Fox, CP; Hawkes, EA; Jakobsen, LH; Lewis, KL; Maurer, MJ; Savage, KJ; Smedby, KE; Villa, D | 1 |
| Ahn, MJ; Burtness, B; Cohen, EEW; Dinis, J; Ge, J; Harrington, KJ; Lerman, N; Licitra, L; Lin, J; Mach, N; Machiels, JP; Mehra, R; Soria, A; Soulières, D; Swaby, RF; Tourneau, CL | 1 |
| Abbi, B; Ayesha, B; Fineberg, S; Gupta, A; Kumthekar, A; Lanjewar, S; Sanghavi, N; Xie, X | 1 |
| Clement, PM; Cohen, EEW; Cupissol, D; de Souza Viana, L; Fayette, J; Gauler, T; Geng, Y; Geoffrois, L; Guigay, J; Haddad, R; Keilholz, U; Kornek, G; Licitra, L; Machiels, JP; Melichar, B; Rauch, D; Ribaldo Nicolau, U; Rolland, F; Tahara, M; Vermorken, J; Zanetta-Devauges, S; Zografos, E | 1 |
| Ahn, MJ; Arora, RS; Bello, M; Chan, A; Cohen, EEW; Dechaphunkul, A; Geng, Y; Guo, Y; He, X; Kamble, K; Kandil, A; Kang, JH; Kim, SB; Kumar, V; Li, P; Li, W; Tang, PZ; Wang, CH; Zhang, Q; Zografos, E | 1 |
| Abrams, J; Albain, KS; Badve, SS; Berenberg, JL; Brufsky, AM; Dees, EC; Desbiens, C; Ellis, MJ; Geyer, CE; Goetz, MP; Goggins, TF; Gomez, HL; Gray, RJ; Hayes, DF; Kaklamani, VG; Keane, MM; Lively, T; Mahalcioiu, C; Makower, DF; Mayer, IA; Olson, JA; Paik, S; Reddy, PS; Saphner, TJ; Sledge, GW; Sparano, JA; Toppmeyer, DL; Wagner, LI; Wood, WC | 1 |
| Bhojwani, D; Carroll, WL; E, S; Evans, WE; Goodings, C; Li, C; Seibel, NL; Xu, H; Yang, JJ; Yang, W; Zhang, H; Zhao, X | 1 |
| Agrawal, RK; Ahmed, I; Bishop, J; Bowden, SJ; Brookes, CL; Brunt, AM; Canney, P; Churn, M; Dunn, J; Fernando, IN; Goodman, A; Grieve, R; Herring, K; Latief, TN; Marshall, A; Poole, CJ; Rea, DW; Ritchie, D; Spooner, D; Stevens, A | 1 |
| Chong, G; Churilov, L; Garwood, MJ; Hawkes, EA | 1 |
| Chen, H; Liu, Z; Xu, J; Yang, J; Yang, Y | 1 |
| Beerepoot, LV; Fiets, WE; Ham, JC; Husson, O; Jeurissen, FJF; Jonker, MA; Slingerland, M; van der Graaf, WTA; van Herpen, CML; van Meerten, E | 1 |
| Ahn, MJ; Auclair, V; Berrocal, A; Bertolini, F; Castro, G; Cheung, WY; Chirovsky, D; Grünwald, V; Guillaume, X; Harrington, K; Joo, S; Kuyas, H; Shah, R; Sjoquist, K; Yang, MH | 1 |
| Beham-Schmid, C; Deutsch, A; Greinix, H; Hatzl, S; Neumeister, P; Pichler, M; Posch, F; Prochazka, KT; Stöger, H | 1 |
| Abboud, MR; Chahrour, M; El-Khoury, H; El-Solh, H; Ghanem, KM; Hamideh, D; Muwakkit, SA; Saab, R; Saifi, O; Tamim, H; Tarek, N | 1 |
| Jain, D; Panda, S; Rajeshwari, M; Sakthivel, P; Singh, CA; Yogal, R | 1 |
| Abrahamsson, J; Grell, K; Grosjean, M; Gupta, R; Hjalgrim, LL; Jiang, C; Jónsson, ÓG; Kanerva, J; Lund, B; Moriyama, T; Nersting, J; Nielsen, RL; Nielsen, SN; Overgaard, U; Pruunsild, K; Quist-Paulsen, P; Schmiegelow, K; Tulstrup, M; Vaitkeviciene, G; Wolthers, BO; Yang, JJ; Zhang, H | 1 |
| Bago-Horvath, Z; Balic, M; Filipits, M; Gnant, M; Greil, R; Hulla, W; Kwasny, W; Lax, SF; Rudas, M; Singer, CF | 1 |
| Liu, L; Tan, L; Xie, Y; Yang, J | 1 |
| Lau, A; Li, KY; Su, YX; Yang, WF | 1 |
| Ahearne, M; Cheung, CK; Creasey, T; Cwynarski, K; Elliot, J; Eyre, TA; Fox, CP; Khwaja, J; Linton, K; Martinez-Calle, N; McKay, P; Miall, F; Mula Kh, A; Parsons, KE; Preston, G; Schofield, J; Shah, N; Smith, J; Timmins, MA; Wilson, MR | 1 |
| Bao, Q; Cheng, J; Han, J; Hu, Y; Liu, X; Song, R; Wang, W; Wang, Z; Wu, S; Yao, Y; Yu, L; Yu, W; Yu, X; Yu, Y; Zhang, G; Zhang, W; Zhao, M | 1 |
| Kim, M; Kim, RY; Park, WK; Park, YG; Park, YH | 1 |
| Berkowitz, RS; Elias, KM; Goldstein, DP; Horowitz, NS; Jareemit, N | 1 |
| Cacciavillano, W; Fiscina, S; Fortunati, D; Innocenti, S; Kaplan, J; López Martí, J; Ponzone, A; Rose, A; Zubizarreta, P | 1 |
| Asano, N; Igarashi, T; Izutsu, K; Katayama, N; Kato, K; Kinoshita, T; Miyawaki, K; Miyazaki, K; Nishikawa, M; Nishikori, M; Nishimura, Y; Ohata, K; Ohshima, K; Okamoto, M; Sakai, R; Sunami, K; Suzumiya, J; Takahashi, N; Tamaru, S; Yamada, T; Yamaguchi, M; Yamamoto, G; Yano, H; Yoshida, I | 1 |
| Andrews, RM; Arora, AK; Cohen, VML; Hay, G; Mohammad, M; Plowman, PN; Sagoo, MS | 1 |
| Avivi, I; Blumenthal, DT; Bokstein, F; Gibstein, L; Perry, C; Ram, R; Sarid, N; Weiss-Meilik, A | 1 |
| Imaduddin, M; Kar, M; Muduly, DK; Sultania, M; Vigneshwaran, B | 1 |
| Grommes, C; Holdhoff, M; Kaley, TJ; Mrugala, MM; Nayak, L; Perez-Heydrich, C; Swinnen, LJ | 1 |
| Fujii, T; Harigai, M; Kaneko, Y; Kuramoto, N; Nakano, K; Saito, K; Saito, R; Saito, S; Sasaki, S; Sugimoto, N; Suzuki, Y; Takada, H; Tanaka, M; Tanaka, Y | 1 |
| Blackwood, L; Harper, A; Smallwood, K | 1 |
| Akiyama, F; Inaji, H; Kurosumi, M; Masuda, N; Ohashi, Y; Ohno, S; Ohsumi, S; Saji, S; Sato, N; Shimomura, A; Takao, S; Tokuda, Y; Tsuda, H; Watanabe, T | 1 |
| Grommes, C | 1 |
| Fujii, T; Harigai, M; Ito, H; Kaneko, Y; Kuramoto, N; Nakano, K; Saito, K; Saito, R; Saito, S; Sasaki, S; Sugimoto, N; Suzuki, Y; Takada, H; Tanaka, M | 1 |
| Leach, M; McKay, P; Oun, H; Wilson, M | 1 |
| Aoyanagi, N; Endo, D; Kumazawa, K; Nagai, T; Nomura, M; Ono, H; Shimizu, A; Sumiya, R | 1 |
| Ji, P; Wu, Y; Yan, X; Yang, L; Zhang, Z; Zhao, J; Zhou, W | 1 |
| Cohen, KJ; Naung, H | 1 |
| El Darsa, H; Ghosh, S; Owen, C; Peters, A; Puckrin, R; Stewart, D | 1 |
| Jamilloux, Y; Kerever, S; Kodjikian, L; Mathis, T; Sejournet, L; Seve, P | 1 |
| Chae, EJ; Chae, H; Cho, H; Huh, J; Jeong, H; Kim, H; Kim, KW; Kim, S; Lee, JB; Lee, K; Lee, SW; Park, CS; Ryu, JS; Suh, C; Yoon, DH | 1 |
| Alva, A; Bandini, M; Curran, C; Diamantopoulos, LN; Gallina, A; Grivas, P; Grunewald, CM; Gupta, S; Jain, RK; Lee, JL; McGregor, BA; Mossanen, M; Necchi, A; Niegisch, G; Olson, KM; Pond, GR; Ravi, P; Singh, P; Skelton, WP; Sonpavde, GP; Su, C; Tward, JD | 1 |
| Bertram, S; Dührsen, U; Ganser, A; Hüttmann, A; Ibach, S; Kroschinsky, F; Tometten, M | 1 |
| Xiang, RM; Yan, JP | 1 |
| Cwynarski, K; Eyre, TA; Fox, CP; Martinez-Calle, N; McKay, P; Wilson, MR | 1 |
| Furukawa, M; Kachi, H; Kawaratani, H; Matsuura, K; Mitoro, A; Osaki, Y; Ozutsumi, T; Sawada, Y; Takagi, H; Tsuji, Y; Yamao, J; Yoshiji, H | 1 |
| Chen, Y; Chng, WJ; de Mel, S; Goh, YT; Grigoropoulos, NF; Lee, YS; Lim, ST; Liu, X; Nagarajan, C; Ng, LCK; Ong, SY; Phipps, C; Tan, MSY; Tan, YC; Yong, KY | 1 |
| Chen, CS; Cheng, CL; Chiu, KY; Ho, HC; Hung, SC; Li, JR; Ou, YC; Wang, SS; Yang, CK | 1 |
| Coupland, S; Gibb, A; Irion, L; Jones, N | 1 |
| Burtness, B; Clement, PM; Cohen, EEW; Cong, XJ; Del Campo, JM; Dupuis, N; Ehrnrooth, E; Fayette, J; Gauler, T; Geoffrois, L; Gibson, N; Grau, JJ; Guigay, J; Haddad, RI; Krämer, N; Licitra, LF; Machiels, JH; Mailliez, A; Merlano, MC; Solca, F; Tahara, M; Vermorken, JB | 1 |
| Katai, H; Miyakita, Y; Muragaki, Y; Narita, Y; Ohno, M; Takahashi, M | 1 |
| Savage, KJ | 1 |
| Anca, AF; Bacalbasa, N; Balescu, I; Brasoveanu, V | 1 |
| Brichova, M; Heissigerova, J; Karolova, J; Klimova, A; Mrazova, K; Pytlik, R; Rihova, E; Spicka, I; Svozilkova, P | 1 |
| Bekkenk, MW; de Haas, ERM; Horvath, B; Melchers, RC; Quint, KD; Sanders, CJG; van Rossum, MM; Veraart, JCJM; Vermeer, MH; Willemze, R | 1 |
| Fröhling, S; Glimm, H; Hurtz, HJ; Hutter, B; Jordan, K; Klink, B; Müller, LP; Rüssel, J; Stenzinger, A; Stögbauer, F; Terziev, D; Weber, T; Wickenhauser, C | 1 |
| Fanale, M; Fayad, LE; Feng, L; Ford, P; Fowler, N; Goy, A; Hagemeister, F; Hartig, K; Kantarjian, HM; Kwak, LW; McLaughlin, P; Medeiros, LJ; Naig, A; Neelapu, S; Oki, Y; Orlowski, R; Pro, B; Rodriguez, MA; Romaguera, JE; Samaniego, F; Smith, J; Valentinetti, M; Wang, M; Younes, A | 1 |
| Hagihara, M; Hua, J; Ide, S; Inoue, M; Mese, T; Ohara, S | 1 |
| Kaur, J; Paul, BS; Singh, G | 1 |
| Buckingham, W; Ejlertsen, B; Eriksen, JO; Ferree, S; Hood, T; Jensen, MB; Lænkholm, AV; Nielsen, TO; Ram, N; Wehn, P | 1 |
| Ospina-García, N; Pascual, B; Preti, HA; Román, GC; Schwartz, MR | 1 |
| Kansara, R | 1 |
| Akizawa, Y; Kanno, T; Matsui, H; Shozu, M; Usui, H | 1 |
| Driscoll, C; Elmore, S; Fehr, AE; Gilbert, UD; Hategekimana, V; Larrabee, K; Lehmann, L; May, L; Moore, M; Mpunga, T; Muhayimana, C; Rubagumya, F; Shulman, LN; Shyirambere, C; Uwizeye, FR; Xu, MJ | 1 |
| Chen, B; Chen, K; Ding, T; Fan, N; Kang, H; Lai, J; Lin, Z; Ma, J; Ma, Y; Wang, Q; Xu, X; Yuan, Y; Zeng, Q; Zhuang, L | 1 |
| Eder-Czembirek, C; Kornek, G; Rechinger, S; Seemann, R; Selzer, E | 1 |
| Ahn, MJ; Burtness, B; Cheng, J; Cohen, EEW; Dinis, J; Harrington, KJ; Le Tourneau, C; Licitra, L; Mach, N; Machiels, JP; Mehra, R; Soria, A; Soulières, D; Swaby, RF; Zhang, P | 1 |
| Hoang-Xuan, K; Houillier, C; Royer-Perron, L | 1 |
| Berger, MF; Campos, C; Codega, P; Daras, M; DeAngelis, LM; Grommes, C; Hatzoglou, V; Kaley, TJ; Lin, A; Manne, M; Mellinghoff, IK; Nolan, CP; Panageas, KS; Pentsova, EI; Piotrowski, AF; Reiner, AS; Stone, J; Tang, SS; Thomas, AA; Viale, A; Wolfe, J | 1 |
| Bubalo, J; Dang, T; Davis, LE; Fu, R; Gundle, KR; Paxton, J; Ryan, CW; Stork, L; Wippel, B | 1 |
| Coulter, J; Frijstein, MM; Golfier, F; Lok, CAR; Massuger, LFAG; Seckl, MJ; Ten Kate-Booij, MJ; van Trommel, NE | 1 |
| Alderuccio, JP; Davis, JL; de la Fuente, MI; Echegaray, JJ; Harbour, JW; Lossos, IS; Markoe, A; Omuro, A; Reis, IM | 1 |
| Assi, T; Bakouny, Z; El Karak, F; El Rassy, E; Ghosn, M; Pavlidis, N | 1 |
| Al Sibai, K; Atassi, B; Diab, M; Elayoubi, JA; Kim, S; Küçük, Ö; Nagasaka, M; Sukari, A | 1 |
| Kamimura, R; Kanemoto, Y; Kashima, S; Koyama, T; Miyamoto, K; Miyanaga, H; Oishi, T; Sakahira, H; Soyama, H; Takahashi, H; Watanabe, A | 1 |
| Cocks, K; Contente, M; DeRosa, M; Shaw, JW; Simpson, S; Taylor, FC | 1 |
| Singh, V; Zhao, CW | 1 |
| Allan, JN; Van Besien, K | 1 |
| Galazka, P; Marjanska, A; Marjanski, M; Styczynski, J; Wysocki, M | 1 |
| Kawano, Y; Kodama, Y; Kusuda, M; Mitsunobu, T; Nakagawa, S; Nishikawa, T; Okamoto, Y | 1 |
| Castellino, A; Chiappella, A; Nicolosi, M; Novo, M; Santambrogio, E; Vassallo, F; Vitolo, U | 1 |
| Joshi, A; Krishna, V; Noronha, V; Patil, V; Prabhash, K | 1 |
| Abikhair, M; Arumugaswamy, A; Bajel, A; Chan, KL; Cher, L; Gregory, G; Grigg, A; Leung, T; Opat, S; Ritchie, D; Tam, C | 1 |
| Han, W; Im, SA; Moon, HG; Moon, WK; Noh, DY; Park, IA; Park, SJ; Shin, HC | 1 |
| Asadi, N; Bini, A; Caroli, G; Dell'Amore, A; Dolci, G; Stella, F | 1 |
| Charoenkwan, P; Choeyprasert, W; Natesirinilkul, R; Sittipreechacharn, S | 1 |
| Burger, JA; Challagundla, P; Champlin, RE; Cortes, JE; Estrov, Z; Faderl, S; Ferrajoli, A; Garris, R; Huang, X; Jorgensen, JL; Kantarjian, HM; Kebriaei, P; Luthra, R; O'Brien, S; Ravandi, F; Thomas, DA; Wang, SA; Wen, S | 1 |
| Cai, Z; He, J; Huang, H; Lai, X; Li, L; Lin, M; Luo, Y; Shi, J; Tan, Y; Xie, W; Ye, X; Zhang, J; Zheng, W; Zhu, X | 1 |
| Choi, MK; Hoon Lim, D; Kang, ES; Kim, DW; Kim, SJ; Kim, WS; Ko, YH; Park, JH; Pyo, DH; Seok, H | 1 |
| Benigno, BB | 1 |
| Ando, H; Ichikawa, M; Kishida, Y; Kuromi, Y; Maeda, T; Matsumoto, Y; Matsuyama, J; Oda, K; Oikawa, T; Saito, K; Sakuma, J; Sato, T; Yamada, M | 1 |
| Cai, HQ; Li, YC; Wang, ZG; Xu, YL; Yang, J | 1 |
| Kalkanis, SN; Kim, EY; Kim, JK; Mikkelsen, T; Rock, J; Rosenblum, M; Ryu, S; Yechieli, R | 1 |
| Bain, E; Birhiray, RE; Reeves, DJ | 1 |
| Christensen, RH; Clemmensen, KK; Harila-Saari, A; Heyman, M; Jonsson, OG; Rosthøj, S; Schmiegelow, K; Shabaneh, DN; Wesenberg, F | 1 |
| Abe, E; Harada, H; Ishibashi, N; Koizumi, M; Kubota, S; Matsushita, H; Miyawaki, D; Nomiya, T; Ogo, E; Ohmori, Y; Onishi, H; Onodera, S; Shibamoto, Y; Sugie, C; Sumi, M; Suzuki, K; Takahashi, I; Takemoto, M; Tamaki, Y; Tokumaru, S | 1 |
| Chang, WJ; Kim, SJ; Kim, WS; Ko, YH | 1 |
| Domínguez, ME; Fasce, HM; Iturbe, J; Langui, M; Leone, BA; Leone, J; Leone, JP; Machiavelli, MR; Ortiz, E; Pérez, JE; Romero Acuña, L; Romero, AO; Vallejo, CT; Zwenger, AO | 1 |
| Abrahamsson, J; Appell, ML; Bechensteen, AG; Bergan, S; Harila-Saari, A; Heyman, M; Jonsson, OG; Levinsen, M; Maxild, JB; Nersting, J; Niemi, M; Rosthøj, S; Rotevatn, EØ; Schmiegelow, K; Söderhäll, S | 1 |
| Ahn, HS; Kang, HJ; Kim, H; Kim, HS; Lee, JW; Park, JD; Park, KD; Park, SH; Shin, HY; Wang, KC | 1 |
| Deangelis, LM; Omuro, A; Pentsova, E | 1 |
| Chamberlain, MC | 2 |
| Chang, HK; Chen, SC; Hsueh, S; Lin, YC; Lo, YF; Wu, CE | 1 |
| Handa, H; Hanyuda, N; Hayashi, T; Hoshino, T; Kamio, T; Koya, H; Mukai, R; Murakami, H; Nojima, Y; Saitoh, T; Toyama, K; Tsukamoto, N; Yokohama, A | 1 |
| Bickels, J; Flusser, G; Gortzak, Y; Issakov, J; Kolander, Y; Kushnir, I; Merimsky, O | 1 |
| Fujimaki, K; Hagihara, M; Hashimoto, C; Ishibashi, D; Ishigatsubo, Y; Ishii, Y; Ishiyama, Y; Kishimoto, K; Koyama, S; Motomura, S; Numata, A; Ohshima, R; Sakai, R; Tachibana, T; Taguchi, J; Takahashi, H; Takasaki, H; Takemura, S; Tomita, N; Watanabe, R | 1 |
| Alsner, J; Kyndi, M; Myhre, S; Nord, S; Overgaard, J; Sørensen, FB; Sørlie, T; Tramm, T | 1 |
| Cohen, EE; Haddad, RI; Licitra, LF; Machiels, JP; Tahara, M | 1 |
| Namekawa, M | 1 |
| Chen, YJ; Gao, P; He, XL; Li, JX; Niu, CH; Wang, C; Wang, Y; Zhang, HN | 1 |
| Marwaha, RK; Oberoi, S; Trehan, A | 1 |
| Al-Rasheedy, I; Nichols, AC; Palma, DA; Stitt, L; Winquist, E | 1 |
| Aricò, M; Barisone, E; Basso, G; Cazzaniga, G; Conter, V; Fabbri, G; Fagioli, F; Giraldi, E; Paganin, M; Polato, K; Valsecchi, MG | 1 |
| Chang, WH; Chen, PC; Chen, WM; Chiou, HJ; Hsu, HE; Hung, GY; Wu, HT; Yen, CC; Yen, HJ | 1 |
| Asklid, A; Fornander, T; Söderlund Leifler, K; Stenmark Askmalm, M | 1 |
| Aurilio, G; Bagnardi, V; Curigliano, G; Goldhirsch, A; Graffeo, R; Iera, M; Locatelli, M; Martella, S; Munzone, E; Nolè, F; Petit, JY; Rey, P; Rotmensz, N | 1 |
| Xu, M; Xu, S; Yu, X | 1 |
| Wang, W; Wang, Z; Xiao, X | 1 |
| Cote, RJ; Godoy, G; Groshen, S; Kryvenko, ON; Lerner, SP; Mata, DA; Skinner, DG; Stadler, WM; Stein, JP; von Rundstedt, FC | 1 |
| Calaminus, G; Göbel, U; Haas, R; Harms, D; Leuschner, I; Schneider, DT; Schönberger, S; Teske, C | 1 |
| Chung, SH; Kim, JD; Yoon, GW | 1 |
| Barni, S; Botti, G; Colantuoni, G; D'Aiuto, M; Daniele, B; Daniele, G; De Laurentiis, M; De Maio, E; de Matteis, A; De Placido, S; Di Maio, M; Di Rella, F; Forestieri, V; Gallo, C; Gori, S; Gravina, A; Iodice, G; Labonia, V; Landi, G; Lauria, R; Montanino, A; Morabito, A; Nuzzo, F; Pacilio, C; Perrone, F; Piccirillo, MC; Riccardi, F; Rossi, E; Signoriello, S; Tinessa, V | 1 |
| Ando, K; Kikuchi, T; Kikuti, YY; Kojima, M; Moriuchi, M; Murayama, H; Nakamura, N; Ogawa, Y; Tokunaka, M; Tsuboi, K; Yabe, M | 1 |
| Aviles, A; Fernandez-Diez, J; Nambo, MJ; Neri, N; Silva, L | 1 |
| Chan, KK; Chu, MM; Ma, Y; Ngan, HY; Tse, KY | 1 |
| Beneragama, D; Herath, S; Kulatunga, A; Liyanage, I; Navinan, MR; Shivanthan, C; Yudhishdran, J | 1 |
| Ambrogi, F; Ardoino, I; Biganzoli, E; Boracchi, P; Coradini, D; Daidone, MG; Demicheli, R; Moliterni, A | 1 |
| Aricò, M; Basso, G; Buffardi, S; Carraro, E; Casale, F; Cesaro, S; Conter, V; d'Amore, ES; D'Angelo, P; Garaventa, A; Lo Nigro, L; Lombardi, A; Moleti, ML; Mura, R; Mussolin, L; Piglione, M; Pillon, M; Porta, F; Rosolen, A; Sala, A; Santoro, N | 1 |
| Ghatak, A; Gupta, S; Husain, N; Jamal, N; Khan, H; Kushwaha, VS; Negi, MP | 1 |
| Bhojwani, D; Bowman, WP; Campana, D; Cheng, C; Coustan-Smith, E; Downing, JR; Evans, WE; Gruber, TA; Inaba, H; Jeha, S; Leung, WH; Pei, D; Pui, CH; Relling, MV; Ribeiro, RC; Rubnitz, JE; Sandlund, JT | 1 |
| Esiashvili, N; Flowers, CR; Jegadeesh, N; Khan, MK; Liu, Y; Okwan-Duodu, D; Rajpara, R; Shi, Z | 1 |
| Argiris, A | 1 |
| Caponigro, F; Clement, PM; Cohen, EE; Cong, XJ; Cupissol, D; de Castro, G; de Souza Viana, L; Del Campo, JM; Ehrnrooth, E; Fayette, J; Gauler, T; Grau, JJ; Guigay, J; Haddad, RI; Keilholz, U; Licitra, LF; Machiels, JP; Tahara, M; Vermorken, JB | 2 |
| Bartlett, JM; Caldas, C; Cameron, DA; Cardoso, F; Desmedt, C; Di Leo, A; Dunn, JA; Earl, HM; Ejlertsen, B; Jensen, MB; Larsimont, DP; McConkey, CC; Munro, AF; O'Malley, FP; Poole, CJ; Pritchard, KI; Rea, DW; Shepherd, LE; Twelves, CJ | 1 |
| Higuchi, Y; Hirono, S; Iwadate, Y; Matsutani, T; Nagano, O; Saeki, N; Serizawa, T | 1 |
| Arellano-Galindo, J; Bekker-Méndez, VC; Dueñas-González, MT; García-Jiménez, X; Jaimes-Reyes, EZ; Jiménez-Hernández, E; Marín-Palomares, T; Martínez Villegas, O; Mejía-Aranguré, JM; Ortíz-Fernández, A; Ortíz-Torres, MG; Sánchez-Jara, B; Tiznado-García, HM | 1 |
| Killock, D | 1 |
| Bourhis, J; Economopoulou, P; Psyrri, A | 1 |
| Moreau, P; Touzeau, C | 1 |
| Chang, J; Ding, H; Hao, SG; Hu, D; Li, ZC; Liu, LG; Ma, LY; Ma, YJ; Tao, R; Yan, Y; Zhang, WH | 1 |
| Cooper, LJ; Gopalakrishnan, V; Hou, P; Kerr, M; Ketonen, L; Khatua, S; Kundu, U; Lee, DA; Moore, BD; Rytting, M; Sandberg, DI; Sitton, C; Thall, PF; Yang, G; Zaky, W | 1 |
| Aftimos, P; Ameye, L; Beauduin, M; Bejarano Hernández, S; Cornez, N; de Azambuja, E; Delhaye, F; Diaz, M; Focan, C; Lemort, M; Paesmans, M; Piccart-Gebhart, M; Shih-Li, C; Suter, T; Vandenbossche, S; Vindevoghel, A | 1 |
| Hashimoto, K; Kizaki, S; Matsui, H; Shozu, M; Usui, H | 1 |
| Kenter, G; Lok, C; Massuger, L; Sweep, F; Ten Kate-Booij, M; van Trommel, N; Vree, M | 1 |
| Cheah, CY; Chihara, D; Dabaja, BS; Fowler, NH; Gombos, DS; Milgrom, S; Pinnix, CC | 1 |
| Alyea, EP; Blum, W; Carter, S; Champlin, RE; Chen, YB; Devine, SM; Giralt, S; Hars, V; Horowitz, MM; Hsu, JW; Larson, RA; Linker, C; Mulkey, F; Owzar, K; Shea, TC; Sibley, AB; Slack, J; Soiffer, RJ; Stone, RM; Vij, R | 1 |
| Hagiwara, S; Ito, A; Madokoro, Y; Matsukawa, N; Mizuno, M; Ookita, K | 1 |
| Chang, Y; Cui, Y; Fu, X; Li, L; Li, W; Li, X; Ma, W; Nan, F; Su, L; Sun, Z; Wang, J; Wang, X; Wu, J; Xue, H; Zhang, L; Zhang, M; Zhang, X | 1 |
| Burger, E; Ferreri, AJ; Finke, J; Fricker, H; Fritsch, K; Grishina, O; Ihorst, G; Illerhaus, G; Kasenda, B; Mikesch, K; Schorb, E; Valk, E; Zucca, E | 1 |
| Boursi, B; Brensinger, CM; Chen, L; Clark, AS; Curtis, JR; Lewis, JD; Mamtani, R; Osterman, MT; Scott, FI; Xie, F; Yun, H | 1 |
| Specenier, P; Vermorken, J | 1 |
| Choi, YJ; Kang, CH; Kim, KW; Park, JH; Park, KH; Ro, KH; Song, SH | 1 |
| Anderson, H; Holmberg, E; Holmberg, L; Karlsson, P; Killander, F; Lundstedt, D; Malmström, P; Mattsson, J | 1 |
| Boros, A; Hoang-Xuan, K; Mazeron, R; Michot, JM | 1 |
| Han, C; Hou, S; Liu, J; Liu, X; Wang, B; Zhang, Z | 1 |
| Alapetite, C; Beuriat, PA; Faure-Conter, C; Frappaz, D; Grill, J; Szathmari, A; Vasiljevic, A | 1 |
| Belhabri, A; Biron, P; Blay, JY; Chassagne-Clément, C; Ducray, F; Faurie, P; Ferlay, C; Fossard, G; Ghesquières, H; Jouanneau, E; Nicolas-Virelizier, E; Rey, P; Sebban, C; Sunyack, MP; Thiesse, P | 1 |
| Chia, WK; Julia, MI; Leong, CF; Salwati, S; Tang, YL; Wong, CL; Yap, EC | 1 |
| Abdalla, B; Alfaar, AS; Awad, M; Rashed, WM; Taha, H; Zekri, W | 1 |
| Aljurf, M; Bacher, U; Beitinjaneh, A; Chen, YB; de Lima, M; DeFilipp, Z; Gale, RP; Gupta, V; Kebriaei, P; Kharfan-Dabaja, M; Khoury, HJ; Lazarus, HM; Michelis, FV; Nishihori, T; Olsson, RF; Oran, B; Rashidi, A; Rizzieri, DA; Saber, W; Sandmaier, BM; Tallman, MS; Wang, HL; Weisdorf, D; Zhang, MJ | 1 |
| Arima, K; Soga, N; Sugimura, Y | 1 |
| Chang, PM; Chang, SY; Chen, PM; Chu, PY; Huang, JL; Tai, SK; Teng, HW; Tsai, TL; Wang, YF; Yang, MH | 1 |
| Andersen, PK; Cortese, G; Nielsen, D; Nielsen, G; Ryberg, M; Skovsgaard, T | 1 |
| Hakenberg, OW; Klebingat, HJ; Protzel, C | 1 |
| Arndt, CA; Hawkins, DS; Hoots, WK; Inwards, CY; Kleinerman, ES; Koshkina, NV; Morales-Arias, JA; Munsell, MF; Rodriguez, NI | 1 |
| Cabanillas, F; Fayad, L; Hagemeister, F; Kantarjian, H; Kwak, LW; McLaughlin, P; Rodriguez, MA; Romaguera, J; Wang, M; Zhou, Y | 1 |
| Savage, P; Seckl, M; Short, D | 1 |
| Acerno, S; Biassoni, V; Casanova, M; Cefalo, G; Collini, P; Ferrari, A; Fossati-Bellani, F; Gandola, L; Luksch, R; Mariani, L; Massimino, M; Meazza, C; Modena, P; Pecori, E; Pignoli, E; Podda, M; Poggi, G; Polastri, D; Potepan, P; Ravagnani, F; Simonetti, F; Solero, CN; Spreafico, F; Terenziani, M | 1 |
| Gamal El-Deen, HS | 1 |
| Aurer, I; Labar, B; Mitrović, Z; Mrsić, M; Nemet, D; Nola, M; Radman, I; Santek, F; Sertić, D; Serventi-Seiwerth, R; Stern-Padovan, R | 1 |
| Adelstein, SJ; Artignan, X; Balosso, J; Desruet, MD; Fagret, D; Gauchez, AS; Hoffmann, D; Kassis, AI; Rebischung, C; Stefani, L; Vincent, F; Vuillez, J; Wang, K; Zhang, H | 1 |
| Björgvinsdóttir, H; Bohnstedt, C; Hafsteinsdottir, S; Schmiegelow, K; Taskinen, M; Zeller, B | 1 |
| Gourde, JA; Khan, SP; Rodriguez, V; Sabapathy, C | 1 |
| Baleydier, F; Bertrand, Y; Kebaili, K; Mialou, V; Pages, MP; Pondarre, C; Pracros, JP | 1 |
| Cao, Y; Feng, FZ; Wan, XR; Xiang, Y; Yang, XY | 1 |
| Armour, A; Cohen, EE; Garin, AM; Ghiorghiu, S; Hargreaves, L; Hirsch, FR; Khorprasert, C; Licitra, L; Rischin, D; Soulieres, D; Speake, G; Stewart, JS; Swaisland, A; Van Herpen, CM; Varella-Garcia, M; Vodvarka, P; Vokes, EE | 1 |
| Bianchi, S; Biti, G; Borghesi, S; Cataliotti, L; Fambrini, M; Greto, D; Iannalfi, A; Livi, L; Paiar, F; Saieva, C; Scoccianti, S; Simontacchi, G | 1 |
| Becker, HP; Berry, DA; Burstein, HJ; Cirrincione, CT; Cohen, HJ; Dressler, LG; Gralow, JR; Grenier, D; Hart, RD; Hudis, CA; Kartcheske, PA; Kornblith, AB; Magrinat, G; Mahmood, AA; Mauer, AM; Muss, HB; Norton, L; Parker, BA; Partridge, AH; Perez, EA; Theodoulou, M; Wheeler, JD; Winer, EP; Wolff, AC | 1 |
| Agarwal, R; Fisher, RA; Hancock, B; Lindsay, I; Nagai, Y; Newlands, ES; Savage, PM; Schmid, P; Sebire, NJ; Seckl, MJ; Short, D; Wells, M; Wischnewsky, MB | 1 |
| Heyman, M; Kristinsson, J; Mogensen, UB; Rosthøj, S; Saarinen-Pihkala, U; Schmiegelow, K; Vettenranta, K; Wesenberg, F | 1 |
| Jager, A; Sleijfer, S; Verweij, J | 1 |
| Czumbil, L; Gyánó, G; Iványi, JL; Marton, E; Plander, M; Tóth, C | 1 |
| Glaholm, J; Gupta, N; Hackshaw, A; Hutchison, I; Kadalayil, L; Macdougall, H; Monson, K; Tobias, JS | 1 |
| Yamanaka, R | 1 |
| Alaggio, R; Bisogno, G; Carli, M; Casanova, M; Cecchetto, G; Ferrari, A; Fiore, M; Gronchi, A; Meazza, C; Milano, GM | 1 |
| Cao, WF; Cao, XC; Hao, XS; Ning, LS; Niu, Y; Song, YQ; Zhang, B; Zhao, HM | 1 |
| Horiuchi, C; Ikeda, Y; Ishitoya, J; Kawakami, M; Kawano, T; Komatsu, M; Matsuda, H; Niho, T; Nishimura, G; Sakuma, Y; Shiono, O; Taguchi, T; Takahashi, M; Tsukuda, M; Watanabe, M | 1 |
| Otake, T; Takenoshita, S; Watanabe, K; Yasuda, M | 1 |
| Forestier, E; Gustafsson, G; Heyman, M; Kristinsson, J; Lausen, B; Rosthoej, S; Schmiegelow, K; Schroeder, H; Vettenranta, K; Wesenberg, F | 1 |
| Fukuhara, N; Harigae, H; Ishizawa, K; Kameoka, J; Kohata, K; Ohba-Ohtsuka, R; Ohguchi, H; Ohnishi, Y; Okitsu, Y; Tohmiya, Y; Yamada, MF; Yamamoto, J; Yokoyama, H | 1 |
| Mallmann, P; Nitschmann, S | 1 |
| Buchbinder, D; Casillas, J; Linetsky, M; Steinberg, G | 1 |
| Chung, HC; Hong, S; Jeung, HC; Jung, M; Kim, HS; Moon, YW; Oh, KJ; Rha, SY; Roh, JK; Shin, HJ; Yang, WI | 1 |
| Bansal, D; Kulkarni, KP; Marwaha, RK; Trehan, A | 1 |
| Fujita, Y; Fukushima, T; Hirose, Y; Iwao, H; Kaito, M; Kawanami, T; Kurose, N; Masaki, Y; Miki, M; Nakajima, A; Nakamura, T; Sakai, T; Sawaki, T; Tanaka, M; Umehara, H | 1 |
| Castiglione-Gertsch, M; Chua, BH; Cole, BF; Colleoni, M; Goldhirsch, A; Gruber, G; Karlsson, P; Murray, E; Price, KN; Roncadin, M | 1 |
| Aurer, I; Baars, JW; Borchmann, P; DeJong, D; Diehl, V; Döhner, H; Engert, A; Fischer, T; Glossmann, J; Hansmann, ML; Josting, A; Metzner, B; Müller, H; Niederwieser, D; Raemaekers, J; Schäfer-Eckart, K; Schmitz, N; Smardova, L; Sureda, A | 1 |
| Gill, D; Kennedy, G; Marlton, P; Mollee, P; Morris, K; Weston, H | 1 |
| Feng, FZ; Wan, XR; Xiang, Y; Zhou, Y | 1 |
| Cho, WH; Jeon, DG; Jung, ST; Koh, JS; Kong, CB; Lee, JA; Lee, SY; Shin, DS; Song, WS; Yoo, JY | 1 |
| Fukushima, T; Hanada, R; Hasegawa, D; Ishida, Y; Kikuchi, A; Kiyokawa, N; Koh, K; Manabe, A; Ohara, A; Saito, T; Tsuchida, M | 1 |
| Gong, YP; Luo, S; Yang, L; Yang, YM | 1 |
| Arriagada, R; Bourgier, C; Dunant, A; Heymann, S; Marsiglia, H; Mathieu, MC; Pessoa, EL; Spielmann, M; Uzan, C | 1 |
| Bagot, M; Comoz, F; Dompmartin-Blanchere, A; Ortonne, N; Paoletti, MT | 1 |
| Abrey, LE; DeAngelis, LM; Hedvat, C; Nayak, L; Rosenblum, MK | 1 |
| Cho, J; Cho, WH; Jeon, DG; Kim, DH; Kim, MS; Koh, JS; Kong, CB; Lee, JA; Lee, SY; Lim, JS; Song, WS; Yoo, JY | 1 |
| Bahtiyar, M; Chambers, JT; Chambers, SK; Kohorn, EI; McCaffrey, R; Schwartz, PE | 1 |
| Arai, Y; Boku, N; Denda, T; Fujii, H; Hamaguchi, T; Hyodo, I; Iwase, H; Koizumi, W; Ohtsu, A; Saito, H; Shirao, K; Takiuchi, H; Yoshida, M | 1 |
| Shimada, K | 1 |
| Jiang, X; Lin, G; Liu, D; Peng, J; Peng, R; Qin, T; Shi, Y; Teng, X; Wang, S; Wang, X; Yuan, Z | 1 |
| Benesch, M; Deinlein, F; Faldum, A; Fleischhack, G; Gerber, NU; Kortmann, RD; Krauss, J; Kuehl, J; Pietsch, T; Rutkowski, S; von Bueren, AO; von Hoff, K; Warmuth-Metz, M; Zwiener, I | 1 |
| Batchelor, TT; Egerer, G; Engert, A; Herrlinger, U; Kowoll, A; Lamprecht, M; Linnebank, M; Patrij, K; Pels, H; Reiser, M; Schackert, G; Schlegel, U; Schmidt-Wolf, IG; Vogt-Schaden, M; Wätzel, L | 1 |
| Choquet, S; Elhallani, S; Gonzalez-Aguilar, A; Hoang-Xuan, K; Houillier, C; Idbaih, A; Kaloshi, G; Navarro, S; Omuro, A; Ricard, D; Sierra Del Rio, M; Soussain, C | 1 |
| Bardet, E; Benhamou, E; Bontemps, P; Bourhis, J; Calais, G; Daly-Schveitzer, N; Janot, F; Lapeyre, M; Lesaunier, F; Lusinchi, A; Maingon, P; Tao, Y; Tortochaux, J; Tournay, E; Verrelle, P | 1 |
| Eskelin, S; Kivelä, T; Paloheimo, M | 1 |
| Ayari, S; Chevallier, P; Delaunay, J; Dumas, PY; Eveillard, M; Guillaume, T; Leguay, T; Lippert, E; Mohty, M; Pigneux, A; Robillard, N | 1 |
| Bafaloukos, D; Batistatou, A; Bobos, M; Briasoulis, E; Christodoulou, C; Dafni, U; Dimopoulos, MA; Eleftheraki, AG; Fountzilas, G; Gogas, H; Kalofonos, HP; Karanikiotis, C; Karina, M; Kosmidis, P; Markopoulos, C; Papadimitriou, C; Papakostas, P; Pectasides, D; Samantas, E; Stathopoulos, GP; Timotheadou, E | 1 |
| Imholz, ALT; Laddach, N; Lips, EH; Mulder, L; Oonk, AMM; Rodenhuis, S; Savola, SP; Smits, MM; van Rijn, C; Wesseling, J | 1 |
| Girouard, SD; Massarotti, EM; Penson, RT; Velez, NF; Vleugels, RA | 1 |
| Amant, F; Devi, UK; Han, SN; Leunen, K; Neven, P; Vergote, I | 1 |
| Alsina, M; Anasetti, C; Ayala, E; Betts, BC; Fernandez, HF; Field, T; Janssen, WE; Jim, H; Kharfan-Dabaja, MA; Kim, J; Locke, FL; Nishihori, T; Ochoa, L; Perez, L; Perkins, J; Pidala, J; Tomblyn, M; Veerapathran, A; Xu, M | 1 |
| Domenichelli, V; Federici, S; Mordenti, M; Pelusi, G; Pericoli, R; Straziuso, S | 1 |
| Chan, K; Cheung, MC; Prica, A | 1 |
| Akaza, H; Hinotsu, S; Kawai, K; Kimura, T; Miyanaga, N; Miyazaki, J; Nishiyama, H; Oikawa, T; Onozawa, M; Sakurai, H; Shimazui, T; Takaoka, E | 1 |
| Kaun, S; Kiewe, P; Klasen, H; Korfel, A; Martus, P; Möhle, R; Rauch, M; Röth, A; Roth, P; Thiel, E; Weller, M | 1 |
| Chim, CS; Kim, SJ; Kim, WS; Kwong, YL; Leung, AY; Lim, ST; Tang, T; Tse, E | 1 |
| Abrey, LE; Deangelis, LM; Hatzoglou, V; Karimi, S; Partovi, S; Punia, V | 1 |
| Cai, J; Daneshmand, S; Dorff, T; Dorin, R; Fairey, AS; Lieskovsky, G; Miranda, G; Quinn, D; Schuckman, A; Skinner, EC | 1 |
| Bafaloukos, D; Christodoulou, C; Fountzilas, G; Gogas, H; Kalogeras, KT; Koutras, AK; Kouvatseas, G; Kronenwett, R; Linardou, H; Pectasides, D; Samantas, E; Wirtz, RM; Zagouri, F | 1 |
| Bucher, CM; Passweg, JR | 1 |
| Birnbaum, T; Bochmann, K; Straube, A; von Baumgarten, L | 1 |
| Aldrink, JH; Nicol, K; Teich, S; Wang, W | 1 |
| Buaboonnam, J; Cao, X; Inaba, H; Pauley, JL; Pui, CH; Ribeiro, RC; Rubnitz, JE | 1 |
| Agarwal, N; Bhadani, P; Dhakre, G; Gupta, V; Kariholu, PL; Neogi, S | 1 |
| Startsev, VY | 1 |
| Arnesson, LG; Emdin, SO; Fornander, T; Fredriksson, I; Frisell, J; Holmberg, L; Holmqvist, M; Liljegren, G; Palm-Sjövall, M | 1 |
| Ishigatsubo, Y; Kanamori, H; Kodama, F; Motomura, S; Tomita, N | 1 |
| Achard, JL; Charrier, S; Chollet, P; Cure, H; Dauplat, J; De Latour, M; Feillel, V; Ferriere, JP; Le Bouedec, G; Leduc, B; Van Praagh, I | 1 |
| Ayala, A; Carrasco, H; Eftekhari, F; Jaffe, N; Raymond, K | 1 |
| Abu-Ghazaleh, S; Hartmann, LC; Hatfield, AK; Knost, JA; Levitt, R; Long, HJ; Nair, S; Podratz, KC; Rayson, S; Suman, V | 1 |
| Bauernhofer, T; Fridrik, M; Gnant, M; Haider, K; Hausmaninger, H; Jakesz, R; Kubista, E; Kwasny, W; Menzel, C; Mlineritsch, B; Samonigg, H; Seifert, M; Steger, G; Steindorfer, P; Wette, V | 1 |
| Shimizu, C; Watanabe, T | 1 |
| Jackson, AS; Lightman, S; Pavesio, C; Plowman, PN; Taylor, A | 1 |
| Jereb, B; Macedoni-Luksic, M; Todorovski, L | 1 |
| Bacci, G; Benini, S; Bertoni, F; Briccoli, A; Ferrari, S; Incaprera, M; Manara, MC; Mercuri, M; Picci, P; Reverter-Branchat, G; Scotlandi, K; Serra, M | 1 |
| Benkirane, N; Berraho, A; Charif, CM; Loughzail, K | 1 |
| Awada, A; Caponigro, F; Comella, G; Cupissol, D; Gedouin, D; Gérard, B; Giroux, B; Guardiola, E; Kerger, J; Lopez-Pousa, JJ; Pivot, X; Rolland, F; Schneider, M | 1 |
| Chrétien, Y; Durdux, C; Oudard, S | 1 |
| Holmberg, L; Malmström, PU; Mestad, O; Nilsson, J; Nilsson, S; Rintala, E; Sherif, A | 2 |
| Bertsch, H; Fox, K; Glick, J; Harris, EE; Schultz, D; Solin, LJ | 1 |
| Arellano-Rodrigo, E; Bessell, EM; Graus, F; López-Guillermo, A; Montserrat, E; Nomdedeu, B | 1 |
| Berry, DA; Bothun, S; Cirrincione, CT; Demakos, E; Falkson, G; Henderson, IC; Holland, JF; Norton, L; Robbins, A; Weiss, RB; Woolf, SH | 1 |
| Alvegard, TA; Björk, O; Brosjö, O; Follerås, G; Holmström, T; Jonsson, K; Kivioja, A; Monge, O; Müller, C; Saeter, G; Smeland, S; Stenwig, AE; Wiebe, T; Wiklund, T; Willén, H | 1 |
| Emi, Y; Kakeji, Y; Kimura, Y; Maehara, Y; Sakurai, M; Takahashi, I; Yonemura, Y | 1 |
| Fischer, DH; Mason, JO | 1 |
| Ash, D; Dodwell, D; Ulutin, HC | 1 |
| Bozcuk, HS; Samur, M | 1 |
| Hutchins, L; Khan, MA; Kohli, M; Mehta, P | 1 |
| Fukushima, T; Katayama, Y; Komine, C; Watanabe, T; Yokoyama, T; Yoshino, A | 1 |
| Arencibia García, J; Sotolongo Vergo, I; Suárez Cabrera, RE | 1 |
| Bacchini, P; Bacci, G; Bertoni, F; Briccoli, A; Donati, D; Ferrari, S; Forni, C; Galletti, S; Giacomini, S; Longhi, A; Manfrini, M; Rocca, M | 1 |
| CAVANAGH, D; HERNANDEZ-ROMAN, P; MARTIN, DS | 1 |
| Hagan, MP; Heney, NM; Jones, CU; Kaufman, DS; Roberts, JD; Shipley, WU; Toonkel, LM; Wajsman, Z; Winter, KA; Zietman, AL | 1 |
| Assaraf, YG; Ifergan, I; Issakov, J; Meller, I | 1 |
| Kosnikov, AG; Maksimov, SIa; Semiglazov, VF; Semiglazov, VV | 1 |
| Abrey, LE; Anderson, ND; Caron, D; Correa, DD; Crump, M; DeAngelis, LM; Forsyth, P; Mason, WP; Moskowitz, CH; Nimer, SD; Paleologos, N; Stewart, D; Zelenetz, A | 1 |
| Ascari, E; Bertè, R; Broglia, C; Cavalli, C; Dell'Olio, M; Dezza, L; Federico, M; Gobbi, PG; Iannitto, E; Luisi, D; Merli, F; Molica, S; Stelitano, C | 1 |
| Barceló, JR; López-Vivanco, G; Muñoz, A | 1 |
| Allum, WH; Ashley, S; Ebbs, S; Gui, G; Ring, A; Sacks, NP; Smith, IE; Walsh, G; Webb, A | 1 |
| Eden, OB; Gibson, B; Hann, I; Harrison, CJ; Hill, FG; Kinsey, S; Lilleyman, J; Mitchell, C; Richards, S | 1 |
| Ahmed, S; Aitken, M; Coleman, RE; Everard, J; Hancock, BW; Khan, F | 1 |
| Greenberg, ML; Hitzler, JK; Maze, R; Nathan, PC; Spiegler, B; Weitzman, S | 1 |
| Coebergh, JW; Ernst, MF; Poortmans, PM; Roukema, JA; Voogd, AC | 1 |
| Giam, YC; Tan, AW | 1 |
| Bellon, JR; Come, SE; Gelman, RS; Harris, JR; Li, X; Recht, A; Shulman, LN; Silver, BJ | 1 |
| Calais, G | 1 |
| Carrie, C; Claude, L; Petit, T | 1 |
| Bonadonna, G; Gianni, L; Moliterni, A; Valagussa, P; Zambetti, M | 1 |
| Askmalm, MS; Carstensen, J; Nordenskjöld, B; Olsson, B; Rutqvist, LE; Skoog, L; Stål, O | 1 |
| Deckert, M; Montesinos-Rongen, M; Pels, H; Schaller, C; Schlegel, U; Van Roost, D; Wiestler, OD | 1 |
| Benesch, M; Dornbusch, HJ; Lackner, H; Moser, A; Raith, J; Schwinger, W; Sovinz, P; Triebl-Roth, K; Urban, C | 1 |
| Blay, JY; Bleuze, JP; Bompas, E; Chaigneau, L; Cupissol, D; Guardiola, E; Madroszyk, A; Peyrade, F; Pivot, X; Ronchin, P; Schneider, M; Tchiknavorian, X | 1 |
| Batchelor, TT; Betensky, RA; Chon, B; Grossman, SA; Hochberg, FH; Lesser, GJ; Nabors, LB; Plotkin, SR | 1 |
| Abrey, LE; DeAngelis, LM; Demopoulos, A; Enting, RH | 1 |
| Amreek, S; Daljeet, S; Hara, GS; Lovneesh, G; Neeraj, A; Prabhakar, BR; Raman, A; Satish, J | 1 |
| Anderson, S; Bryant, J; Deutsch, M; Jeong, JH; Mamounas, E; Taghian, A; Wolmark, N | 1 |
| Bonazzi, C; Buda, A; Cantú, MG; Dell'Anna, T; Sacco, S; Urso, M | 1 |
| Batchelor, AG; Liddington, MI; Rawlins, JM; Towns, G | 1 |
| Borgstein, E; Broadhead, R; Hesseling, P; Louw, M; Mansvelt, E; Molyneux, E; Schneider, J; Wessels, G | 1 |
| Guan, ZZ; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Liu, DG; Sun, XF; Xia, Y; Xia, ZJ; Zhang, L; Zhen, ZJ; Zhou, ZM | 1 |
| Bruzzi, P; Costanzo, FD; Di Costanzo, F; Dogliotti, L; Falcone, A; Frassineti, G; Rosso, R; Sobrero, A | 1 |
| Batchelor, TT; Buchbinder, BR; Harris, NL | 1 |
| Bonadonna, G; Daidone, MG; Gianni, L; Moliterni, A; Pilotti, S; Valagussa, P; Zambetti, M | 1 |
| Coldman, AJ; Coppin, CM; Durand, R; Gelmon, K; Jackson, SM; Knowling, MA; Le, N; Manji, M; Olivotto, IA; Phillips, N; Ragaz, J; Spinelli, JJ; Weir, L; Wilson, KS | 1 |
| Abrey, LE; DeAngelis, LM; Koutcher, JA; Lis, E; Panageas, KS; Raizer, JJ; Xu, S; Zakian, KL | 1 |
| Armand, JP; Domenge, C; Faivre, S; Gatineau, M; Janot, F; Julieron, M; Luboinski, B; Marti, A; Raymond, E; Rixe, O; Temam, S | 1 |
| Grundy, R; Lander, A; Ng, A; Nishikawa, H | 1 |
| Dichgans, J; Herrlinger, U; Nägele, T; Rieger, J; Steinbach, JP; Weller, M | 1 |
| Bode, U; Deinlein, F; Emser, A; Graf, N; Kortmann, RD; Kuehl, J; Ottensmeier, H; Pietsch, T; Rutkowski, S; Soerensen, N; Warmuth-Metz, M; Wolff, JE | 1 |
| Ikeda, K; Matsumoto, K; Matsuoka, S; Ohta, M; Takeshita, I | 1 |
| Cefalo, G; Fossati-Bellani, F; Gandola, L; Landonio, G; Massimino, M; Mazza, E; Pedrazzoli, P; Pignoli, E; Poggi, G; Siena, S; Spreafico, F; Terenziani, M | 1 |
| Dichgans, J; Hebart, H; Herrlinger, U; Kanz, L; Weller, M | 1 |
| Dillenschneider, E; Greiner, GF | 1 |
| Chintagumpala, M; Davino, N; Helman, L; Hicks, J; Johnson, M; Lau, CC; Man, TK; Meyer, W; Murray, J; Perlaky, L; Shen, J; Triche, T; Visvanathan, J; Wong, KK | 1 |
| Kardinal, CG; Keeney, GL; Kugler, JW; Long, HJ; Nelimark, RA; Nikcevich, DA; Podratz, KC; Rowland, KM; Suman, V; Wos, EJ | 1 |
| Bonetti, M; Carbone, A; Castiglione-Gertsch, M; Coates, AS; Collins, J; Crivellari, D; Fey, MF; Gelber, RD; Goldhirsch, A; Golouh, R; Gruber, G; Holmberg, SB; Lindtner, J; Nasi, ML; Price, KN; Rudenstam, CM; Simoncini, E; Thürlimann, B | 1 |
| Sanuki-Fujimoto, N | 1 |
| Arcangeli, G; Benassi, M; Giannarelli, D; Pinnarò, P; Rambone, R | 1 |
| Allegue, MJ; Bolufer, P; Capote, FJ; Conde, E; de la Serna, J; Debén, G; Fuster, J; García, P; González, JD; González, M; Madero, L; Martín, G; Molines, A; Novo, A; Ortega, JJ; Parody, R; Rodríguez, A; Sanz, MA; Verdeguer, A | 1 |
| Alvegard, TA; Bacci, G; Bernini, G; Bertoni, F; Böhling, T; Brosjö, O; Capanna, R; Comandone, A; Del Prever, AB; Ferrari, S; Longhi, A; Mercuri, M; Müller, C; Picci, P; Ruggieri, P; Saeter, G; Smeland, S; Tienghi, A; Wiebe, T | 1 |
| Einsiedel, HG; Fengler, R; Göbel, U; Hählen, K; Hartmann, R; Henze, G; Janka-Schaub, G; Klingebiel, T; Ludwig, WD; Mann, G; Schrappe, M; von Stackelberg, A | 1 |
| Burhenne, J; Foell, JL; Reiss, T; Rengelshausen, J; Staege, MS; Stiefel, M; Wawer, A | 1 |
| Franzaring, L; Lehmann, J; Stöckle, M; Thüroff, J; Wellek, S | 1 |
| Baltas, D; Filipowicz, I; Hoffmann, G; Kolotas, C; Kontova, M; Kuner, RP; Kurek, R; Martin, T; Pollow, B; Roddiger, SJ; Rogge, B; Zamboglou, N | 1 |
| Chen, CM; Cheng, SH; Clarke, JL; Horng, CF; Huang, AT; Jian, JJ; Liu, MC; Prosnitz, LR; Tsai, SY; Tsou, MH; West, M | 1 |
| Baehring, JM; Hochberg, FH; Kleopa, KA; Stern, BV | 1 |
| Akaza, H; Akine, Y; Hashimoto, T; Hata, M; Hattori, K; Igaki, H; Kagei, K; Miyanaga, N; Ohara, K; Saida, Y; Shimazui, T; Sugahara, S; Tokuuye, K | 1 |
| Grau, C; Jensen, AR; Nielsen, HM; Overgaard, J; Overgaard, M | 1 |
| Jürgens, A; Pels, H; Schlegel, U | 1 |
| Bekkers, R; Kerkmeijer, L; Pyman, J; Quinn, M; Tan, J; Wielsma, S; Wiesma, S | 1 |
| Fischer, L; Herrlinger, U; Jahnke, K; Korfel, A; Martus, P; Thiel, E; Weller, M | 1 |
| Bello, JL; Bethencourt, C; Deben, G; Feliu, E; Hernandez-Rivas, JM; Oriol, A; Parody, R; Ribera, JM; Rivas, C; Sancho, JM | 1 |
| Baehner, FL; Baker, J; Bryant, J; Costantino, JP; Cronin, M; Geyer, CE; Kim, C; Kim, W; Paik, S; Shak, S; Tang, G; Watson, D; Wickerham, DL; Wolmark, N | 1 |
| Wan, X; Xiang, Y; Yang, J; Yang, X | 1 |
| Fujioka, H; Honda, M; Matsumiya, K; Satoh, M; Takada, T; Tujimoto, Y | 1 |
| Boesen, AM; Gregersen, H; Gustafsson, G; Heyman, M; Johnsen, HE; Kjeldahl, M; Nielsen, OJ; Schmidt, K; Schrøder, H | 1 |
| Colevas, AD | 1 |
| Partap, S; Spence, AM | 1 |
| Boesen, AM; Gregersen, H; Gustafsson, G; Johnsen, HE; Kjeldstad, M; Nielsen, OJ; Schmidt, KG; Schrøder, H | 1 |
| An, R; Han, X; Wang, S; Xue, Y; Zhu, K | 1 |
| Asgharzadeh, S; Belasco, J; Chi, SN; Diez, B; Dubowy, R; Dunkel, I; Finlay, J; Gardner, S; Hukin, J; Ji, L; Kellie, S; Levy, A; Miller, DC; Rosenblum, M; Sposto, R; Termuhlen, A; Zacharoulis, S | 1 |
| Koizumi, W; Nakayama, N; Saigenji, K; Sasaki, T; Tanabe, S | 1 |
| Leenstra, S; Majoie, CB; Richel, DJ; Terheggen, F; Troost, D | 1 |
| Edén, P; Fernö, M; Johnsson, A; Niméus-Malmström, E; Ohlsson, M; Ostberg, G; Peterson, C; Ritz, C; Strand, C | 1 |
| Bamias, A; Bozas, G; Dimopoulos, MA; Gika, D; Kastritis, E; Koutsoukou, V; Papadimitriou, C; Rodolakis, A; Vlahos, G; Voulgaris, Z | 1 |
| Anderson, WF; Berman, AW; Lippman, ME; Steinberg, SM; Swain, SM; Vatas, U; Walshe, JM | 1 |
| Fernö, M; Johnsson, A; Malmström, J; Marko-Varga, G; Niméus, E | 1 |
| Chaturvedi, A; Drew, PJ; Fox, JN; Garimella, V; Long, ED; Qutob, O; Turnbull, LW | 1 |
| Antonini, N; Barillot, I; Bartelink, H; Collette, L; Fourquet, A; Hart, G; Hoogenraad, W; Horiot, JC; Jager, J; Jones, H; Pierart, M; Poortmans, P; Struikmans, H; Van den Bogaert, W | 1 |
| Case, MC; Hall, AG; Hogarth, LA; Irving, JA; Matheson, EC | 1 |
| Budrewicz, S; Dubik-Jezierzańska, M; Pawlik, B; Pokryszko-Dragan, A; Turek, T | 1 |
| Escobedo, A; Falo, C; Figueras, A; Lloveras, B; Moreno, A; Varela, M | 1 |
| Nielsen, HM; Overgaard, J; Overgaard, M | 1 |
| Benouaich-Amiel, A; Kaloshi, G; Khe, HX | 1 |
| Antonini, N; Bais, E; Horenblas, S; Kerst, JM; Leijte, JA | 1 |
| Pizzocaro, G | 1 |
| Buchholz, TA; Olivotto, IA; Ragaz, J; Thames, HD; Truong, PT; Woodward, WA | 1 |
| Li, JG; Wan, XR; Xiang, Y; Yang, JJ; Yang, XY | 1 |
| Agrawal, A; Asgeirsson, KS; Chan, SY; Cheung, KL; Ellis, IO; Mathew, J; Mukherjee, A; Robertson, JF | 1 |
| Castiglione-Gertsch, M; Coates, AS; Colleoni, M; Gelber, RD; Gelber, S; Goldhirsch, A; Pagani, O; Price, KN; Simoncini, E | 1 |
| Barberi, W; Foa, R; Giona, F; Malandruccolo, L; Mandelli, F; Martino, P; Moleti, ML; Palumbo, G; Paoloni, F; Pescarmona, E; Testi, AM | 1 |
| Brocca, MC; Coppi, MR; Mele, G; Melpignano, A; Pinna, S; Quarta, G; Romano, A | 1 |
| Lv, W; Mao, Y; Wan, X; Xie, X | 1 |
| Ahnström Waltersson, M; Bostner, J; Fornander, T; Nordenskjöld, B; Skoog, L; Stål, O | 1 |
| Snyder, RL | 1 |
| Guan, ZZ; Huang, HQ; Li, YH; Ling, JY; Liu, DG; Sun, XF; Xia, Y; Xia, ZJ; Zhang, L; Zhen, ZJ; Zhou, ZM | 1 |
| Bondar, G; Kossé, V; Lehmann, U; Maubach, L; Meurer, J; Possinger, K; Schmid, P; Tarutinov, V; Untch, M; Vassiljev, L; Wallwiener, D | 1 |
| Bacci, G; Balladelli, A; Bertoni, F; Briccoli, A; Ferrari, S; Forni, C; Longhi, A; Mercuri, M; Picci, P; Serra, M | 1 |
| Homma, J; Hondoh, H; Morii, K; Onda, K; Sano, M; Shinbo, Y; Takahashi, H; Tamura, T; Tanaka, R; Tsuchiya, N; Yajima, N; Yamanaka, R | 1 |
| Sauer, R; Sautter-Bihl, ML | 1 |
| Dengler, R; Fröhlich, F; Kroll, T; Lobodasch, K; Pachmann, K; Pachmann, U; Rengsberger, M; Schubert, R | 1 |
| Bailey, CC; Campbell, RH; Chong, WK; Cox, T; Ellison, DW; English, MW; Gattamaneni, R; Grundy, RG; Ironside, J; Lashford, LS; Machin, D; Mallucci, C; Picton, S; Punt, JA; Robinson, K; Thorpe, N; Walker, DA; Weston, CL; Wilne, SA | 1 |
| Chiba, S; Izutsu, K; Kako, S; Kanda, Y; Kurokawa, M; Motokura, T; Oshima, K; Sato, H | 1 |
| Höglund, P; Jönsson, P; Schrøder, H; Seidel, H; Skärby, T; Wiebe, T | 1 |
| Chen, L; Fan, Y; Fu, L; Guo, XJ; Lang, RG; Sun, YL | 1 |
| Karantanis, D; Lowe, VJ; Mullan, BP; Nathan, MA; O'eill, BP; Peller, PJ; Subramaniam, RM; Wiseman, GA; Witte, RJ | 1 |
| Arriagada, R; Bourgier, C | 1 |
| Debus, J; Milker-Zabel, S; Wannenmacher, M; Zabel-du Bois, A | 1 |
| Bae, SN; Jung, SG; Kim, CJ; Kim, SJ; Lee, C; Na, YJ | 1 |
| Fujii, Y; Mori, H; Nishiyama, K; Takahashi, H; Yoshimura, J | 1 |
| Jain, S; Mandal, S; Varma, K | 1 |
| Bianchi, S; Biti, GP; Borghesi, S; Cataliotti, L; Leonulli, BG; Livi, L; Meattini, I; Paiar, F; Paoletti, L; Petrucci, A; Rampini, A; Saieva, C; Scoccianti, S | 1 |
| Anderson, P; Chang, EL; Herzog, CE; Hughes, D; Huh, W; Kornguth, DG; Mahajan, A; Pelloski, CE; Woo, SY | 1 |
| Batchelor, TT; Carson, KA; Gerstner, ER; Grossman, SA | 1 |
| Bernstein, ML; Betcher, D; Ferguson, WS; Gebhardt, MC; Goorin, AM; Grier, HE; Harris, M; Healey, JH; Kleinerman, E; Krailo, MD; Link, MP; Meyers, PA; Nadel, H; Nieder, M; Schwartz, CL; Siegal, GP; Weiner, MA; Wells, RJ; Womer, RB | 1 |
| Akashi-Tanaka, S; Ando, M; Fujiwara, Y; Hojo, T; Katsumata, N; Kinoshita, T; Kohno, T; Seki, K; Shibata, T; Shien, T; Shimizu, C | 1 |
| Fischer, L; Kiewe, P; Korfel, A; Martus, P; Thiel, E | 1 |
| Chen, H; Chen, YH; Han, W; Huang, XJ; Liu, DH; Liu, KY; Shi, HX; Wang, Y; Xu, LP | 1 |
| Specenier, PM; Vermorken, JB | 1 |
| Castiglione-Gertsch, M; Coates, AS; Cole, BF; Collins, J; Crivellari, D; Fey, MF; Gelber, RD; Goldhirsch, A; Golouh, R; Gruber, G; Gusterson, BA; Holmberg, SB; Lindtner, J; Price, KN; Simoncini, E; Thürlimann, B; Viale, G | 1 |
| Bacon, C; Egerer, G; Freier, K; Hofele, CM; Thiele, OC | 1 |
| Chen, WK; Chen, YF; Guo, ZM; Su, YR; Wei, MW; Wu, GH; Zeng, ZY | 1 |
| Hills, WJ; Rufino, C; Stehlin, JS | 1 |
| Jakse, R; Lehnert, M; Seewann, HL | 1 |
| Al-Sarraf, M | 1 |
| Sung, HC; Wu, PC; Yang, HY | 1 |
| Cassady, JR; Freeman, AI; Frei, E; Green, DM; Hammond, D; Nesbit, ME; Sallan, SE; Sather, HN; Sinks, LF | 1 |
| Everts, EC; Ireland, KM; Moseley, HS; Stevens, KR; Zielke-Temme, BC | 1 |
| Baughn, SG; Cole, TB; Huang, AT; Lucas, VS | 1 |
| Asselin, B; Bataini, JP; Brugère, J; Garcia-Giralt, E; Jaulerry, M; Jouve, M; Palangie, T; Pouillart, P | 1 |
| Blackledge, G; Crowther, D; Thatcher, N | 1 |
| Baumgartner, G; Heinz, R; Linemayr, G | 1 |
| Glick, JH; Taylor, SG | 1 |
| Akbiyik, N; Amin, VC; Aral, I; Attie, J; Cortes, EP; Eisenbud, L; Heller, K; Kalra, J; Khafif, R; Sciubba, J; Wolk, D | 1 |
| Oliver, RT | 1 |
| Cintrón, J; Figueroa-Vallés, NR; Marcial, VA; Vallecillo, LA; Vélez-García, E | 1 |
| Bartual, J; Bascuas, JL; Gil, M; Magro, E; Roquette, J | 1 |
| Muscato, MS; Perry, MC; Yarbro, JW | 1 |
| Bromer, R; Cummings, C; D'Aoust, J; Fofonoff, S; Hong, WK; Issell, B; Levin, E; Luedke, D; Schaefer, S; Shapshay, S; Strong, S; Vaughan, C; Vincent, M; Welch, J | 1 |
| Crivellari, D; Frustaci, S; Galligioni, E; Grigoletto, E; Magri, MD; Tirelli, U; Tumolo, S; Veronesi, A | 1 |
| Camacho, F; Cinberg, J; Kaplan, BH; Lerner, H; Vogl, SE | 1 |
| Boyce, J; Khulpateea, N; Mehrotra, S; Rosenthal, CJ; Tamarin, S | 1 |
| Böheim, K; Rauchegger, H | 1 |
| Ervin, TJ; Fabian, RL; Lockhart, P; MacIntyre, JM; Miller, D; Norris, CM; Posner, MR; Rose, C; Tuttle, SA; Weichselbaum, RR | 1 |
| Ervin, TJ; Fabian, RL; Miller, D; Norris, CM; Posner, MR; Rose, C; Weichselbaum, RR | 1 |
| Dillard, EA; Dinh, TV; Hannigan, EV | 1 |
| Scherpe, A; Schröder, M; Stennert, E; von Heyden, HW | 1 |
| Blandy, JP; England, HR; Oliver, RT; Risdon, RA | 1 |
| Sutherland, DJ; Tannock, IF | 1 |
| Metz, O; Stoll, W | 1 |
| Ford, HT; Smyth, JF | 1 |
| Aisner, J; Poplin, EA; Van Echo, DA; Whitacre, M; Wiernik, PH | 1 |
| Denck, H; Karrer, K; Pridun, N; Zwintz, E | 1 |
| Bezwoda, WR; de Moor, NG; Derman, DP; Kallenbach, J | 1 |
| Bremer, K; Krischke, W; Niederle, N; Schmidt, CG; Seeber, S | 1 |
| Capizzi, RL; Carney, C; Delaney, D; Kahn, L; Kirsch, M; Lipper, S; Neijstrom, ES; Rudnick, SA | 1 |
| Bauermeister, DE; Brooks, JL; Ryan, JA | 1 |
| Horai, T; Matsuda, M | 1 |
| Briancon, S; Feintrenie, X; Lamaze, R; Lamy, P; Thisse, JY; Watrin, H | 1 |
| Kondilis, D; Kozonis, J; Lissaios, B; Miligos, S; Papadimitriou, G; Papaevangelou, G; Papageorgiou, G; Papaioannou, A; Papavasiliou, K; Plataniotis, G; Polychronis, A; Razis, D; Stathopoulos, G; Throuvhlas, N; Tsarouhas, C; Tsiliakos, S; Vasilaros, S | 1 |
| Schöck, V | 1 |
| Carter, S; Hendrickson, C; Jacobs, C; Kohler, M; Meyers, F | 1 |
| Bonadonna, G; Marchini, S; Tancini, G; Valagussa, P; Veronesi, U | 1 |
| Archibald, SD; Browman, GP; Hryniuk, WM; Kiehl, K; Levine, MN; Russell, R; Young, JE | 1 |
| Soloway, MS | 2 |
| Aisner, J; Cortes, E; Glidewell, OJ; Kennedy, BJ; Leone, LA; Perloff, M; Silver, RT; Tormey, DC; Weinberg, VE; Weiss, RB | 1 |
| Jungi, WF | 1 |
| Mouridsen, HT; Palshof, T | 1 |
| Alberto, P; Barrelet, L; Brunner, KW; Cavalli, F; Jungi, WF; Mermillod, B | 1 |
| Bulbrook, RD; Bush, H; Crowther, D; George, WD; Hayward, JL; Howat, JM; Howell, A; Knight, RK; Rubens, RD; Sellwood, RA | 1 |
| Bruckner, HW; Cohen, CJ; Deppe, G; Goldberg, JD; Gusberg, SB; Holland, JF; Kabakow, B; Rodin, J; Wallach, RC | 1 |
| Hamada, Y; Kanda, K; Nomura, Y; Saeki, K; Tashiro, H | 1 |
| Prout, GR | 1 |
| Kopp, J; Prout, GR | 1 |
| Lang, C; Renner, H; Ziegler, K | 1 |
| Chisholm, GD; Field, G; Hargreave, TB; Smith, G; Theodorou, C | 1 |
| Baker, SR; Natale, RB; Roshon, SG; Wheeler, RH | 1 |
| Bauer, M; Brodovsky, HS; Elson, PJ; Horton, J | 1 |
| Aleksandrova, GI; Dymarskiĭ, LIu; Sanchakova, AV; Trishkina, EA | 1 |
| Hanak, H; Heinz, R | 1 |
| Baum, E; Griffin, T; Littman, P; Nachman, J; Neerhout, R; Norris, D; Ramsay, N; Sather, H; Weetman, B | 1 |
| Javier, G; Montagut, JM; Ortega, JJ | 1 |
| Collins, JP; Goodyear, MD; Kitchen, PR; Mackay, IR; Penschow, J; Riglar, C; Russell, IS; Whittingham, S | 1 |
| Meyerowitz, BE; Sparks, FC; Watkins, IK | 1 |
| Blumenschein, GR; Buzdar, AU; Hortobagyi, GN; Montague, ED; Schell, F; Spanos, W; Yap, HY | 1 |
| Murayama, Y | 1 |
| Barranco, SC; Costanzi, JJ; O'Quinn, AG | 1 |
| Alic, L; Haid, M | 1 |
| Crowe, JP; Flynn, WJ; Gordon, NH; Guyton, SP; Hermann, RE; Hubay, CA; Jones, JC; Mansour, EG; Marshall, JS; Pearson, OH | 1 |
| Barnes, LE; Creech, RH; Horton, J; Kaplan, BH; Lerner, HJ; Schoenfeld, DA; Vogl, SE | 1 |
| Bezwoda, WR; De Moor, NG; Derman, D; Lange, M; Levin, J | 1 |
| Jacobs, C | 2 |
| Bonadonna, G; Rossi, A; Valagussa, P; Veronesi, U | 2 |
| Baumgartner, G | 1 |
| Billings, AA; Bitran, JD; Desser, RK; Kozloff, MF; Michel, A; Recent, W; Shapiro, CM | 1 |
| Mooney, C; Pritchard, J; Souhami, R | 1 |
| Banfi, A; Bonadonna, G; Rossi, A; Tancini, G; Tess, JD; Valagussa, P | 1 |
| Bacci, G; Campanacci, M; Giunti, A; Pagani, P | 1 |
| Gutjahr, P; Pontz, BF | 1 |
| Jarowski, CI; Saper, CB | 1 |
| Finne, PH; Moe, PJ; Seip, M | 1 |
| Mills, EE | 1 |
| Cooper, MR; Ferree, C; Howard, V; Jackson, DV; Muss, HB; Rhyne, AL; Richards, F; Shore, A; Spurr, CL; Stuart, JJ; White, DR | 1 |
| Liffers, R | 1 |
| Fisher, B; Wolmark, N | 1 |
| Amgwerd, R; Hochuli, E; Jungi, WF; Senn, HJ | 1 |
| Fox, RM; Tattersall, MH; Woods, RL | 1 |
| Carpenter, JT; Laws, HL; Maddox, WA; Soong, SJ; Wirtschafter, DD | 1 |
| Bennett, A; Berstock, DA; Carroll, MA | 1 |
| Costanza, ME | 1 |
| Ahuja, RK; Jereb, B; Reid, A | 1 |
| Ranger, IM; von Maillot, K | 1 |
| Albrecht, M; Jepsen, G; Thomsen, K; Trams, G | 1 |
| Wright, EA; Zebro, T | 1 |
| Bateman, JR; Chlebowski, RT; Godfrey, T; Hestorff, R; Lang, JE; Luce, J; Reynolds, R; Ryden, VM; Weiner, JM | 1 |
| Gibb, I; Hall, RR; Heath, AB; Herring, DW | 1 |
| Gibb, I; Hall, RR; Herring, DW; McGill, AC | 1 |
| Turner, AG | 1 |
| Debanne, SM; Eckert, C; Flynn, WJ; Hermann, RE; Hubay, CA; Jones, JC; Mansour, EG; Marshall, JS; McGuire, WL; Pearson, OH; Rhodes, RS | 1 |
| Canellos, GP; Ervin, T | 1 |
| Cooper, RG; Glidewell, O; Holland, JF | 1 |
| Kreienberg, R; Melchert, F; von Nathusius, U | 1 |
| Bennett, A; Berstock, DA; Houghton, J | 1 |
| Grundsell, H; Johnsson, JE; Mattsson, W; Tropé, C | 1 |
| Chang, LS; Chen, KK; Chen, PM; Chiou, TJ; Hsieh, RK; Wei, CH | 1 |
| Chambers, JT; Chambers, SK; Kohorn, EI; Lamb, L; Schwartz, PE | 1 |
| Cappelaere, P; Clavel, M; Clerico, M; Cognetti, F; de Mulder, PH; Schornagel, JH; Tueni, EA; Vermorken, JB; Verweij, J; Wildiers, J | 1 |
| Bagshawe, KD; Begent, RH; Brampton, M; Holden, L; Ledermann, JA; Newlands, ES; Rustin, GJ | 1 |
| Ishihara, S; Kuriyama, M; Nagatani, Y; Ozeki, S; Takahashi, Y; Takeda, A; Takeuchi, T; Taniguchi, M; Ueno, K; Yamamoto, N | 1 |
| Culine, S; Droz, JP; Duvillard, P; Kattan, J; Lhomme, C; Michel, G | 1 |
| Avidano, MA; Singleton, GT | 1 |
| Igawa, M; Ishibe, T; Kadena, H; Shiina, H; Urakami, S; Usui, T | 1 |
| Carstensen, J; Ferraud, L; Nordenskjöld, B; Rutqvist, LE; Skoog, L; Stål, O; Stenmark Askmalm, M; Sullivan, S; Wingren, S | 1 |
| Berns, EM; de Koning, HY; Foekens, JA; Klijn, JG; Portengen, H; van Putten, WL; van Staveren, IL | 1 |
| Hiraishi, M; Konishi, T; Makuuchi, M | 1 |
| Cha, SS; Ebbert, LP; Krook, JE; Langdon, RM; Long, HJ; Pfeifle, DM; Roshon, SG; Tschetter, LK; Veeder, MH | 1 |
| Dimitrov, N; Grundfest-Broniatowski, S; Lerner, HJ; Margolese, RG; Prager, D; Silverman, P | 1 |
| Kito, T; Kodera, Y; Yamamura, Y | 1 |
| Gertenbach, U; Hohenfellner, R; Huber, C; Meyenburg, W; Stöckle, M; Thüroff, JW; Voges, G; Wellek, S | 1 |
| Bianco, A; Cavaniglia, G; Frattina, A; Lunghi, F; Migliorini, V; Paccagnella, A; Pappagallo, GL; Segati, R; Sileni, VC; Zorat, P | 1 |
| Bergmann, L; Hoelzer, D; Jacobi, V; Lob, S; Müller, H | 1 |
| Bartlett, NL; Horning, SJ; Kwak, LW | 1 |
| Cupido, G; Gallina, S; Gebbia, V; Ingria, F; Lo Bue, P; Restivo, G; Spatafora, G; Speciale, R; Testa, A; Zerillo, G | 1 |
| Avilés, A; Díaz-Maqueo, JC; García, EL; Guzmán, R; Narváez, BR; Talavera, A | 1 |
| Benedetti-Panici, P; Greggi, S; Mancuso, S; Salerno, G; Scambia, G | 1 |
| Baiocchi, G; Benedetti-Panici, P; Greggi, S; Mancuso, S; Maneschi, F; Scambia, G | 1 |
| Callans, LS; Jardines, L; Torosian, MH | 1 |
| Cross, WG; Ebbert, LP; Kardinal, CG; Kugler, JW; Long, HJ; Mailliard, JA; Rayson, S; Tschetter, LK; Webb, MJ; Wieand, HS | 1 |
| Kennedy, AW | 1 |
| Doughty, JC; Kane, E; McArdle, CS; McCarter, DH; Reid, AW | 1 |
| Abrams, J; Aisner, J; Budman, D; Cirrincione, C; Citron, M; Holland, J; Muss, H; Panasci, L; Perloff, M; Perry, M | 1 |
| Kageyama, S; Kawai, T; Kawakami, S; Tsuzuki, M; Yamauchi, T; Yonese, J; Yoshimura, K | 1 |
| Clahsen, PC; Sylvester, RJ; van de Velde, CJ; van Driel, OJ; Welvaart, K | 1 |
| Kunii, Y; Nitta, A; Ota, K; Takahashi, N | 1 |
| Bondar', GV; Bukhteev, SV; Zabudkin, AF | 1 |
| Ackland, SP; Bonaventura, A; Christie, D; Dady, P; Denham, JW; Hamilton, CS; Lamb, DS; O'Brien, M; Spry, NA; Stewart, JF | 1 |
| Barraclough, B; Boyages, J; Langlands, AO; Ung, O | 1 |
| Baloch, Z; Lieber, CP; Mason, BA; Prestipino, AJ; Sataloff, DM; Seinige, UL | 1 |
| Bouffet, E; Doz, F; Gentet, JC; Mottolese, C; Plantaz, D; Ponvert, D; Roche, H; Stephan, JL; Thyss, A; Tron, P | 1 |
| Castiglione, M; Coates, AS; Collins, J; Gelber, RD; Goldhirsch, A; Hacking, A; Lindtner, J; Marini, G; Price, KN; Rudenstam, CM | 1 |
| Anderson, JR; Cecalupo, AJ; Finlay, JL; Hutchinson, RJ; Kadin, ME; Kjeldsberg, CR; Meadows, AT; Provisor, AJ; Woods, WG | 1 |
| Imamura, H; Kikkawa, N; Kobayashi, K; Okamura, Y; Shin, E; Takatsuka, Y; Tamaki, Y; Tono, T; Yagyu, T | 1 |
| Angelini, F; Ausili Cefaro, GP; Blengio, F; Cirulli, S; Cognetti, F; Colella, E; Giannarelli, D; Lo Russo, V; Merlano, M; Scasso, F | 1 |
| Inoue, T; Ishii, E; Koga, H; Matsuzaki, A; Miyake, K; Miyazaki, S; Nibu, K; Take, H; Ueda, K; Yanai, F | 1 |
| García Reboll, L; Jiménez Cruz, JF; Martínez Jabaloyas, JM; Pontones Moreno, JL; Ruíz Cerdá, JL; Vera Donoso, CD | 1 |
| Kalifa, C; Lemerle, J; Raquin, M; Rodary, C; Tabone, MD; Valteau-Couanet, D | 1 |
| Cher, L; Glass, J; Gruber, ML; Hochberg, FH | 1 |
| Khairallah, S; Lattouf, AN; Saadé, M | 1 |
| Bhansali, MB; Deshmane, VH; Fakih, AR; Parikh, DM; Parikh, HK; Rao, RS | 1 |
| Renner, H; van Kampen, M | 1 |
| Adachi, I; Fukami, A; Koyama, H; Nomura, Y; Tominaga, T | 1 |
| Arriagada, R; Chomy, P; de Cremoux, H; Le Chevalier, T; Ruffié, P | 1 |
| Burgers, JM | 1 |
| Astier, A; Brun, B; Goutallier, D; Hernigou, P; le Bourgeois, JP | 1 |
| Bauer, HC; Brosjö, O; Kreicbergs, A; Lindholm, J; Nilsonne, U; Silfverswärd, C; Strander, H; Szamosi, A | 1 |
| Bloch, DA; Brown, DM; Kitchell, BE; Luck, EE; Orenberg, EK; Woods, LL | 1 |
| Bisagni, G; Ceci, G; Cocconi, G; De Lisi, V; Di Blasio, B; Finardi, C; Lottici, R; Passalacqua, R | 1 |
| Burghouts, JT; Conroy, T; de Graeff, A; Fickers, MM; Lalisang, FM; Paillot, B; Wagener, DJ; Wils, J | 1 |
| Ito, T; Komatsu, Y; Moriya, N; Ogasawara, H; Saito, S; Sakata, Y; Sugimoto, N; Tamura, Y; Tsushima, K; Yamada, Y | 1 |
| Heinonen, E; Karnani, P; Kauppila, A; Kuoppala, T; Mäenpää, JU; Nieminen, U; Salmi, T; Sipilä, P | 1 |
| Hata, Y; Inoue, T; Konno, T; Nakanishi, M; Ogita, M; Ohira, S; Sasaki, F; Taguchi, K; Takahashi, H; Uchino, J | 1 |
| Bacci, G; Brach del Prever, A; Casadei, R; Ferrari, S; Gherlinzoni, F; Mercuri, M; Monti, C; Picci, P; Ruggieri, P; Tienghi, A | 1 |
| Etoh, T; Ishimaru, T; Mitsugi, K; Nakano, S; Niho, Y; Ueda, A; Yasutake, T | 1 |
| Argüello, A; Barrantes, JC; Barrantes, M; García, I; Jiménez, R; Lobo-Sanahuja, F | 1 |
| Balbay, MD; Ergen, A; Koçal, C; Ozen, H; Remzi, D; Sahin, A; Uluçay, S | 1 |
| Kondoh, M; Miki, T; Nakamura, N; Nakano, E; Nishimura, K; Okuyama, A; Seguchi, T | 1 |
| Lightman, S; Montefiore, DS; Plowman, PN | 1 |
| Cvitkovic, E; Domenge, C; Gandia, D | 1 |
| Geertsen, PF; Larsen, SK; Sengeløv, L; von der Maase, H | 1 |
| Cowan, RA; Obasaju, CK; Wilkinson, PM | 1 |
| Smith, PJ; Stevens, M; Tiedemann, K; Toogood, IR | 1 |
| Dorigo, A; Kwan, YL; Mansberg, R | 1 |
| Cortés-Funes, H; Costas, P; Díaz-Puente, M; Lianes, P; Mendiola, C; Passas, J; Paz-Ares, L; Rivera, F | 1 |
| Arrigoni, F; Poletti, EM; Sacco, R; Saturno, F; Ventriglia, L | 1 |
| Abeloff, MD; Falkson, G; Falkson, HC; Gilchrist, K; Gray, R; Tormey, DC | 1 |
| Kim, TH; Packer, RJ; Priest, JR; Rorke, LB; Simonton, SC; Spiegel, RH; Watterson, J | 1 |
| Gupta, D; Muralikrishna, BV; Singh, DP; Singh, G | 1 |
| Plasswilm, L; Sauer, R | 1 |
| Byhardt, R; Caplan, R; Heaney, J; Shipley, W; Tester, W; True, L; Venner, P; Whittington, R | 1 |
| Freiha, F; Reese, J; Torti, FM | 1 |
| Barbanti, G; De Capua, B; De Lauretis, A; Francini, G; Frediani, B; Manganelli, A; Mondillo, S; Petrioli, R; Salvestrini, F | 1 |
| Lönn, S; Lönn, U; Nilsson, B; Stenkvist, B | 1 |
| Johnson, JT; Myers, EN; Wagner, RL | 1 |
| Arriagada, R; Fontaine, F; Le Chevalier, T; Mouriesse, H; Spielmann, M; Thomas, F; Tursz, T | 1 |
| Bastit, D; Boulet, D; Fruchart, C; Moncondult, M; Piguet, H; Stamatoullas, A; Tilly, H | 1 |
| Carstensen, JM; Nordenskjöld, B; Rutqvist, LE; Skoog, L; Stål, O; Sullivan, S; Wingren, S | 1 |
| Botet, J; Brennan, M; Gerdes, H; Huang, Y; Karpeh, M; Kelsen, D; Klimstra, D; Lauers, G; Lightdale, C; Quan, V; Saltz, L; Schwartz, G | 1 |
| Bassot, V; Brasnu, D; Laccourreye, L; Laccourreye, O; Naudo, P; Roux, FX | 1 |
| Korzeniowski, S; Sas-Korczyńska, B; Skolyszewski, J | 1 |
| Arrigoni, M; Barbara, A; Besenzon, L; Brach del Prever, A; Cordero di Montezemolo, L; Fidani, P; Knerich, R; Locatelli, D; Loiacono, G; Madon, E; Magrassi, L; Perilongo, G; Pezzotta, S; Rigobello, L; Urgesi, A | 1 |
| Albanell, J; Banus, JM; Bellmunt, J; Bermejo, B; Carulla, J; De Torres, JA; Lopez-Pacios, MA; Morote, J; Ribas, A; Rovirosa, A; Sole, LA; Vera, R | 1 |
| Jekunen, AP; Kairemo, KJ; Kajanti, MJ; Lehtonen, HP | 1 |
| Ganssauge, F; Plasswilm, L; Sauer, R; Seegenschmiedt, MH | 1 |
| Abramson, N; Aron, BS; Atkins, JN; Bowman, DM; Costantino, JP; Dignam, J; Dimitrov, NV; Fisher, B; Glass, AG; Mamounas, EP; Margolese, RG; Redmond, C; Sutherland, CM; Wickerham, DL; Wolmark, N | 1 |
| Bertino, JR; DeAngelis, LM; Fleisher, M; Lin, S; Tong, WP | 1 |
| Bower, M; Fife, K; Holden, L; Newlands, ES; Paradinas, FJ; Rustin, GJ | 1 |
| Babini, L; Barbieri, E; Battista, G; Bendandi, M; Canini, R; Fanti, S; Frezza, G; Gherlinzoni, F; Gozzetti, A; Merla, E; Monetti, N; Pisi, P; Rimondi, MR; Tura, S; Zinzani, PL; Zompatori, M | 1 |
| Hosaka, M; Jinza, S; Kubota, Y; Masuda, M; Mikata, K; Noguchi, K; Noguchi, S | 1 |
| Hudis, CA; Norton, L | 1 |
| Everington, D; Forrest, AP; George, WD; Harnett, AN; McArdle, CS; Prescott, RJ; Smith, DC; Stewart, HJ | 1 |
| Altug, U; Erol, D; Uygur, MC; Yaman, I | 1 |
| White, RM | 1 |
| Arai, K; Iwasaki, Y; Kitamura, M | 2 |
| Akimoto, M; Horiuchi, K | 1 |
| Deeb, LS; Shabb, NS; Shamseddine, AI; Uthman, SM; Yamout, BI | 1 |
| Hagiwara, A; Imanishi, T; Kitamura, K; Ohgaki, M; Sakakura, C; Shirasu, M; Takahashi, T; Yamasaki, J | 1 |
| Bünemann, H; Heilmann, HP; Janik, I; Willers, H; Würschmidt, F | 1 |
| Gates, J; Levine, P; Maiman, M; Mathews, RP; Remy, JC; Serur, E | 1 |
| Behrendt, H; Langeveld, NE; van den Berg, H; Veenhof, CH | 1 |
| Akrivos, T; Diakomanolis, E; Dimopoulos, MA; Giannakoulis, N; Michalas, S; Papadimitriou, CA; Sarris, K; Vassilakopoulos, G; Vlahos, G; Voulgaris, Z | 1 |
| Anderson, DP; Katz, SE; Rootman, J; Wade, NK | 1 |
| Jung, WH; Koo, JY; Lee, HD; Oh, KK; Suh, CO; Yoon, DS | 1 |
| Bacci, G; Bertoni, F; Campanacci, M; Cesari, M; Ferrari, S; Forni, C; Gasbarrini, A; Mercuri, M; Sottili, S; Tienghi, A | 1 |
| Johnson, JT; Myers, EN; Pitman, KT | 1 |
| Audretsch, W; Carl, UM; Gripp, S; Hartmann, KA; Kolotas, C; Muskalla, K; Rezai, M; Schmitt, G; Schnabel, T; Waap, I; Zamboglou, N | 1 |
| Abramson, N; Atkins, JN; Bryant, J; DeCillis, A; Deschenes, L; Dignam, J; Dimitrov, NV; Emir, B; Fisher, B; Margolese, RG; Shibata, H; Wickerham, DL; Wolmark, N | 1 |
| Andersson, M; Bach, F; Gadeberg, CC; Hansen, PS; Jensen, MB; Kjaer, M; Mouridsen, HT; Overgaard, J; Overgaard, M; Rose, C; Zedeler, K | 1 |
| Ashley, S; Baum, M; Ebbs, S; Ellis, P; McKinna, J; Sacks, N; Smith, I; Walsh, G | 1 |
| Arias, M; Cassileth, PA; Donofrio, KA; Fernandez, H; Hurley, J; Lee, YJ; Mies, C; Morrell, LE; Raub, WA; Richman, SP | 1 |
| Arcangeli, G; Comandini, E; D'Angelo, L; D'Aprile, M; Giovinazzo, G; Lopez, M; Mauri, M; Micheli, A; Scala, T; Tersigni, R | 1 |
| Tsukuda, M | 1 |
| Akaza, H; Takeshima, H | 1 |
| Cherlow, JM; Gaynon, PS; Lukens, JN; Nachman, J; Sather, HN; Sensel, MG; Trigg, ME; Wolff, L | 1 |
| Akamine, T; Hanada, N; Hiraoka, T; Hongo, H; Kitamura, N; Kondo, K; Mori, T; Tabira, Y; Toyota, N; Yoshioka, M | 1 |
| Abdel-Wahab, M; Brandon, A; Lee, Y; Ling, S; Markoe, A; Mies, C; Morrell, L; Raub, W; Wolfson, A | 1 |
| Cartei, G; Iop, A; Isaia, A | 1 |
| Bacci, G; Bernini, G; Brach del Prever, A; Capanna, R; Cesari, M; Comandone, A; Ferrari, S; Longhi, A; Mercuri, M; Picci, P; Tienghi, A | 1 |
| Clemens, M; Dichgans, J; Herrlinger, U; Kortmann, RD; Meyermann, R; Petersen, D; Schabet, M; Will, BE | 1 |
| Abeloff, MD; Cummings, FJ; Falkson, G; Gelman, RS; Osborne, CK; Pandya, KJ; Sledge, GW; Tormey, D | 1 |
| Hart, G; Koning, C | 1 |
| Castiglione-Gertsch, M; Coates, A; Collins, J; Gelber, RD; Goldhirsch, A; Gudgeon, A; Hacking, A; Isley, M; Lindtner, J; Rudenstam, CM; Senn, HJ; Tattersall, M | 1 |
| Fridrik, M; Gnant, M; Hausmaninger, H; Jakesz, R; Kolb, R; Kubista, E; Samonigg, H; Sevelda, P; Steger, G; Steindorfer, P; Stierer, M; Tschurtschenthaler, B | 1 |
| Boiardi, A; Pozzi, A; Salmaggi, A; Silvani, A | 1 |
| Amoroso, M; Benedetti-Panici, P; Cutillo, G; Greggi, S; Mancuso, S; Maneschi, F; Paratore, MP; Salerno, MG; Scambia, G; Scorpiglione, N | 1 |
| Falletta, V; Pavone, C; Pavone-Macaluso, M; Piazza, F; Serretta, V; Vasile, P | 1 |
| Hamajima, N; Kito, T; Kosaka, T; Miyazaki, I; Ogawa, M; Saji, S; Tanemura, H; Yamamura, Y; Yonemura, Y | 1 |
| Alvegård, TA; Elomaa, I; Monge, OR; Nilbert, M; Saeter, G; Wiebe, T | 1 |
| Fowble, B; Freedman, G; Goldstein, LJ; Hanlon, AL; Hoffman, JP; Patchefsky, A; Sigurdson, ER | 1 |
| Cavalli, F; Ghielmini, M; Sanna, P; Van den Bosch, S | 1 |
| Delbos, O; Guiter, J; Legouffe, E; Navratil, H; Robert, M; Sahwi, A | 1 |
| Arai, S; Ichiyanagi, O; Iijima, Y; Kubota, Y; Nakada, T; Sasagawa, I; Suzuki, Y | 1 |
| Abeloff, MD; Davidson, NE; Donehower, RC; Fetting, JH; Kennedy, MJ; Mikhak, B; Waterfield, W; Zahurak, M | 1 |
| Bacci, G; Cesari, M; Fasano, MC; Ferrari, S; Lamanna, G; Zolezzi, C | 1 |
| Hall, RR; Reading, J; Roberts, JT; Thomas, DJ | 1 |
| Hatzl-Griesenhofer, M; Huber, H; Maschek, W; Pichler, R; Wahl, G; Wimmer, G | 1 |
| Arai, K; Iwasaki, Y; Kitamura, M; Nakajima, Y | 1 |
| Chan, CC; de Smet, MD; Kohler, D; Solomon, D; Vancs, VS | 1 |
| Edmonds, P; Gallagher, CJ; LeVay, J; Oliver, RT; Ong, J; Ostrowski, MJ; Raja, M; Shamash, J; Williams, M | 1 |
| Görlich, M; Jandrig, B | 1 |
| Fukuda, K; Kim, YH; Kitano, H; Kokufu, I; Taniguchi, H; Yamada, K; Yamamoto, M; Yano, T | 1 |
| Fushiki, H; Hasegawa, K; Izumi, R; Kono, I; Nishida, M; Noda, K; Noguchi, H; Okuda, H; Sugimori, H; Takizawa, K; Tanaka, T; Udagawa, Y; Umesaki, N; Yamamoto, K | 1 |
| Carter, SR; Grimer, RJ; Kabukcuoglu, Y; Mangham, DC; Spooner, D; Tillman, RM | 1 |
| Nasu, K; Nishimura, M; Ohta, H; Shintaku, M; Takahashi, Y | 1 |
| Fujimura, S; Hasumi, T; Kobayashi, S; Okada, S; Sato, N | 1 |
| Fridrik, M; Gnant, M; Haider, K; Hausmaninger, H; Jakesz, R; Kolb, R; Kubista, E; Manfreda, D; Mittlböck, M; Mlineritsch, B; Samonigg, H; Steger, G; Steindorfer, P; Stierer, M; Tschurtschenthaler, G | 1 |
| Babin-Boilletot, A; Brunat-Mentigny, M; Kalifa, C; Mahmoud, HH; Pacquement, H; Schmitt, C; Tabone, MD; Terrier, P | 1 |
| Bisagni, G; Boni, C; Ceci, G; Cocconi, G; De Lisi, V; Di Blasio, B; Morandi, P; Passalacqua, R; Savoldi, L; Zadro, A | 1 |
| Bang, YJ; Ha, SW; Huh, DS; Kim, IH; Park, CI; Wu, HG | 1 |
| Crabo, L; Hall, TC; Shokeir, MO; Taylor, MA; Wreggit, GR | 1 |
| Camacho, FM; Cantillana, J; Macher, G; Martínez-Sahuquillo, A; Moreno, JC; Murga, M; Naranjo, M; Proaño, J; Romero, F | 1 |
| Holden, L; Mulholland, PJ; Newlands, ES; Rustin, GJ; Seckl, MJ | 1 |
| Akaza, H; Akine, Y; Ita, Y; Kawai, K; Kikuchi, K; Miyanaga, N; Ohara, K; Okumura, T; Sekido, N; Shimazui, T; Takeshima, H; Uchida, K | 1 |
| Armata, J; Balcerska, A; Balwierz, W; Bogusławska-Jaworska, J; Bubała, H; Chybicka, A; Filiks-Litwin, B; Gorczyńska, E; Juszczak, K; Kowalczyk, J; Kołecki, P; Lukowska, K; Matysiak, M; Rokicka-Milewska, R; Rola-Kurc, E; Sońta-Jakimczyk, D; Stencel, D; Strojny, W; Wachowiak, J; Wieczorek, M; Wysocki, M; Zelenay, E | 1 |
| Abbas, A; Barbor, P; Fryer, C; Ghamdi, SA; Khattab, T; Smith, S | 1 |
| Bagiella, E; Benson, MC; Ennis, RD; O'Toole, KM; Olsson, CA; Petrylak, DP; Singh, P | 1 |
| Fodor, J; Major, T; Nemeth, G; Polgar, C; Toth, J | 1 |
| Gillespie, AM; Hancock, BW; Kumar, S | 1 |
| Rühl, U | 1 |
| Bonadonna, G; Cipriani, S; Daidone, MG; Luisi, A; Silvestrini, R; Valagussa, P; Zambetti, M | 1 |
| Ragaz, J; Spinelli, JJ | 1 |
| Anthoney, A; de Bono, JS; Graham, J; Kaye, SB; Kirk, D; Paul, J; Simpson, A; Underwood, M | 1 |
| Ahern, V; Boyages, J; Rangan, AM; Yip, D | 1 |
| Chan, CM; Hung, WK; Lau, Y; Yip, AW | 1 |
| Aapro, MS; Alberto, P; Allal, AS; Berney, CR; Marti, MC; Morel, P; Rohner, S; Roth, AD | 1 |
| Királyfalvi, L; Németh, A; Nyárády, Z; Olasz, L; Tornóczky, T | 1 |
| Bacci, G; Bertoni, F; Campanacci, M; Casadei, R; Fabbri, N; Ferrari, S; Forni, C; Longhi, A; Picci, P; Ruggieri, P; Versari, M | 1 |
| Cheng, DK; Ng, TY; Ngan, HY; Wong, LC | 1 |
| Bang, SM; Bang, YJ; Byun, JH; Chang, HM; Choe, KJ; Heo, DS; Kim, NK; Kim, SR; Lee, KH; Noh, DY | 1 |
| Achour, E; Azar, N; Belanger, C; Cassoux, N; Delattre, JY; Gerber, S; Hoang-Xuan, K; Leblond, V; Levy, V; Ribrag, V; Soussain, C; Suzan, F | 1 |
| Costa, A; Daidone, MG; Dellapasqua, S; Lacava, J; Lena, MD; Leone, B; Paradiso, A; Simone, G; Vallejo, C | 1 |
| Bacchini, P; Bacci, G; Bertoni, F; De Giorgi, U; Ferrari, S; Fiorentini, G; Forni, C; Longhi, A; Mercuri, M; Picci, P; Rimondini, S; Tienghi, A | 1 |
| Gebski, V; Machin, D; Tai, BC; White, I | 1 |
| Biganzoli, E; Bonoldi, E; Boracchi, P; Fanelli, M; Gasparini, G; Morabito, A | 1 |
| Foekens, JA; Klijn, JG; Look, MP; Martin, PM; Romain, S | 1 |
| Chen, IH; Chen, JS; Liaw, CT; Ng, SH; Wang, CH; Wang, HM; Yang, TS | 1 |
| Bolis, G; Cervantes, A; Colombo, N; Guastalla, JP; Hoctin-Boes, G; Lacave, AJ; Lhommé, C; Namer, M; Nooij, MA; Pecorelli, S; Poveda, A; Scotto di Palumbo, V; van Hoesel, Q; Vergote, I; Vermorken, JB; Wagenaar, HC; Zanetta, G | 1 |
| Bastert, G; Bojar, H; Sauerbrei, W; Schmoor, C; Schumacher, M | 1 |
| Murakami, M | 1 |
| Bessho, F; Hanada, R; Hoshi, Y; Ikuta, K; Ishimoto, K; Kaneko, T; Kinoshita, A; Koike, K; Maeda, M; Manabe, A; Nakazawa, S; Ohara, A; Okawa, H; Okimoto, Y; Saito, T; Sato, T; Sugita, K; Toyoda, Y; Tsuchida, M; Tsunematsu, Y | 1 |
| Fujii, T; Furukawa, Y; Jo, Y; Kinugawa, K; Kobayashi, T; Matsuki, T; Morioka, M; Sone, A; Tanaka, H | 1 |
| Abzumanov, AS; Barash, NIu; Bozhok, AA; Ivanov, VG; Ivanova, OA; Migmanova, NSh; Nurgaziev, KSh; Popova, RT; Seleznev, IK; Semiglazov, VF; Topuzov, EE | 1 |
| DeAngelis, LM; Gijtenbeek, JM; Rosenblum, MK | 1 |
| Abrahamova, J; Kocak, I; Kroslakova, D; Kubala, E; Machova, D; Malec, V; Pavlikova, E; Pavlikova, I; Prausova, J; Simova, E; Sirakova, I; Tuma, P; Van Praagh, I; Wagnerova, M | 1 |
| Hannequin, JR; Nonnenmacher, J; Offner, C; Simon, P | 1 |
| Bertè, R; Cavanna, L; Civardi, G; Lazzaro, A; Moroni, CF; Vallisa, D | 1 |
| Blamey, RW; Chan, SY; Cheung, KL; Robertson, JF; Tan, SM; Willsher, PC | 1 |
| Calabrò, F; Marini, L; Pizzocaro, G; Schnetzer, S; Sella, A; Sternberg, CN | 1 |
| Ferreri, AJ; Reni, M | 1 |
| Bamberg, M; Dieckmann, K; Kortmann, RD; Kühl, J; Meisner, C; Pietsch, T; Timmermann, B | 1 |
| Belpomme, D; Clendeninn, N; Domenge, C; Humblet, Y; Johnston, A; Kelly, C; Penning, C; Pivot, X; Ruxer, R; Schneider, M; Stern, J; Tortochaux, J; Wadler, S | 1 |
| Jokura, H; Kumabe, T; Saito, R; Yoshimoto, T | 1 |
| Dillon, JJ; Fleming, GF; Hartman, AR | 1 |
| Cooney, J; Kaminski, M; Stiff, P | 1 |
| Döhner, H; Gabler, A; Haas, R; Hartmann, F; Hensel, M; Ho, AD; Jung, W; Schlenk, RF; Trümper, L; Weber-Nordt, R | 1 |
| Boardman, CH; Dowdy, SC; Hartmann, LC; Long, HJ; Podratz, KC; Wilson, TO | 1 |
| Bessot, M; Colombel, P; Duprez, A; Fays, J; Lorenzini, G; Mauuary, G | 1 |
| DiSaia, PJ; Forney, JP; Futoran, RJ; Morrow, CP | 1 |
| Ardiet, C; Brunat-Mentigny, M; Chassard, JL; Mayer, M; Pommatau, E | 1 |
| Bertrand, JC; Chastang, C; Szpirglas, H | 1 |
| Banzet, P; Belaich, S; Chastang, C; Civatte, J; Cottenot, F; Israel, L; Jacquillat, C; Maral, J; Puissant, A | 1 |
| Eilber, FR; Morton, DL | 1 |
| Boesel, C; Ertel, IJ | 1 |
| Heiss, WD; Mamoli, B; Turnheim, M | 1 |
| Ghavimi, F; Mehta, BM; Mosende, C; Nirenberg, A; Rosen, G | 1 |
| Arwidi, A; Lindholm, CE; Mattsson, W; von Eyben, F | 1 |
| Andréasson, L; Hellekant, C; Mattsson, W | 1 |
| Applebaum, E; Bytell, DE; DeWys, WD; Sisson, GA; Taylor, SG | 1 |
| George, SL; Komp, D; Lane, DM; Lonsdale, D; Pullen, J; Ragab, A; Starling, KA | 1 |
| Berlie, J; Brulé, G; Carton, M; Chauvergne, J; Clavel, B; Gary-Bobo, J; Guerrin, J; Klein, T; Pommatau, E | 1 |
| Eilber, FR; Grant, T; Morton, DL | 1 |
| Edmonson, JM; Gilchrist, GS; Ivins, JC; Pritchard, DJ; Ritts, RE; Taylor, WF | 1 |
| Amgwerd, R; Bigler, R; Creux, G; Enderlin, F; Engelhart, G; Heinz, C; Hochueli, R; Jungi, WF; Lanz, R; Senn, HJ; Simeon, B; Sprenger, F; Wick, A | 1 |
| Hackenbruch, W; Oechsler, H; Wündisch, GF | 1 |
| Mutz, ID | 1 |
| Bremer, AM; Cohen, M; Freeman, AI; Sinks, LF; Sumer, T; Thomas, PR | 1 |
| Denck, H | 1 |
| Gynning, I; Mattsson, W | 1 |
| Neiger, M; Veraguth, P | 1 |
| Klein, HO; Leviatan, A; Tritsch, H | 1 |
| Cohen, D; Grover, NB; Weiss, DW; Yron, I | 1 |
| Karrer, K; Pridun, N; Zwintz, E | 3 |
| DeSanto, LW; Ritts, RE; Woods, JE | 1 |
| Bulbrook, RD | 1 |
| Freireich, EJ; Graw, RG; Henderson, ES; Leventhal, BG; Levine, AS; Simon, R | 1 |
| Bacci, G; Cagnano, R; Donati, U; Figus, E; Pagani, PA | 1 |
| Alexander, JC; Block, JB; Chretien, PB; Hoye, RC; Ketcham, AS; Tarpley, JL | 1 |
| Benson, JW | 1 |
| Golomb, FM | 1 |
| Belew, PW; Eastham, RJ; Jennings, BR; Maguda, TA; Mason, JM | 1 |
| Carbone, PP | 1 |
| Friedman, M | 1 |
| Bajetta, E; Bonadonna, G; Brambilla, C; Brugnatelli, L; Brusamolino, E; De Lena, M; Musumeci, R; Rossi, A; Tancini, G; Valagussa, P; Veronesi, U | 1 |
| Helman, P; Sealy, R | 1 |
| Cooperman, EM | 1 |
| Airoldi, M; Bongioannini, G; Bussi, M; Cavalot, A; Orecchia, R; Ragona, R; Sola, B; Valente, G | 1 |
| Karaseva, VV; Korolev, VV; Stepanov, VG | 1 |
| Bavli, IaL; Chepik, OF; Golubeva, OM; Ivanova, OA; Orlov, AA; Seleznev, IK; Semiglazov, VF; Topuzov, EE | 1 |
| Basco, V; Kuusk, U; Rebbeck, P | 1 |
| Chlebowski, RT | 1 |
| Kawanishi, Y; Kuge, S; Kuriyama, Y; Kuwabara, S; Nakano, M; Toyama, K; Yaguchi, M | 1 |
| Amrein, PC; Fabian, RL | 1 |
| Bartolucci, AA; Bass, D; Carpenter, JT; Ketcham, A; Marcial, V; Moore, M; Singh, KP; Smalley, R; Vélez-García, E; Vogel, CL | 1 |
| Akaza, H; Isaka, S; Kagawa, S; Koiso, K; Kotake, T; Machida, T; Maru, A; Matsumura, Y; Miyagawa, I; Niijima, T | 1 |
| Conti, R; Cusumano, F; Grassi, M; Rovini, D; Salvadori, B; Squicciarini, P | 1 |
| Boiardi, A; Croci, D; Perego, E; Silvani, A; Solero, CL | 1 |
| Falkson, CI; Falkson, G; Gelman, RS; Glick, J; Harris, J | 1 |
| Aga, Y; Miki, H; Yokota, K; Yokota, T | 1 |
| Bonichon, F; Chauvergne, J; Dilhuydy, JM; Durand, M; Mauriac, L | 1 |
| Bernard, JL; Bouffet, E; Carrie, C; Frappaz, D; Gentet, JC; Joannard, A; Lapras, C; Raybaud, C; Roche, H; Tron, P | 1 |
| Boyages, J; Driessen, C; Langlands, AO; Lindeman, GJ | 1 |
| Armata, J; Balwierz, W; Bogusławska-Jaworska, J; Chybicka, A; Cyklis, R; Derulska, D; Duczmal, B; Jackowska, T; Jakowicka, M; Rokicka-Milewska, R | 1 |
| García Zueco, JC; López Gómez, L; Martín Guerrero, Y; Torres Gómez, M | 1 |
| Jungi, WF; Senn, HJ | 1 |
| Grieve, RJ; Howell, A; Kelly, KA; Monypenny, IJ; Morrison, JM; Walker, RA; Waterhouse, JA | 1 |
| Cooper, MR; Eudey, L; Falkson, G; Gilchrist, KW; Mansour, EG; Osborne, CK; Shatila, AH; Tormey, DC | 1 |
| Levine, PA; Tabbara, IA | 1 |
| Butturini, A; Gale, RP | 1 |
| Canellos, GP; Harrington, DP; Jochelson, MS; Klatt, MM; Pinkus, GS; Rosenthal, DS; Shipp, MA; Skarin, AT; Yeap, BY | 1 |
| Forsthuber, T; Fuhr, HG; Gamm, H; Hennekeuser, HH; Hinterberger, R; Kreiter, H; Lindemann, A; Oster, W; Schmitz, G; Thoenes, W | 1 |
| Baiocchi, G; Battaglia, F; Conte, M; Gallo, A; Greggi, S; Laurelli, G; Panici, PB; Rabitti, C; Ragusa, G; Scambia, G | 1 |
| Canellos, GP; Shipp, MA; Weeks, JC; Yeap, BY | 1 |
| Glasser, DB; Lane, JM | 1 |
| Abu-Zahra, H; Arnold, A; Bramwell, V; Findlay, B; Gent, M; Goodyear, MD; Levine, MN; Skillings, J | 1 |
| Bais, EM; Boogerd, W; Dalesio, O; van der Sande, JJ | 1 |
| Hovi, L; Saarinen, UM; Sariola, H | 1 |
| Ashby, M; Atkinson, K; Biggs, J; Concannon, A; Dodds, A; Downs, K; Wilson, F; Young, S | 1 |
| Armata, J; Balwierz, W; Bogusławska-Jaworska, J; Chybicka, A; Cyklis, R; Darmal, B; Derulska, D; Jackowska, T; Jakowicka, M; Rokicka-Milewska, R | 1 |
| Hartmann, LC; Ingle, JN; Marschke, RF; Schaid, DJ | 1 |
| Bacigalupo, A; Corvò, R; Frassoni, F; Gualandi, F; Lamparelli, T; Occhini, D; Scarpati, D; Sessarego, M; Van Lint, MT; Vitale, V | 1 |
| Ferrari, AM; Marsden, FW; McCarthy, SW; Stephens, FO | 1 |
| Kotz, R; Kropej, D; Ritschl, P; Salzer-Kuntschik, M; Schiller, C | 1 |
| Fujinami, S; Miura, T; Ogihara, Y; Sato, K; Sudo, A | 1 |
| Hochberg, FH; Loeffler, JS; Prados, M | 1 |
| Allen, S; Bosworth, H; Budman, D; Lehrman, D; Lichtman, SM; Schulman, P; Vinciguerra, V; Weiselberg, L; Weiss, R | 1 |
| Cserhati, MD; Exner, GU; Groscurth, P; Honegger, HP; von Hochstetter, A | 1 |
| Raabe, NK | 1 |
| Avril, A; Dilhuydy, JM; Durand, M; Mauriac, L | 1 |
| Frischbier, HJ; Maass, H; Schreer, I; Stegner, HE | 1 |
| Nielsen, H | 1 |
| Clendeninn, NJ; Collier, MA; Dimery, IW; Eble, ML; Jacobs, CD; Karp, D; Molina, A; Vokes, EE | 1 |
| Airoma, G; Bianco, AR; Caponigro, F; Gridelli, C; Incoronato, P; Palmieri, G; Pepe, R | 1 |
| Bhansali, MB; Fakih, AR; Parikh, DM; Parikh, HK; Rao, RS | 1 |
| Beck, D; de Crousaz, H; Deonna, T; Janzer, RC; Miklossy, J; von der Weid, NX | 1 |
| Mwangemi, PM | 1 |
| Crone-Muenzebrock, LS; Garbrecht, M; Henne-Bruns, D; Hossfeld, DK; Kremer, B; Walter, TA; Weh, HJ | 1 |
| Hayashi, A; Kyuma, Y | 1 |
| Berkowitz, RS; Bernstein, MR; Goldstein, DP | 1 |
| Burns, I; Byrne, M; Gill, G; Harvey, V; Levi, JA; Raghavan, D; Sandeman, T; Snyder, R; Tattersall, M; Thomson, D | 1 |
| Brodin, O; Nou, E; Rikner, G; Steinholtz, L | 1 |
| De Boben, M; Diedrich, H; Freund, M; Ganser, A; Heil, G; Henke, M; Heyll, A; Hiddemann, W; Knauf, U; Koch, P | 1 |
| Bode, U; Fengler, R; Hartmann, R; Henze, G; Janka, G; Jürgens, H; Riehm, H | 1 |
| Alberti, G; Anghinoni, E; Bisagni, G; Botti, E; Cocconi, G; di Blasio, B | 1 |
| Abu-Zahra, H; Arnold, A; Bramwell, V; DePauw, S; Findlay, B; Gent, M; Hryniuk, WM; Levin, L; Levine, MN; Skillings, J | 1 |
| Neuhaus, KL; Zeymer, U | 1 |
| Hahn, RG; Keating, JP; Morgan, WR; Zincke, H | 1 |
| Ayala, A; Carrasco, H; Hudson, M; Jaffe, MR; Jaffe, N; Murray, J; Raymond, AK; Robertson, R; Wallace, S | 1 |
| Albo, VC; Hammond, GD; Leikin, SL; Miller, DR; Palmer, NF; Sather, HN | 1 |
| Cirrincione, C; DeAngelis, LM; Heinemann, MH; Krol, G; Thaler, HT; Yahalom, J | 1 |
| Dahl, GV; Johnson, FL; Kalwinsky, DK; Look, AT; Mason, C; Mirro, J; Murphy, SB; Pui, CH; Ruggiero, M; Schell, M | 1 |
| Avella, M; Bacci, G; Brach Del Prever, A; Capanna, R; Gherlinzoni, F; Mancini, A; Mercuri, M; Padovani, G; Picci, P; Ruggieri, P | 1 |
| Dahl, GV; Hudson, MM; Kalwinsky, DK; Pui, CH | 1 |
| Kato, T; Koshikawa, T; Miyake, K; Nagai, T; Sahashi, M; Sakata, T; Takashi, M | 1 |
| Kawada, Y; Kawamoto, S; Kuriyama, M; Nagatani, Y; Sakai, S; Shinoda, I; Takahashi, Y; Takeuchi, T; Ueno, K; Yamamoto, N | 1 |
| Eden, OB | 1 |
| Donhuijsen, K; Günzel, K; Höffken, K; Kath, R; Schmidt, CG | 1 |
| Donovski, L; Kumanov, Kh; Ormanov, I; Panchev, P; Tsvetkov, M | 1 |
| Carbone, PP; Cummings, FJ; Gilchrist, K; Grage, T; Gray, R; Tormey, DC; Woll, JE; Wolter, J | 1 |
| Archibald, SD; Browman, GP; Goodyear, MD; Levine, MN; Russell, R; Young, JE | 1 |
| Blessing, JA; Hatch, KD; Kemp, GM; Muss, HB; Soper, JT; Webster, KD | 1 |
| Engstrom, PF; Horton, J; Kaplan, BH; Lerner, HJ; Schoenfeld, DA; Vogl, SE | 1 |
| Adamo, V; Altavilla, G; Buemi, B; Caristi, N; Scalisi, R; Tropea, F | 1 |
| Baris, G; de Boer, MF; de Jong, PC; Eijkenboom, WM; Knegt, PP; van Andel, JG | 1 |
| Black, M; Frenkiel, S; Gravenor, D; Margolese, R; Panasci, L | 1 |
| Huang, SC; Lui, LT; Lynn, TC | 1 |
| Borlase, BC; Braun, TJ; Johnson, FB; Kennaugh, RC; Meyer, TJ; Meyers, AD; Pearlman, NW; Spofford, BF; Stiegmann, GV | 1 |
| Bocher, R; Dammer, R; Langanke, B | 1 |
| Barzilay, J; Rahima, M; Rakowsky, E; Sidi, J | 1 |
| Bahadur, S; Chatterjee, TK | 1 |
| Rosen, G | 1 |
| Camacho, F; Davis, TE; Seltzer, V; Vogl, SE | 1 |
| Bottomley, RM; Fletcher, W; Gad-el-Mawla, N; Heilbrun, LK; Smith, RE | 1 |
| Ikeda, H; Kagami, Y; Koshiba, R; Narimatsu, N; Nishio, M; Saitoh, A; Sakurai, T | 1 |
| Irie, G; Kamada, T; Matsuoka, Y; Shirato, H; Takamura, A; Tsuji, H; Tsujii, H | 1 |
| Gardin, G; Grimaldi, A; Merlano, M; Rosso, R | 1 |
| Abele, R; Cavalli, F; Gervasi, A; Grossenbacher, R; Honegger, HP; Kaplan, E; Lehmann, W; Mermillod, B; Wolfensberger, M | 1 |
| Campbell, JB; Dorman, EB; Helliwell, TR; McCormick, M; Miles, J; Morton, RP; Rugman, F; Stell, PM; Stoney, PJ; Vauhan, ED | 1 |
| Carlini, P; Cognetti, F; Frassineti, GL; Marangolo, M; Molinari, A; Pinnarò, P | 1 |
| Badellino, F; Berrino, P; Campora, E; Canavese, G; Galli, A; Margarino, G; Santi, PL; Scala, M | 1 |
| Arnold, H; Busch, FW; Günther, E; Heim, ME; Kraft, H; Krüger, HU; Steinke, B | 1 |
| Bergh, J; Brodin, O; Nõu, E | 1 |
| Brincker, H | 1 |
| Dziambor, U; Lotze, W; Richter, P; Sarembe, B | 1 |
| Benedetti Panici, P; Greggi, S; Mancuso, S; Scambia, G | 1 |
| Athanassiou, A; Bafaloukos, D; Barbounis, V; Christodoulou, K; Dimitriadis, M; Pectasides, D | 1 |
| Adamo, V; Altavilla, G; d'Aquino, S; Rigano, A | 1 |
| Haas, J; Jakse, R; Lehnert, M; Scherlacher, A | 2 |
| Irie, G; Kamada, T; Matsuoka, Y; Takamura, A; Tsuji, H; Tsujii, H; Usubuchi, H | 1 |
| Baba, T; Furukohri, N; Itoh, T; Munakata, A; Ogasawara, H; Saitoh, S; Sakata, Y; Tamura, Y; Tsushima, K; Yoshida, Y | 1 |
| Hiraishi, M; Hirata, T; Idezuki, Y; Koike, H; Konishi, T; Mafune, K; Miyama, T | 1 |
| Forrest, PA; Prescott, RJ; Stewart, HJ | 1 |
| Baxter, DH; Mohr, RM; O'Donnell, MR | 1 |
| Clifford, P; Grant, HR | 1 |
| Amoroso, D; Bertelli, G; Botto, F; Campora, E; Conte, PF; Pronzato, P; Rosso, R; Sertoli, MR | 1 |
| Benson, MC; Connor, JP; Olsson, CA; Rapoport, F; Sawczuk, IS | 1 |
| Boyages, J; Connolly, J; Harris, JR; Recht, A; Rose, MA; Schnitt, S; Silver, B | 1 |
| Barten, G; Rösler, EM | 1 |
| Kumanov, Kh; Ormanov, I; Tsvetkov, M | 1 |
| Chilcote, RR; Coccia, PF; Jenkin, RD; Kersey, JH; Meadows, AT; Pringle, KC; Rosenstock, J; Siegel, SE; Sposto, R; Stolar, CJ | 1 |
| Albo, VC; Hammond, GD; Leikin, SL; Miller, DR; Sather, H | 1 |
| Abrams, J; Aisner, J; Eisenberger, M; Ellenberg, S; Krasnow, S; Silva, H; Sinibaldi, V; Van Echo, D | 1 |
| Glück, S; Grabensee, B; Heering, P; Kreusser, W; Meschig, R; Plewig, G | 1 |
| Cedermark, B; Fornander, T; Glas, U; Johansson, H; Nordenskjöld, B; Rotstein, S; Rutqvist, LE; Skoog, L; Somell, A; Theve, T | 1 |
| Bonadonna, G; Brambilla, C; Valagussa, P; Zambetti, M | 1 |
| Behrendt, H; Hermans, J; Schuwirth, C; van der Does-van den Berg, A; van Leeuwen, EF; van Wering, ER; Verkes, RJ | 1 |
| Hattori, T; Jinushi, K; Kim, R; Niimoto, M; Saeki, K; Saeki, T; Toi, M; Yanagawa, E; Yoshinaka, K | 1 |
| Hansen, HS; Lindeløv, B | 1 |
| Lackman, RD; Weiss, AJ | 1 |
| Boyages, J; Come, S; Connolly, JL; Gelman, R; Gore, SM; Henderson, IC; Recht, A; Rose, MA; Schnitt, SJ; Silver, B | 1 |
| Adair, S; Camitta, B; Casper, J; Civin, C; Graham, M; Lauer, S; Leventhal, B; Mahoney, D; Munoz, L; Shuster, JJ | 1 |
| Andrew, M; Barr, RD; Desai, SJ; deVeber, LL; Pai, MK | 1 |
| Arafah, BM; Crowe, JP; Gordon, NH; Hubay, CA; Marshall, JS; McGuire, W; Pearson, OH | 1 |
| Mann, WJ; Patsner, B; Tenhoppen, DJ | 1 |
| Bander, N; Geller, N; Herr, HW; Morse, MJ; Scher, HI; Sogani, PC; Sternberg, CN; Vaughan, ED; Watson, RC; Yagoda, A | 1 |
| Beauduin, M; Bosly, A; Delaunois, L; Doyen, C; Francis, C; Humblet, Y; Longueville, J; Machiels, J; Symann, M; Weynants, P | 1 |
| Bianco, AR; D'Istria, M; De Placido, S; Delrio, G; Gallo, C; Marinelli, A; Pagliarulo, C; Petrella, G | 1 |
| Berry, D; Crist, W; Doering, E; Fernbach, D; Pullen, J; Shuster, J; van Eys, J; Wharam, M | 1 |
| Bashir, R; Gabbai, AA; Hochberg, FH; Hotleman, K; Linggood, RM | 1 |
| Cooper, MR; Falkson, G; Gilchrist, KW; Gray, R; Mansour, EG; Osborne, CK; Shatila, AH; Tormey, DC | 1 |
| Grieve, RJ; Harris, RI; Leyland, MJ; Patton, WN; Sangster, G | 1 |
| Abeloff, MD; Berkman, AW; Markman, M; Waterfield, WC | 1 |
| Anderson, T; Byhardt, RW; Cox, JD; Hoffmann, RG; Holoye, PY; Libnoch, JA | 1 |
| Levin, VA | 1 |
| Kobayashi, O; Matsui, H; Sekiya, S; Takamizawa, H | 1 |
| Eggen, BM; Moe, PJ | 1 |
| Bader, J; Bagley, CS; Danforth, DN; Lippman, ME; Sorace, RA; Steinberg, SM; Swain, SM; Wesley, MN | 1 |
| Scher, HI; Sternberg, CN; Yagoda, A | 1 |
| Arnet, B; Baumgartner, C; Beck, D; Berchtold, W; Bertrand, AM; Bleher, EA; Caflisch, U; Delaleu, B; Feldges, A; Stucki, F | 1 |
| Brucher, P; Ferrière, JM; Gaston, R; Grenier, N; Le Guillou, M; Piechaud, T | 1 |
| Creagan, ET; Eagan, RT; Frytak, S; Nichols, WC; Richardson, RL | 1 |
| Dimery, IW; Legha, SS | 1 |
| Fowble, B; Glick, J; Goodman, R | 1 |
| Bode, U; Erps, M; Schiffer, D | 1 |
| Jakubovicz, D; Koren, G; Peeters, M; Zipursky, A | 1 |
| Biran, S; Brufman, G; Sulkes, A | 1 |
| Ferguson, JC; Harding, MJ; Kaye, SB; Soukop, M | 1 |
| Avella, M; Bacci, G; Boriani, S; Capanna, R; Dallari, D; Galletti, S; Giunti, A; Madon, E; Mancini, A; Mercuri, M | 1 |
| Armata, J; Dłuzewska, A | 1 |
| Ochocka, M; Zelenay, E | 1 |
| Castiglione, M; Gelber, RD; Goldhirsch, A | 1 |
| Eisenberger, MA; Ellenberg, S; Friedman, M; Leyland-Jones, B | 1 |
| Antunez, AR; Crowe, JP; Gordon, NH; Hubay, CA; Marshall, JS; McGuire, WL; Pearson, OH | 1 |
| Andersen, KW; Brincker, H; Dombernowsky, P; Jakobsen, A; Mouridsen, HT; Panduro, J; Rank, F; Rose, C | 1 |
| Ahmann, FR; Jones, SE; Moon, TE | 1 |
| Fowble, BL; Fox, KR; Glick, JH; Glover, DJ; Goodman, RL; Haller, DG; Hurwitz, S; Mackie, JA; Rosato, EF; Weiler, C | 1 |
| Kikuchi, M; Konda, S; Minato, K; Ogawa, M; Ota, K; Shimoyama, M; Takatsuki, K; Tominaga, S; Tsugane, S; Yunoki, K | 1 |
| Baum, ES; Bleyer, WA; Ertel, IJ; Fryer, CJ; Hammond, GD; Krailo, M; Makley, JT; Weetman, RM; Yunis, EJ | 1 |
| Airoldi, M; Brando, V; Gabriele, P; Orecchia, R; Pedani, F | 1 |
| Harnett, AN; Plowman, PN | 1 |
| Tominaga, T | 1 |
| Bezwoda, WR; Derman, DP; Nissenbaum, M | 1 |
| Bateman, JR; Bulcavage, L; Chlebowski, RT; Luce, J; Reynolds, R; Weiner, JM | 1 |
| Luini, A; Veronesi, U; Zucali, R | 1 |
| Baumgarten, E; Buchmann, S; Fengler, R; Grosch-Wörner, I; Henze, G; Schulte-Overberg, U | 1 |
| Kim, TH; Nesbit, ME; Ramsay, NK; Steeves, RA | 1 |
| Koch, U; Rauchfuss, A | 1 |
| Scheiber, A; Schmidt-Gollwitzer, K; Schönegg, W; Wessel, J | 1 |
| Beattie, CW; Das Gupta, TK; Hart, G; Mehta, RR | 1 |
| Bode, U | 1 |
| Cześnin, K; Sablińska, B | 1 |
| Falkson, G; Gelman, RS; Pretorius, FJ | 1 |
| Bonadonna, G; Tancini, G; Valagussa, P | 1 |
| Dembo, AJ | 1 |
| Belli, F; Bufalino, R; Cascinelli, N; Di Fronzo, G; Galluzzo, D; Greco, M; Merson, M; Oriana, R; Sacchini, V; Veronesi, U | 1 |
| Goldobenko, GV; Iarmonenko, SP; Muratkhodzhaev, NK; Svetitskiĭ, PV | 1 |
| Airoldi, M; Camoletto, D; Fazio, M; Gandolfo, S; Negri, L; Ozzello, F; Pedani, F; Vercellino, V | 1 |
| Bonadonna, G; Brambilla, C; Rossi, A; Tancini, G; Valagussa, P; Veronesi, U; Zambetti, M | 1 |
| Cherchi, PL; Dessole, S; Fadda, G; Piras, G; Sardu, GM | 1 |
| Blumenschein, GR; Buzdar, AU; Fastenberg, NA; Hortobagyi, GN; Jessup, JM; Martin, RG; Montague, ED | 1 |
| Airoldi, M; Fazio, M; Gandolfo, S; Ozzello, F; Pedani, F | 1 |
| Jakse, R; Lehnert, M; Scherlacher, A | 1 |
| Djerassi, I; Kim, JS; Reggev, A | 1 |
| Ayala, A; Cangir, A; Carrasco, H; Eftekhari, F; Jaffe, N; Robertson, R; Takaue, Y; Wallace, S; Wang, A | 1 |
| Johnson, JT; Mayernik, DG; Myers, EN; Nolan, TA; Schramm, VL; Sigler, BA; Srodes, CH; Wagner, RL | 1 |
| Bennett, JM; Carbone, PP; Cummings, F; Falkson, G; Kalish, LA; Olson, JE; Taylor, SG; Tormey, DC | 1 |
| Bonadonna, G; Valagussa, P | 1 |
| Durrant, KR; Giraud-Saunders, AM; Gough, MH; McPherson, K; Paine, CH; Vessey, MP | 1 |
| Ausserer, B; Bettelheim, P; Gadner, H; Grienberger, H; Grümayer, ER; Haas, OA; Krepler, P; Kummer, M; Pawlovsky, J; Schmidmeier, W | 1 |
| Lee, YT | 1 |
| Hall, RR | 1 |
| Delgado, G; Edwards, BK; Marantz, AB; Posada, JG; Schein, PS; Smith, FP; Yeung, KY | 1 |
| Herr, HW | 1 |
| Chambers, JT; Schwartz, PE | 1 |
| Glatstein, E; Glenn, J; Kinsella, T; Lack, EE; Potter, DA; Restrepo, C; Rosenberg, SA; Seipp, CA; Wesley, R; White, DE | 1 |
| Bachenheimer, L; Beiser, C; Byrne, P; Dritschilo, A; Goldberg, R; Smith, F; Smith, L; Stefanik, D; Ueno, W | 1 |
| Taguchi, T | 1 |
| Diez, E; Figueiredo, L; Jamardo, D; Nogueira March, JL; Ojea, A; Perez Villanueva, J | 1 |
| Boyd, NF; Campbell, JA; Elhakim, T; Heasman, KZ; Sutherland, HJ | 1 |
| Ford, J; Margolese, R; Panasci, L | 1 |
| Goplerud, DR; Krebs, HB; Myers, M; Wheelock, JB | 1 |
| Benchev, V; Pavlov, P | 1 |
| Hong, WK; Kies, MS; Levitan, N | 1 |
| Hoshino, A; Ito, Y; Kamiya, O; Kinoshita, T; Kojima, T; Nagata, K; Ohara, K; Sugiura, I | 1 |
| Freiha, FS; Hannigan, JF; Harker, WG; McWhirter, KM; Meyers, FJ; Palmer, JM; Shortliffe, LD; Torti, FM | 1 |
| Southwick, HW | 1 |
| Vahlensieck, W; Weissbach, L | 1 |
| Stephens, FO | 3 |
| Richard, JM; Sancho, H | 1 |
| Leroux-Robert, J | 1 |
| Simmonds, WP | 1 |
| Griffen, WO; Humphrey, L; Sosin, H | 1 |
| Goncharova, MG; Murav'eva, NI; Sharoukhova, KS; Smirnova, KD; Sokolova, VD | 1 |
| Watt, J | 1 |
| Hoeg, K; Kolstad, P; Norman, N | 1 |
| Bluming, AZ; Fass, L; Iversen, OH; Morrow, RH; Ziegler, JL | 1 |
| Clifford, P; Demissie, A; Guerra, A; Gunvén, P; Henle, G; Henle, W; Hewetson, JF; Klein, G; Rocchi, G; Singh, S; Svedmyr, A | 1 |
| Williams, RG | 1 |
| Aur, RJ; Borella, L; Green, AA; Pinkel, D; Simone, JV | 1 |
| Benoist, M; Brocheriou, C; Chikhani, P; Guilbert, F; Rouchon, C | 1 |
| Goepfert, H; Jesse, RH; Lindberg, RD | 1 |
| Deck, M; Ghavimi, F; Murphy, ML; Rosen, G; Tan, C; Vanucci, R | 1 |
| Hill, GJ; Larsen, RR | 1 |
| Kaulen-Becker, L | 1 |
| Lewis, GC | 1 |
| Donaldson, RC | 1 |
| Reymann, F | 1 |
| Nkrumah, FK; Perkins, IV | 1 |
| Kiehn, C; Mandel, MA | 1 |
| Abeloff, MD; Baker, RR; Lee, JM; Lenhard, RE | 1 |
| Chamoun, CD; Downing, V; Huseby, RA | 1 |
| Heenan, PJ; Wright, JL | 1 |
| Clark, DB; Norrell, H; Slagel, DE; Wilson, CB | 1 |
| Edelstyn, GA; Marcrae, KD | 1 |
| Frew, I | 1 |
| Burns, BC; Rutledge, F; Smith, JP; Soffar, S | 1 |
| Hall, TC | 1 |
| Engel, S; Jacobi, H; Richter, G | 1 |
| Meriwether, WD; Ramsey, HE; Ward, SP | 1 |
| Donaldson, M; Lulenski, G; Newcombe, D | 1 |
| Tindel, S | 1 |
| Carnot, F; Galey, JJ; Lemoine, G; Mathey, J; Maurel, A; Vanetti, A | 1 |
| Ansfield, FJ; Davis, HL; Korbitz, BC; Ramirez, G | 1 |
| Bottomley, RH | 1 |
| Carbone, PP; Fass, L; Kyalwazi, SK; Morrow, RH; Ziegler, JL | 1 |
| Goldstein, DP | 1 |
| Espiner, HJ | 1 |
| Andrýsek, O; Dvorák, O; Stránská, E | 1 |
| Brunner, KW; Ryssel, HJ; Sonntag, RW | 1 |
| Burge, KM; Winkelmann, RK | 1 |
86 review(s) available for methotrexate and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Primary central nervous system lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Tumor Microenvironment | 2022 |
Primary Central Nervous System Lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Combined Modality Therapy; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Stem Cell Transplantation | 2022 |
Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature.
Topics: Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 2022 |
Central Nervous System Lymphoma: Novel Therapies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local | 2022 |
Pralatrexate for Peripheral T-Cell Lymphoma (PTCL): Chance Only Supports The Prepared Mind.
Topics: COVID-19; Folic Acid Antagonists; Humans; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Meta-Analysis as Topic; Methotrexate; Neoplasm Recurrence, Local; SARS-CoV-2; Skin Neoplasms; Systematic Reviews as Topic; United States | 2023 |
The role of central nervous system (CNS) prophylaxis in preventing DLBCL patients from CNS relapse: A network meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cyclophosphamide; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Network Meta-Analysis; Prospective Studies; Rituximab; Vincristine | 2022 |
CNS prophylaxis for diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local | 2022 |
Primary central nervous system other iatrogenic immunodeficiency-associated lymphoproliferative disorders presenting as extraosseous plasmacytoma with a progressive clinical course: A case report and literature review.
Topics: Aged; Arthritis, Rheumatoid; Central Nervous System; Disease Progression; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Iatrogenic Disease; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Neoplasm Recurrence, Local; Plasmacytoma | 2023 |
Chemoresistance-Related Stem Cell Signaling in Osteosarcoma and Its Plausible Contribution to Poor Therapeutic Response: A Discussion That Still Matters.
Topics: Adolescent; Bone Neoplasms; Child; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Humans; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Signal Transduction | 2022 |
Prophylaxis strategies containing high dose intravenous methotrexate on preventing CNS relapse for patients with diffuse large B-cell lymphoma at intermediate to high risk: A study based on 12 cohorts in the rituximab era.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Rituximab; Vincristine | 2022 |
Performance status, comorbidities, and cycles of methotrexate exert the greatest influence on outcomes of primary and secondary CNS lymphomas: the Lexington experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Comorbidity; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies | 2023 |
Prevention and management of secondary central nervous system lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Prospective Studies; Retrospective Studies | 2023 |
CNS prophylaxis in aggressive B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Rituximab | 2022 |
Treatments and outcomes in high-risk gestational trophoblastic neoplasia: A systematic review and meta-analysis.
Topics: Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies | 2023 |
Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies; Rituximab; Vincristine | 2023 |
Systemic Therapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma- A Systematic Review and Meta-Analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Recurrence, Local; Squamous Cell Carcinoma of Head and Neck | 2020 |
Challenges in the Treatment of Newly Diagnosed and Recurrent Primary Central Nervous System Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Central Nervous System; Central Nervous System Neoplasms; Cranial Irradiation; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prospective Studies; Retrospective Studies; Transplantation, Autologous | 2020 |
Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur-uracil with CMF (N·SAS-BC 01 trial and CUBC trial).
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Neoplasm Recurrence, Local; Prospective Studies; Randomized Controlled Trials as Topic; Tegafur | 2021 |
Central Nervous System Lymphomas.
Topics: Central Nervous System; Central Nervous System Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Tumor Microenvironment | 2020 |
Secondary CNS relapse in diffuse large B-cell lymphoma: defining high-risk patients and optimization of prophylaxis strategies.
Topics: Central Nervous System Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Models, Neurological; Neoplasm Recurrence, Local; Rituximab; Secondary Prevention | 2017 |
Central Nervous System Prophylaxis Strategies in Diffuse Large B Cell Lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Rituximab; Vincristine | 2018 |
Comparison of second-line treatments of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Recurrence, Local; Network Meta-Analysis; Nivolumab; Progression-Free Survival; Randomized Controlled Trials as Topic; Squamous Cell Carcinoma of Head and Neck; Survival Analysis | 2019 |
Aggressive Non-Hodgkin lymphomas: risk factors and treatment of central nervous system recurrence.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Risk Factors; Stem Cell Transplantation; Treatment Outcome | 2019 |
Recurrent primary cardiac osteosarcoma: a case report and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Fatal Outcome; Heart Neoplasms; Humans; Ifosfamide; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Reoperation | 2014 |
Primary CNS lymphoma arising in the region of the optic nerve presenting as loss of vision: 2 case reports, including a patient with a massive intracerebral hemorrhage.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Blindness; Cerebral Hemorrhage; Female; Humans; Hypopituitarism; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Recurrence, Local; Optic Nerve Neoplasms; Predictive Value of Tests; Remission Induction; Rituximab; Vascular Endothelial Growth Factor A | 2014 |
[Malignant lymphoma in the central nervous system: overview].
Topics: Blood-Brain Barrier; Central Nervous System Neoplasms; Humans; Lymphoma; Methotrexate; Neoplasm Recurrence, Local; Positron-Emission Tomography | 2014 |
Temporal changes in the efficacy of chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Head and Neck Neoplasms; Humans; Linear Models; Methotrexate; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2014 |
The role of chemotherapy for metastatic, relapsed and refractory osteosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Deoxycytidine; Docetaxel; Etoposide; Gemcitabine; Humans; Ifosfamide; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Taxoids | 2014 |
Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but Also.
Topics: Anthracyclines; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Centromere; Chromosomes, Human, Pair 17; Clinical Trials, Phase III as Topic; Cyclophosphamide; Disease-Free Survival; DNA Topoisomerases, Type II; DNA-Binding Proteins; Fluorescent Dyes; Fluorouracil; Genetic Markers; Humans; In Situ Hybridization, Fluorescence; Methotrexate; Neoplasm Recurrence, Local; Neoplasms; Poly-ADP-Ribose Binding Proteins; Prognosis; Proportional Hazards Models; Treatment Outcome | 2015 |
Research Progress in Head and Neck Squamous Cell Carcinoma: Best Abstracts of ICHNO 2015.
Topics: Afatinib; Antineoplastic Agents; Carcinoma, Squamous Cell; Early Detection of Cancer; Head and Neck Neoplasms; Humans; Immunotherapy; Meta-Analysis as Topic; Methotrexate; Molecular Diagnostic Techniques; Molecular Targeted Therapy; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Papillomavirus Vaccines; Postoperative Care; Precision Medicine; Quinazolines; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Squamous Cell Carcinoma of Head and Neck; Therapies, Investigational | 2015 |
Multiple myeloma: from front-line to relapsed therapies.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance, Neoplasm; Humans; Methotrexate; Multiple Myeloma; Neoplasm Recurrence, Local; Oligopeptides; Randomized Controlled Trials as Topic; Salvage Therapy; Stem Cell Transplantation; Thalidomide; Transplantation, Autologous; Vincristine | 2015 |
Afatinib in squamous cell carcinoma of the head and neck.
Topics: Afatinib; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Disease-Free Survival; Head and Neck Neoplasms; Humans; Maximum Tolerated Dose; Methotrexate; Neoplasm Recurrence, Local; Quinazolines; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2016 |
[Role of radiotherapy in the treatment of NK/T-cell nasal type and primary cerebral lymphomas].
Topics: Antineoplastic Agents; Brain Neoplasms; Chemotherapy, Adjuvant; Dementia; Humans; Lymphoma; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Neoplasm Recurrence, Local; Nose Neoplasms; Prognosis; Radiotherapy Dosage; Radiotherapy, Adjuvant; Stem Cell Transplantation | 2016 |
Practical issues in the management of low-risk gestational trophoblast tumors.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Drug Resistance, Neoplasm; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Leucovorin; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Risk Assessment; Treatment Outcome; Uterine Neoplasms | 2008 |
[Medical management of primary central nervous system lymphoma refractory or resistant to standard of care treatment].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Dacarbazine; Drug Discovery; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Methotrexate; Neoplasm Recurrence, Local; Rituximab; Salvage Therapy; Temozolomide; Topotecan | 2009 |
[Interstitial mycosis fungoid: a rare variant of mycosis fungoids. Two cases].
Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Clobetasol; Female; Humans; Immunophenotyping; Male; Methotrexate; Middle Aged; Mycosis Fungoides; Neoplasm Recurrence, Local; PUVA Therapy; Skin Neoplasms; T-Lymphocyte Subsets | 2011 |
[Treatment strategy for central nervous system involvement in intravascular large B-cell lymphoma].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Prednisolone; Rituximab; Vascular Neoplasms; Vincristine | 2011 |
Successful combined treatment for giant mesenteric desmoid tumor: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Diagnostic Imaging; Female; Fibromatosis, Aggressive; Humans; Kidney Neoplasms; Mesentery; Methotrexate; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Nephrectomy; Peritoneal Neoplasms; Remission Induction; Vinblastine; Wilms Tumor | 2012 |
Combined modality therapy versus chemotherapy alone as an induction regimen for primary central nervous system lymphoma: a decision analysis.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Decision Support Techniques; Humans; Infant; Life Expectancy; Lymphoma; Markov Chains; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Quality of Life; Quality-Adjusted Life Years; Remission Induction; Survival Analysis; Treatment Outcome; Young Adult | 2012 |
[Recent advance in adjuvant therapy for breast cancer].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Tamoxifen; Tegafur; Uracil | 2002 |
[Bladder cancer: realities and perspectives].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Female; Genes, erbB-2; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Urinary Bladder Neoplasms; Vinblastine | 2003 |
Ten-year outcome after combined modality therapy for inflammatory breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Life Tables; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pennsylvania; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome | 2003 |
[Radiation and concomitant chemotherapy after surgery for breast cancer].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pilot Projects; Postoperative Care; Radiotherapy Dosage; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Time Factors | 2004 |
[Sequencing of adjuvant treatment after surgery for invasive breast cancer].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Hormones; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prognosis; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Tamoxifen; Time Factors; Trastuzumab | 2004 |
Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Agents, Alkylating; Brain Neoplasms; Central Nervous System Neoplasms; Cohort Studies; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Drug Evaluation; Drug Resistance, Neoplasm; Eye Neoplasms; Female; Humans; Immunotherapy; Life Tables; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Temozolomide; Treatment Outcome | 2004 |
Signet ring cell adenocarcinoma of the urachus.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Doxorubicin; Fatal Outcome; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Tomography, X-Ray Computed; Urachus; Vinblastine | 2004 |
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study.
Topics: Adult; Aged; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic; Risk Factors; Survival Analysis; Treatment Outcome | 2005 |
Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Fluorouracil; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Patient Selection; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Taxoids; Treatment Outcome | 2006 |
[Primitif cerebral lymphoma].
Topics: Age Factors; Aged; Antimetabolites, Antineoplastic; Biopsy; Brain; Brain Neoplasms; Combined Modality Therapy; Diagnosis, Differential; Epstein-Barr Virus Infections; Eye Neoplasms; HIV Infections; Humans; Immunocompromised Host; Incidence; Lymphoma; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiotherapy Dosage; Time Factors; Tomography, X-Ray Computed | 2006 |
Recurrent head and neck cancer: current treatment and future prospects.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Fluorouracil; Forecasting; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Recurrence, Local; Palliative Care; Salvage Therapy | 2008 |
Chemotherapy strategies in squamous cell carcinoma of the head and neck.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Immunotherapy; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Random Allocation; Sex Factors; Time Factors | 1984 |
[Methotrexate citrovorum factor therapy in advanced hypernephromas (author's transl)].
Topics: Adenocarcinoma; Alkylating Agents; Bleomycin; Drug Therapy, Combination; Humans; Kidney Neoplasms; Leucovorin; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Vincristine | 1980 |
Integration of chemotherapy into a combined modality treatment plan for head and neck cancer: a review.
Topics: Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Recurrence, Local; Random Allocation | 1981 |
[Adjuvant chemotherapy in breast cancer: status in 1984].
Topics: Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Neoplasm Recurrence, Local; Time Factors | 1984 |
Adjuvant systemic therapy in primary breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Estrogen Antagonists; Female; Fluorouracil; Humans; Mastectomy; Melphalan; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Random Allocation; Receptors, Estrogen; Tamoxifen; Time Factors | 1984 |
Intravesical chemotherapy.
Topics: Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Humans; Methotrexate; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Thiotepa; Urinary Bladder Neoplasms | 1984 |
Intravesical and systemic chemotherapy in the management of superficial bladder cancer.
Topics: Administration, Topical; Aged; Antineoplastic Agents; Biopsy; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Endoscopy; Female; Humans; Male; Methotrexate; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Random Allocation; Risk; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms; Vitamins | 1984 |
[Progress in the internist treatment of bladder tumors].
Topics: Antineoplastic Agents; BCG Vaccine; Cisplatin; Doxorubicin; Ethoglucid; Humans; Leucovorin; Methotrexate; Mitomycins; Neoplasm Metastasis; Neoplasm Recurrence, Local; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1982 |
Adjuvant drug strategies in the treatment of recurrent respiratory papillomatosis.
Topics: Adolescent; Adult; Age of Onset; Aged; Chemotherapy, Adjuvant; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Interferons; Isotretinoin; Laryngeal Neoplasms; Laser Therapy; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Papilloma; Remission Induction; Retrospective Studies; Tracheal Neoplasms | 1995 |
Recurrent breast cancer: presentation, diagnosis, and treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Breast Neoplasms; Central Nervous System Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Mastectomy; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Palliative Care; Radiotherapy; Soft Tissue Neoplasms | 1993 |
Persistent nonmetastatic gestational trophoblastic disease.
Topics: Adult; Antineoplastic Agents; Chorionic Gonadotropin; Dilatation and Curettage; Female; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms | 1995 |
Experience of the EORTC Radiotherapy/Chemotherapy Group in osteosarcoma trials.
Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disarticulation; Doxorubicin; Europe; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Survival Analysis; Treatment Outcome; Vincristine | 1993 |
Treatment of olfactory neuroblastoma. A report of 11 cases.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Esthesioneuroblastoma, Olfactory; Female; Follow-Up Studies; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Nasal Cavity; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Nose Neoplasms; Radiotherapy Dosage; Remission Induction; Retrospective Studies; Survival Rate | 1996 |
Adjuvant drug therapy for operable breast cancer.
Topics: Age Distribution; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Risk Assessment; Tamoxifen | 1996 |
[Characteristic and effective usage of adriamycin].
Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Humans; Methotrexate; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms; Vinblastine | 1996 |
Meningeal carcinomatosis as the presenting manifestation of gastric adenocarcinoma.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Doxorubicin; Fluorouracil; Humans; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Stomach Neoplasms | 1997 |
Arterial infusion chemotherapy for peritoneal and liver metastasis in gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lymphatic Metastasis; Methotrexate; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Stomach Neoplasms | 1997 |
[Treatment for recurrent head and neck carcinomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Combined Modality Therapy; Epirubicin; Fluorouracil; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy Dosage | 1998 |
[Recurrent urological cancer--diagnose and treatment].
Topics: Abdomen; Administration, Intravesical; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Biomarkers, Tumor; Chemotherapy, Adjuvant; Cisplatin; Cystoscopy; Doxorubicin; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Nuclear Proteins; Prostate-Specific Antigen; Prostatic Neoplasms; Ultrasonography; Urinary Bladder Neoplasms; Vinblastine | 1998 |
[MTX/5FU sequential therapy for advanced and recurrent gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Disseminated Intravascular Coagulation; Female; Fluorouracil; Folic Acid Antagonists; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Quality of Life; Ribonucleotide Reductases; Stomach Neoplasms; Thymidylate Synthase; Treatment Outcome | 2001 |
[Adjuvant therapy of breast cancer].
Topics: Adult; Age Factors; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Goserelin; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ovariectomy; Postoperative Care; Preoperative Care; Prognosis; Risk Factors; Tamoxifen | 2001 |
Therapeutic management of refractory or relapsed primary central nervous system lymphomas.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Hematopoietic Stem Cell Transplantation; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine | 2001 |
Meta-analysis of adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy in postmenopausal women with estrogen receptor-positive, node-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Survival Rate | 2001 |
Treating the relapsed patient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Recurrence, Local; Salvage Therapy; Survival Rate | 1992 |
Current management, local management, and survival statistics of high-grade osteosarcoma. Experience in Japan.
Topics: Adult; Aged; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Follow-Up Studies; Humans; Japan; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Osteosarcoma; Osteotomy; Survival Analysis; Survival Rate | 1991 |
The therapy of primary brain lymphoma.
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Evaluation Studies as Topic; Eye Neoplasms; Humans; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Life Tables; Lymphoma, Non-Hodgkin; Meningeal Neoplasms; Methotrexate; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Radiotherapy; Spinal Neoplasms; Survival Rate; Transplantation | 1991 |
Acute fatal myeloencephalopathy after combined intrathecal chemotherapy in a child with acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Child; Coma; Cytarabine; Female; Humans; Injections, Spinal; Methotrexate; Neoplasm Recurrence, Local; Paralysis; Paraplegia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Spinal Cord Diseases | 1991 |
Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Double-Blind Method; Female; Head and Neck Neoplasms; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Placebos; Prospective Studies; Randomized Controlled Trials as Topic; Remission Induction | 1990 |
Chemotherapy of primary brain tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Brain Stem; Child; Eflornithine; Ependymoma; Fluorouracil; Glioblastoma; Humans; Hydroxyurea; Lomustine; Medulloblastoma; Methotrexate; Mitoguazone; Mitolactol; Neoplasm Recurrence, Local; Ornithine; Prednisone; Risk; Thioguanine; Vincristine | 1985 |
[Cisplatin-based chemotherapy in the treatment of advanced-stage tumors of the bladder].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Urinary Bladder Neoplasms; Vinblastine | 1988 |
The application of a two-stage design for clinical trials in patients with recurrent head and neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Clinical Trials as Topic; Drug Evaluation; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Recurrence, Local; Organoplatinum Compounds; Random Allocation; Research Design | 1988 |
Adjuvant systemic therapy for resectable breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Immunotherapy; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Prognosis; Research Design; Tamoxifen | 1985 |
Patterns of metastasis and natural courses of breast carcinoma.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Receptors, Estrogen; Recurrence | 1985 |
The prognosis and management of recurrent abdominal malignancies.
Topics: Abdominal Neoplasms; Adolescent; Adult; Antineoplastic Agents; Bile Duct Neoplasms; Chemotherapy, Cancer, Regional Perfusion; Colonic Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Injections, Intra-Arterial; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Palliative Care; Pancreatic Neoplasms; Prognosis; Rectal Neoplasms; Stomach Neoplasms; Thiotepa | 1969 |
The use of cytotoxic drugs in the surgery of malignant disease.
Topics: Abdominal Neoplasms; Alkylating Agents; Animals; Antimetabolites; Antineoplastic Agents; Carcinoma, Basal Cell; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Dysgerminoma; Female; Fluorouracil; Head; Head and Neck Neoplasms; Hodgkin Disease; Humans; Injections, Intra-Arterial; Leg; Melanoma; Melphalan; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Nitrogen Mustard Compounds; Pregnancy; Sarcoma; Sarcoma, Ewing; Skin Neoplasms; Vinblastine; Wilms Tumor | 1968 |
Chemotherapy of breast cancer.
Topics: Adrenal Cortex Hormones; Alkaloids; Alkylating Agents; Androgens; Antimetabolites; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Cytosine; Estrogens; Fluorouracil; Hormones; Humans; Mercaptopurine; Methotrexate; Mitomycins; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds; Thiotepa | 1968 |
313 trial(s) available for methotrexate and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vincristine | 2022 |
Efficacy of Methotrexate Alone vs Methotrexate Plus Low-Dose Prednisone in Patients With Alopecia Areata Totalis or Universalis: A 2-Step Double-Blind Randomized Clinical Trial.
Topics: Adult; Alopecia Areata; Double-Blind Method; Female; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Quality of Life; Treatment Outcome | 2023 |
Longitudinal Analysis of Ocular Manifestation and Interleukin During Intravitreal Treatment of Vitreoretinal Lymphoma With Methotrexate.
Topics: Eye Diseases; Eye Neoplasms; Humans; Interleukin-10; Intravitreal Injections; Lymphoma; Methotrexate; Neoplasm Recurrence, Local; Retinal Neoplasms; Retrospective Studies; Vitreous Body | 2023 |
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bronchiolitis Obliterans Syndrome; Cyclophosphamide; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Mycophenolic Acid; Neoplasm Recurrence, Local; Tacrolimus; Unrelated Donors | 2023 |
Long-term Outcomes in Primary CNS Lymphoma After R-MVP and High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplant.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Disease Progression; Hematopoietic Stem Cell Transplantation; Humans; Leukoencephalopathies; Lymphoma; Methotrexate; Neoplasm Recurrence, Local; Rituximab; Transplantation, Autologous; Vincristine | 2023 |
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention.
Topics: Enzyme Inhibitors; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methotrexate; Mucositis; Mycophenolic Acid; Neoplasm Recurrence, Local; Tacrolimus | 2023 |
Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Docetaxel; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Recurrence, Local; Platinum; Squamous Cell Carcinoma of Head and Neck | 2023 |
Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial.
Topics: Afatinib; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; ErbB Receptors; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Quinazolines; Squamous Cell Carcinoma of Head and Neck; Treatment Adherence and Compliance; Treatment Outcome | 2019 |
Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III trial
Topics: Adult; Afatinib; Aged; Aged, 80 and over; Antineoplastic Agents; Asian People; Carboplatin; Cisplatin; Disease Progression; Disease-Free Survival; Feasibility Studies; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Progression-Free Survival; Squamous Cell Carcinoma of Head and Neck | 2019 |
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Agents; Breast Neoplasms; Bridged-Ring Compounds; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Taxoids; Treatment Outcome; Young Adult | 2020 |
Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemoradiotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Treatment Outcome; Young Adult | 2020 |
Methotrexate plus or minus cetuximab as first-line treatment in a recurrent or metastatic (R/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for cisplatin combination treatment, a phase Ib-randomized phase II study Commence.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Recurrence, Local; Quality of Life; Squamous Cell Carcinoma of Head and Neck | 2020 |
Immunohistochemistry for c-myc and bcl-2 overexpression improves risk stratification in primary central nervous system lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Central Nervous System Neoplasms; Cytarabine; Disease Progression; Female; Follow-Up Studies; Humans; Immunohistochemistry; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Retrospective Studies; Risk Assessment; Survival Rate | 2020 |
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Rituximab; Vincristine | 2020 |
Impact of contemporary regimens on the outcomes and toxicity of primary CNS lymphoma: a single-center retrospective analysis of 73 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Rituximab; Survival Rate; Venous Thromboembolism | 2021 |
The efficacy, safety and cost-effectiveness of hydroxychloroquine, sulfasalazine, methotrexate triple therapy in preventing relapse among patients with rheumatoid arthritis achieving clinical remission or low disease activity: the study protocol of a rand
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Neoplasm Recurrence, Local; Quality of Life; Randomized Controlled Trials as Topic; Severity of Illness Index; Sulfasalazine; Treatment Outcome | 2021 |
Phase I/II trial of lenalidomide, methotrexate, leucovorin, cytarabine, and rituximab (LeMLAR) in relapsed or refractory diffuse large B cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Lenalidomide; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Rituximab; Survival Analysis | 2021 |
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer.
Topics: Administration, Intravenous; Administration, Oral; Afatinib; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Biopsy; Carcinoma, Squamous Cell; Disease-Free Survival; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Predictive Value of Tests; Quinazolines; Squamous Cell Carcinoma of Head and Neck | 2017 |
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Chemotherapy-Induced Febrile Neutropenia; Cyclophosphamide; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Lymphoma, Mantle-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Rituximab; Survival Rate; Time Factors; Treatment Failure; Vincristine | 2018 |
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Disease Progression; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Squamous Cell Carcinoma of Head and Neck | 2019 |
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma.
Topics: Adenine; Adult; Agammaglobulinaemia Tyrosine Kinase; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Circulating Tumor DNA; Female; Humans; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Rituximab; Treatment Outcome; Young Adult | 2019 |
Bilateral radiation therapy followed by methotrexate-based chemotherapy for primary vitreoretinal lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Chemoradiotherapy; Disease-Free Survival; Female; Follow-Up Studies; Humans; Intraocular Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retinal Neoplasms; Survival Rate; Time Factors | 2019 |
A Q-TWiST Analysis Comparing Nivolumab and Therapy of Investigator's Choice in Patients with Recurrent/Metastatic Platinum-Refractory Squamous Cell Carcinoma of the Head and Neck.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Disease Progression; Docetaxel; Follow-Up Studies; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Recurrence, Local; Nivolumab; Quality of Life; Squamous Cell Carcinoma of Head and Neck; Survival | 2019 |
The circadian schedule for childhood acute lymphoblastic leukemia maintenance therapy does not influence event-free survival in the NOPHO ALL92 protocol.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Circadian Rhythm; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Prospective Studies; Survival Rate | 2014 |
Sixteen years follow-up results of a randomized phase II trial of neoadjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) compared with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in stage III breast cancer: GOCS experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Prospective Studies; Survival; Young Adult | 2014 |
Clinical characteristics and treatment outcome of Langerhans cell histiocytosis: 22 years' experience of 154 patients at a single center.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Female; Follow-Up Studies; Histiocytosis, Langerhans-Cell; Humans; Infant; Infant, Newborn; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisolone; Prognosis; Retrospective Studies; Salvage Therapy; Seoul; Survival Rate; Time Factors; Vinblastine; Young Adult | 2014 |
Relationship between the prognostic and predictive value of the intrinsic subtypes and a validated gene profile predictive of loco-regional control and benefit from post-mastectomy radiotherapy in patients with high-risk breast cancer.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemoradiotherapy; Cyclophosphamide; ErbB Receptors; Female; Fluorouracil; Gene Expression Profiling; Humans; Immunohistochemistry; Ki-67 Antigen; Lymph Node Excision; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Predictive Value of Tests; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 2014 |
Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy.
Topics: Afatinib; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Clinical Protocols; Disease Progression; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Quinazolines; Retreatment; Squamous Cell Carcinoma of Head and Neck | 2014 |
Postinduction minimal residual disease monitoring by polymerase chain reaction in children with acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Humans; Infant; Italy; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Real-Time Polymerase Chain Reaction; Remission Induction; Steroids; Treatment Outcome | 2014 |
Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Doxorubicin; Extremities; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Prognosis; Retrospective Studies; Survival Rate; Taiwan | 2015 |
The RAD51 135G>C polymorphism is related to the effect of adjuvant therapy in early breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Cytosine; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Genotype; Guanine; Humans; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Predictive Value of Tests; Prognosis; Rad51 Recombinase; Radiotherapy, Adjuvant; Sequence Analysis, DNA; Treatment Outcome | 2015 |
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Survival Rate; Taxoids | 2015 |
Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory/relapsed cutaneous T-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Recombinant Proteins; Remission Induction; Skin Neoplasms; Survival Analysis; T-Lymphocytes; Treatment Outcome; Tretinoin | 2015 |
p53 status identifies triple-negative breast cancer patients who do not respond to adjuvant chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Female; Fluorouracil; Genes, p53; Humans; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Phenotype; Prognosis; Prospective Studies; Survival Analysis; Topoisomerase II Inhibitors; Treatment Outcome; Triple Negative Breast Neoplasms; Tumor Suppressor Protein p53 | 2015 |
Long-term results of the AIEOP LNH-97 protocol for childhood lymphoblastic lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Child; Cyclophosphamide; Disease Progression; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Male; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2015 |
Gefitinib, Methotrexate and Methotrexate plus 5-Fluorouracil as palliative treatment in recurrent head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Fluorouracil; Gefitinib; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Quality of Life; Quinazolines; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2015 |
Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Infant; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Remission Induction; Risk Factors; United States; Vincristine | 2015 |
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.
Topics: Adult; Afatinib; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Quinazolines; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2015 |
Cardiac assessment of early breast cancer patients 18 years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Echocardiography; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Heart Failure; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Prognosis; Proportional Hazards Models; Survival Rate; Ventricular Dysfunction, Left | 2015 |
Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Female; Follow-Up Studies; Humans; Immunotherapy; Intraocular Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Procarbazine; Prognosis; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Vincristine | 2016 |
Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncolo
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Disease-Free Survival; Drug Administration Schedule; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors; Vidarabine | 2015 |
DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; China; Cisplatin; Deoxycytidine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Natural Killer T-Cells; Neoplasm Recurrence, Local; Polyethylene Glycols; Remission Induction; Young Adult | 2016 |
Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial.
Topics: Afatinib; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Quinazolines; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2016 |
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Stem Cell Transplantation; Thiotepa; Transplantation, Autologous | 2016 |
No breast cancer subgroup can be spared postoperative radiotherapy after breast-conserving surgery. Fifteen-year results from the Swedish Breast Cancer Group randomised trial, SweBCG 91 RT.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Estrogen Antagonists; Female; Fluorouracil; Follow-Up Studies; Humans; Longitudinal Studies; Lymph Node Excision; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy, Adjuvant; Sweden; Tamoxifen; Tumor Burden | 2016 |
Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Mantle-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Recurrence; Rituximab; Salvage Therapy; Vincristine | 2008 |
Treatment of relapsed or refractory aggressive non-hodgkin lymphoma with two ifosfamide-based regimens, IMVP and ICE.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Treatment Outcome | 2008 |
Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Gefitinib; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Quality of Life; Quinazolines; Survival Analysis; Treatment Outcome | 2009 |
Adjuvant chemotherapy in older women with early-stage breast cancer.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Deoxycytidine; Doxorubicin; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Receptors, Estrogen; Survival Analysis | 2009 |
Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
Topics: Administration, Oral; Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 2009 |
Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Malta; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Risk Assessment; Time Factors; Treatment Outcome; Turkey; United Kingdom; Vincristine; Young Adult | 2010 |
Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Endpoint Determination; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Taxoids; Vitamin B Complex | 2010 |
Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy.
Topics: Age Factors; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Mastectomy, Segmental; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Receptors, Estrogen; Regression Analysis; Tamoxifen; Time Factors | 2011 |
Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Methotrexate; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Prognosis | 2010 |
The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99-15 study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Central Nervous System Neoplasms; Child; Child, Preschool; Cohort Studies; Cytarabine; Female; Humans; Infant; Injections, Spinal; Male; Methotrexate; Neoplasm Recurrence, Local; Netherlands; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prospective Studies; Remission Induction; Spinal Puncture; Survival Rate; Time Factors; Treatment Outcome | 2012 |
Neoadjuvant and adjuvant chemotherapy of cervical cancer: mature results of the phase 2 PBM-PFU protocol.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Humans; Leucovorin; Maximum Tolerated Dose; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2011 |
A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Drug Resistance, Neoplasm; Female; Fluorouracil; Follow-Up Studies; Humans; Irinotecan; Japan; Male; Methotrexate; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Salvage Therapy; Stomach Neoplasms; Survival Rate; Treatment Outcome | 2011 |
Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent.
Topics: Carcinoma, Squamous Cell; Cause of Death; Chemoradiotherapy; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Palliative Care; Squamous Cell Carcinoma of Head and Neck | 2011 |
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Greece; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Proportional Hazards Models; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2012 |
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation.
Topics: Adult; Aged; Case-Control Studies; Combined Modality Therapy; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Quality of Life; Sirolimus; Survival Rate; T-Lymphocytes, Regulatory; Tacrolimus; Transplantation, Homologous; Treatment Outcome; Young Adult | 2012 |
Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial.
Topics: Age Factors; Aged; Antimetabolites; Central Nervous System Neoplasms; Combined Modality Therapy; Confidence Intervals; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Leukopenia; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Survival Analysis; Watchful Waiting | 2012 |
The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Oncology G
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemoradiotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; In Situ Hybridization, Fluorescence; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor B; Vascular Endothelial Growth Factor C; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factor Receptor-3; Vascular Endothelial Growth Factors; Young Adult | 2012 |
Long-term survival of patients with advanced/recurrent carcinoma of cervix and vagina after neoadjuvant treatment with methotrexate, vinblastine, doxorubicin, and cisplatin with or without the addition of molgramostim, and review of the literature.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Recombinant Proteins; Survival Analysis; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vinblastine | 2002 |
Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian Breas
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Goserelin; Humans; Methotrexate; Neoplasm Recurrence, Local; Ovariectomy; Premenopause; Survival Rate; Tamoxifen | 2002 |
Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carbazoles; Disease Progression; Drug Administration Schedule; Edema; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pyridines; Survival Analysis; Treatment Outcome | 2003 |
Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer -- Nordic cystectomy trial 2.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Rate; Urinary Bladder Neoplasms | 2002 |
Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cause of Death; Chemotherapy, Adjuvant; Cyclophosphamide; Disease Progression; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prednisone; Vincristine | 2003 |
Brachytherapy boost to the tumour bed in high risk patients after limited surgery for breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Mastectomy; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Patient Satisfaction; Prognosis; Risk Factors; Salvage Therapy; Treatment Outcome | 2003 |
Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arm; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Leg; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis; Treatment Outcome | 2003 |
RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Confidence Intervals; Cystectomy; Female; Humans; Male; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiation-Sensitizing Agents; Radiotherapy; Remission Induction; Urinary Bladder Neoplasms; Vinblastine | 2003 |
[The modern organ- and function-sparing surgical treatment in oncology].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma in Situ; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Electrosurgery; Endometrial Neoplasms; Estrogen Receptor Modulators; Female; Fluorouracil; Humans; Hysterectomy; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Postoperative Care; Progestins; Prognosis; Prospective Studies; Radiotherapy Dosage; Risk Factors; Survival Analysis; Time Factors; Uterine Cervical Neoplasms | 2003 |
Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172).
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Disease-Free Survival; Humans; Infant; Leukocyte Count; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2004 |
A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Radiation Dosage; Risk Factors; Survival Analysis; Treatment Outcome | 2004 |
[Radiation and concomitant chemotherapy after surgery for breast cancer].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pilot Projects; Postoperative Care; Radiotherapy Dosage; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Time Factors | 2004 |
Clinical relevance of different sequencing of doxorubicin and cyclophosphamide, methotrexate, and Fluorouracil in operable breast cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Odds Ratio; Risk Factors; Treatment Outcome | 2004 |
Mutation and accumulation of p53 related to results of adjuvant therapy of postmenopausal breast cancer patients.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Genes, p53; Humans; Methotrexate; Mutation; Neoplasm Metastasis; Neoplasm Recurrence, Local; Postmenopause; Radiotherapy, Adjuvant; Tamoxifen; Treatment Outcome; Tumor Suppressor Protein p53 | 2004 |
Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Taxoids; Treatment Outcome | 2004 |
Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized c
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Melphalan; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Statistics, Nonparametric; Survival Analysis; Tamoxifen; Treatment Outcome | 2004 |
Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Survival Rate | 2005 |
Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; British Columbia; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy, Modified Radical; Methotrexate; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiotherapy, Adjuvant; Risk Assessment; Survival Analysis; Treatment Outcome | 2005 |
UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastoma.
Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Glioblastoma; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 2005 |
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Cyclophosphamide; Etoposide; Follow-Up Studies; Humans; Infant; Intelligence; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Neuropsychological Tests; Postoperative Care; Proportional Hazards Models; Remission Induction; Survival Analysis; Vincristine | 2005 |
Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endometrial Neoplasms; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Vinblastine | 2006 |
Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Ca
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Postmenopause; Prognosis; Retrospective Studies | 2005 |
Benefits of axillary radiotherapy unclear in women with early stage breast cancer undergoing conservative breast surgery without axillary dissection.
Topics: Antineoplastic Agents; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Neoplasm Recurrence, Local; Tamoxifen | 2005 |
A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early-stage breast cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymph Node Excision; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Tamoxifen | 2006 |
Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Extremities; Female; Follow-Up Studies; Heart Failure; Humans; Ifosfamide; Italy; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Patient Compliance; Prospective Studies; Renal Insufficiency; Scandinavian and Nordic Countries; Treatment Outcome | 2005 |
Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Female; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Risk Factors; Salvage Therapy; Survival Rate; Thioguanine; Time Factors; Treatment Outcome | 2005 |
Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2006 |
Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients.
Topics: Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Axilla; Bayes Theorem; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy, Modified Radical; Methotrexate; Middle Aged; Models, Biological; Multivariate Analysis; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Receptors, Estrogen | 2006 |
Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy, Adjuvant; Risk; Tamoxifen; Treatment Failure | 2006 |
[Bladder preservation for locally advanced bladder cancer by transurethral resection, systemic chemotherapy and radiation].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Radiotherapy Dosage; Urinary Bladder Neoplasms; Vinblastine | 2006 |
A phase II study of combined chemotherapy with methotrexate, 5-fluorouracil, and low-dose cisplatin (MFP) for histologically diffuse-type advanced and recurrent gastric cancer (KDOG9501).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Effusion, Malignant; Stomach Neoplasms; Survival Analysis; Treatment Outcome | 2006 |
The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapy.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms; Vinblastine | 2007 |
Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Radiation; Female; Fluorouracil; Humans; Mastectomy, Segmental; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiotherapy; Radiotherapy Dosage; Risk | 2007 |
Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prognosis; Survival Rate; Tamoxifen | 2007 |
The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Colum
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy, Modified Radical; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Regression Analysis | 2007 |
Neoadjuvant chemotherapy in locally advanced primary breast cancers: the Nottingham experience.
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Survival Rate; Treatment Outcome; United Kingdom | 2007 |
Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Receptors, Estrogen; Tamoxifen | 2007 |
Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Cisplatin; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Outcome; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine | 2007 |
Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclin D; Cyclins; Cyclophosphamide; Drug Resistance, Neoplasm; Female; Fluorouracil; Gene Amplification; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; p21-Activated Kinases; Postmenopause; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Tamoxifen | 2007 |
[Modified BFM-90 regimen greatly improves treatment outcomes of chinese childhood and adolescent lymphoblastic lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asian People; Asparaginase; Child; Child, Preschool; China; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Treatment Outcome; Vincristine | 2007 |
Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Germany; Humans; Leuprolide; Lymphatic Metastasis; Methotrexate; Neoplasm Recurrence, Local; Perimenopause; Premenopause; Survival Rate; Treatment Outcome; Ukraine | 2007 |
Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neurotoxicity Syndromes; Prednisone; Procarbazine; Retrospective Studies; Salvage Therapy; Survival Analysis; Vincristine | 2007 |
Intrathecal chemotherapy for refractory disseminated medulloblastoma.
Topics: Adolescent; Adult; Antineoplastic Agents; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Drug Therapy; Female; Humans; Immunosuppressive Agents; Infant; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Nimustine; Nitrosourea Compounds; Retrospective Studies; Survival Analysis | 2008 |
Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Comorbidity; Cyclophosphamide; Female; Fluorouracil; Humans; Incidence; Italy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Radiation Injuries; Radiotherapy, Adjuvant; Risk Assessment; Risk Factors; Treatment Outcome | 2008 |
Long-term outcome in PCNSL patients treated with high-dose methotrexate and deferred radiation.
Topics: Adult; Antimetabolites, Antineoplastic; Brain Neoplasms; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Kaplan-Meier Estimate; Lymphoma; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy; Survival Rate; Time; Treatment Outcome | 2008 |
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Infant; Lung Neoplasms; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Survival Rate | 2008 |
Primary central nervous system lymphoma: monocenter, long-term, intent-to-treat analysis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cranial Irradiation; Disease Progression; Disease-Free Survival; Feasibility Studies; Female; Follow-Up Studies; Humans; Karnofsky Performance Status; Longitudinal Studies; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome | 2008 |
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Premenopause; Retrospective Studies; Treatment Outcome | 2008 |
Chemotherapy strategies in squamous cell carcinoma of the head and neck.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Immunotherapy; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Random Allocation; Sex Factors; Time Factors | 1984 |
A trial of outpatient chemotherapy for recurrent head and neck tumors.
Topics: Aged; Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Clinical Trials as Topic; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Lomustine; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Time Factors; Vinblastine | 1980 |
Integration of chemotherapy into a combined modality treatment plan for head and neck cancer: a review.
Topics: Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Recurrence, Local; Random Allocation | 1981 |
A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neck.
Topics: Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Female; Head and Neck Neoplasms; Humans; Leukocyte Count; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Prospective Studies; Random Allocation | 1983 |
[Indications for cytostatic therapy of recurrent cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Female; Germany, West; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Vinblastine; Vindesine | 1984 |
Pre- and postoperative chemoendocrine treatment with or without postoperative radiotherapy for locally advanced breast cancer.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymph Nodes; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Random Allocation; Vincristine | 1983 |
[High-dosage intralumbar methotrexate administration. A report on clinical experience].
Topics: Child; Child, Preschool; Clinical Trials as Topic; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Injections, Spinal; Leukemia, Lymphoid; Lumbosacral Region; Meningeal Neoplasms; Methotrexate; Neoplasm Recurrence, Local | 1983 |
A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; California; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Leucovorin; Male; Methotrexate; Neoplasm Recurrence, Local; Probability; Random Allocation | 1983 |
Adjuvant CMF in breast cancer: comparative 5-year results of 12 versus 6 cycles.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Menstruation; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prospective Studies; Random Allocation; Receptors, Estrogen | 1983 |
Prospective randomized trial of one-hour sequential versus simultaneous methotrexate plus 5-fluorouracil in advanced and recurrent squamous cell head and neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Clinical Trials as Topic; Diarrhea; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Mouth Diseases; Neoplasm Recurrence, Local; Random Allocation | 1983 |
Systemic therapy for superficial bladder cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma in Situ; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; FANFT; Female; Fluorouracil; Humans; Male; Methotrexate; Mice; Neoplasm Recurrence, Local; Pyridoxine; Urinary Bladder Neoplasms; Vitamin A | 1984 |
A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer. A Cancer and Leukemia Group B study.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Heart Diseases; Humans; Leukopenia; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Random Allocation; Time Factors; Vincristine | 1984 |
Adjuvant systemic therapy in primary breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Estrogen Antagonists; Female; Fluorouracil; Humans; Mastectomy; Melphalan; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Random Allocation; Receptors, Estrogen; Tamoxifen; Time Factors | 1984 |
Short- or long-term chemotherapy for node-positive breast cancer: LMF 6 versus 18 cycles. SAKK study 27/76.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis | 1984 |
A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Melphalan; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis | 1984 |
Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation).
Topics: Aged; Antineoplastic Agents; Carcinoma; Cell Differentiation; Cisplatin; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Ovary; Random Allocation; Thiotepa | 1983 |
Intravesical chemotherapy.
Topics: Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Humans; Methotrexate; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Thiotepa; Urinary Bladder Neoplasms | 1984 |
Resume of selected studies of the National Bladder Cancer Collaborative Group A and new protocols.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Humans; Isomerism; Isotretinoin; Methotrexate; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Random Allocation; Registries; Thiotepa; Tretinoin; Urinary Bladder Neoplasms | 1984 |
Methotrexate alone or with regional subcutaneous Corynebacterium parvum in the treatment of recurrent and metastatic squamous cancer of the head and neck.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Clinical Trials as Topic; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Immunotherapy; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Propionibacterium acnes | 1982 |
Treatment of metastatic breast cancer in estrogen receptor positive patients. A randomized trial comparing tamoxifen alone versus tamoxifen plus CMF.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Random Allocation; Receptors, Estrogen; Tamoxifen | 1982 |
Use of methotrexate and 5-FU for recurrent head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Clinical Trials as Topic; Diarrhea; Drug Therapy, Combination; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infections; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neutropenia | 1982 |
Multimodal treatment in operable breast cancer: five-year results of the CMF programme.
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prospective Studies | 1981 |
[Aggressive cytostatic treatment of osteogenic sarcoma in childhood (author's transl)].
Topics: Adolescent; Age Factors; Antibiotics, Antineoplastic; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Vincristine | 1981 |
High-dose methotrexate and cis-platinum in the treatment of recurrent head and neck cancer.
Topics: Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 1981 |
A randomized comparative trial of chemotherapy and irradiation therapy for stage II breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Melphalan; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Care; Prospective Studies; Radiotherapy Dosage; Random Allocation | 1981 |
The current status of systemic adjuvant therapy in the management of primary breast cancer.
Topics: Age Factors; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Probability; Random Allocation; Tamoxifen | 1981 |
Divergent effect of adjuvant chemo-immunotherapy on recurrence rates in node-negative and node-positive breast cancer patients.
Topics: BCG Vaccine; Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Random Allocation | 1980 |
Methotrexate treatment of advanced head and neck cancers: a dose response evaluation.
Topics: Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Random Allocation | 1981 |
Favorable factors in the adjuvant therapy of breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Melphalan; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 1982 |
Significance of relapse after adjuvant treatment with combination chemotherapy or 5-fluorouracil alone in high-risk breast cancer. A Western Cancer Study Group Project.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Random Allocation | 1981 |
Antiestrogen, cytotoxic chemotherapy, and bacillus Calmette-Guerin vaccination in stage II breast cancer: a preliminary report.
Topics: Actuarial Analysis; BCG Vaccine; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Receptors, Estrogen; Tamoxifen | 1980 |
Adjuvant methotrexate, vinblastine and cisplatin chemotherapy for invasive transitional cell carcinoma: Taiwan experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Risk Factors; Time Factors; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 1996 |
Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head a
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chi-Square Distribution; Cisplatin; Disease-Free Survival; Europe; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Remission Induction; Vincristine | 1994 |
Intra-arterial chemotherapy using a reservoir for endocrine-refractory prostate cancer.
Topics: Abdominal Muscles; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Implants; Fluorouracil; Humans; Iliac Artery; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Thigh | 1994 |
p53 expression and the result of adjuvant therapy of breast cancer.
Topics: Aneuploidy; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; DNA Damage; DNA, Neoplasm; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Mastectomy, Modified Radical; Methotrexate; Neoplasm Recurrence, Local; Postoperative Care; Premenopause; Risk Factors; Tumor Suppressor Protein p53 | 1995 |
[Clinical evaluation of sequential MTX/5-FU therapy for gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Fluorouracil; Humans; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Stomach Neoplasms; Survival Rate | 1995 |
Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent endometrial carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endometrial Neoplasms; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Vinblastine | 1995 |
[A pilot study of combined chemotherapy using methotrexate (MTX), 5-fluorouracil (5-FU) and pirarubicin (THP) for advanced or recurrent gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Stomach Neoplasms | 1995 |
[The role of M-VAC polychemotherapy in the treatment of advanced urothelial carcinoma of the bladder].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Doxorubicin; Epirubicin; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Remission Induction; Urinary Bladder Neoplasms; Vinblastine | 1993 |
Epirubicin, methotrexate and bleomycin in the management of recurrent squamous cell head and neck cancer. A GSTTC randomised phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Epirubicin; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis | 1993 |
Chemotherapeutic treatment of recurrent and/or metastatic nasopharyngeal carcinoma: a retrospective analysis of 40 cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Retrospective Studies | 1993 |
Value of serum beta 2 microglobulin as an indicator of early relapse in diffuse large cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Leucovorin; Life Tables; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Remission Induction; Survival Analysis; Vincristine | 1993 |
Radical hysterectomy: a randomized study comparing two techniques for resection of the cardinal ligament.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cervix Uteri; Cisplatin; Female; Follow-Up Studies; Humans; Hysterectomy; Intraoperative Complications; Ligaments; Lymph Node Excision; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Complications; Uterine Cervical Neoplasms | 1993 |
Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vinblastine | 1995 |
Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Fluoxymesterone; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Regression Analysis; Thiotepa; Treatment Failure; Vinblastine; Vincristine | 1995 |
Ten-year results of a randomized trial evaluating prolonged low-dose adjuvant chemotherapy in node-positive breast cancer: a joint European Organization for Research and Treatment of Cancer-Dutch Breast Cancer Working Party Study. Cooperating Investigator
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Recurrence, Local; Prospective Studies | 1995 |
[Clinical study of ambulatory cancer chemotherapy for recurrent breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Administration Schedule; Female; Fluorouracil; Home Care Services, Hospital-Based; Home Infusion Therapy; Humans; Infusions, Intravenous; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 1994 |
Simultaneous adjuvant radiation therapy and chemotherapy in high-risk breast cancer--toxicity and dose modification: a Transtasman Radiation Oncology Group Multi-Institution study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Australia; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiation Oncology; Radiotherapy; Radiotherapy Dosage; Radiotherapy, Adjuvant | 1995 |
Combined chemotherapy and radiotherapy for patients with breast cancer and extensive nodal involvement.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Postoperative Care; Radiotherapy Dosage; Recurrence; Retrospective Studies; Time Factors | 1995 |
Preirradiation chemotherapy including "eight drugs in 1 day" regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cognition Disorders; Combined Modality Therapy; Disease-Free Survival; Feasibility Studies; Female; Humans; Infant; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Survival Analysis | 1995 |
Effect of systemic adjuvant treatment on first sites of breast cancer relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Incidence; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prednisone; Proportional Hazards Models; Survival Analysis; Tamoxifen; Treatment Outcome | 1994 |
Disseminated nonlymphoblastic lymphoma of childhood: a Childrens Cancer Group study, CCG-552.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Female; Humans; Hydrocortisone; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Remission Induction; Treatment Outcome; Vincristine | 1994 |
[Intra-arterial infusion chemotherapy for recurrent breast cancer via an implantable system--the second report].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 1994 |
Randomised phase II study of methotrexate (MTX) versus methotrexate plus lonidamine (MTX + LND) in recurrent and/or metastatic carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Indazoles; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 1994 |
[Clinical trial of protocol-AL851 for children with high-risk acute lymphoblastic leukemia. Kyushu Yamaguchi Children's Cancer Study Group (KYCCSG)].
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Risk; Survival Rate | 1994 |
[Neo-adjuvant M-VAC in the treatment of infiltrating bladder tumors].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1994 |
Perioperative chemotherapy in patients with oral cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Humans; Male; Methotrexate; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Prospective Studies | 1994 |
[Clinical evaluation of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on advanced and recurrent breast cancer. Clinical study group of CMF for breast cancer in Japan].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 1994 |
Alternating radiotherapy and chemotherapy in limited small cell lung cancer: the IGR protocols. French FNCLCC Lung Cancer Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy Dosage; Remission Induction; Survival Rate; Treatment Failure | 1994 |
Experience of the EORTC Radiotherapy/Chemotherapy Group in osteosarcoma trials.
Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disarticulation; Doxorubicin; Europe; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Survival Analysis; Treatment Outcome; Vincristine | 1993 |
M-VAC combination in locally advanced, locally recurrent or metastatic breast carcinoma. A phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Doxorubicin; Female; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Treatment Outcome; Vinblastine | 1994 |
[Combination of 5-FU, high dose methotrexate, epirubicin and cisplatin (FEMTX-P protocol) in non surgical or locally recurrent metastatic gastric cancers].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Stomach Neoplasms; Treatment Outcome | 1993 |
[Sequential methotrexate/5-fluorouracil therapy with 5'-deoxy-5-fluorouridine against advanced gastric cancer: comparison between bolus injection and drip infusion of 5-fluorouracil administration. Hirosaki Cooperative Study Group for Cancer Chemotherapy]
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Floxuridine; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intravenous; Leukopenia; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Stomach Neoplasms | 1994 |
[Combination therapy with low dose adriamycin for advanced or recurrent breast cancer. Hokkaido Breast Cancer Treatment Study Group].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Picibanil; Survival Rate; Tamoxifen; Treatment Outcome | 1993 |
Stage III abdominal non-Hodgkin's lymphoma in Costa Rican children: comparison of two consecutive trials of treatment.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Costa Rica; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Infusions, Intravenous; Leucovorin; Life Tables; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Prospective Studies; Remission Induction; Survival Rate; Vincristine | 1994 |
A phase II study of cisplatin plus methotrexate with folinic acid rescue in metastatic or locally recurrent transitional cell carcinoma of the urothelium.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Female; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms | 1993 |
Effective multi-agent chemotherapy for advanced abdominal lymphoma and FAB L3 leukemia of childhood.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prednisolone; Remission Induction; Retrospective Studies; Survival Rate; Teniposide; Vincristine | 1993 |
Maintenance tamoxifen after induction postoperative chemotherapy in node-positive breast cancer patients: the Eastern Cooperative Oncology Group Trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Fluoxymesterone; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Receptors, Estrogen; Survival Rate; Tamoxifen; Thiotepa; Vinblastine | 1993 |
[Simultaneous radiochemotherapy in recurrent and metastatic breast neoplasm. Clinical experience].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Mitomycin; Neoplasm Recurrence, Local; Radiotherapy Dosage; Radiotherapy, Adjuvant; Treatment Outcome | 1995 |
Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy; Salvage Therapy; Survival Analysis; Treatment Failure; Urinary Bladder Neoplasms; Vinblastine | 1996 |
A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Muscle, Smooth; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Prospective Studies; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1996 |
Comparison between a cisplatin-containing regimen and a carboplatin-containing regimen for recurrent or metastatic bladder cancer patients. A randomized phase II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Epirubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms; Vinblastine | 1996 |
Higher frequency of gene amplification in breast cancer patients who received adjuvant chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Gene Amplification; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Polymerase Chain Reaction; Tamoxifen; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase | 1996 |
A long-term assessment of adjuvant chemotherapy on outcome of patients with extracapsular spread of cervical metastases from squamous carcinoma of the head and neck.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Disease-Free Survival; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Treatment Outcome | 1996 |
Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Recombinant Proteins; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Whole-Body Irradiation | 1996 |
Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Infusions, Parenteral; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Risk Factors; Stomach Neoplasms; Survival Rate; Ultrasonography | 1996 |
CNS-85 trial: a cooperative pediatric CNS tumor study--results of treatment of medulloblastoma patients.
Topics: Adolescent; Age Factors; Antineoplastic Agents; Cerebellar Neoplasms; Cerebellum; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Italy; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Radiation Dosage; Retrospective Studies; Survival Rate; Vincristine | 1996 |
M-CAVI, a neoadjuvant carboplatin-based regimen for the treatment of T2-4N0M0 carcinoma of the bladder.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Follow-Up Studies; Humans; Karnofsky Performance Status; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1996 |
Simultaneous radiochemotherapy for recurrent and metastatic breast carcinoma: evaluation of two treatment concepts.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Combined Modality Therapy; Cyclophosphamide; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Mitomycin; Neoplasm Recurrence, Local; Palliative Care; Prognosis; Radiotherapy; Remission Induction | 1996 |
Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of finding
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Receptors, Estrogen; Survival Rate | 1996 |
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Gallium Radioisotopes; Hodgkin Disease; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prednisone; Radioimmunodetection; Radiotherapy; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine | 1996 |
Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Incidence; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Odds Ratio; Radiotherapy, Adjuvant; Receptors, Estrogen; Survival Analysis; Survival Rate; Tamoxifen | 1996 |
A phase I study of methotrexate administration following 5-fluorouracil.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Survival Rate | 1996 |
[Arterial infusion chemotherapy for advanced gastric cancer by sequential MTX/5-FU].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Drug Administration Schedule; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Methotrexate; Neoplasm Recurrence, Local; Stomach Neoplasms | 1996 |
Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Survival Rate; Uterine Cervical Neoplasms | 1997 |
A phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Analysis; Uterine Cervical Neoplasms; Vinblastine | 1997 |
Breast conserving therapy in stage I & II breast cancer in Korea.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Korea; Mastectomy, Modified Radical; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pilot Projects | 1997 |
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Estrogen Antagonists; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Receptors, Estrogen; Risk; Survival Analysis; Tamoxifen; Treatment Failure; Treatment Outcome | 1997 |
Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Modified Radical; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Premenopause; Proportional Hazards Models; Survival Analysis | 1997 |
A Phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced breast carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Doxorubicin; Female; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Rate; Vinblastine | 1998 |
Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Female; Humans; Infant; Injections, Spinal; Male; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Remission Induction; Survival Analysis | 1998 |
The importance of postoperative radiation therapy in multimodality management of locally advanced breast cancer: a phase II trial of neoadjuvant MVAC, surgery, and radiation.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Female; Humans; Mastectomy, Modified Radical; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy; Survival Analysis; Vinblastine | 1998 |
Vinorelbine, bleomycin and methotrexate as a salvage therapy for patients with head and neck squamous carcinoma in relapse after cisplatin/fluorouracil.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Feasibility Studies; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Vinblastine; Vinorelbine | 1998 |
Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Fluoxymesterone; Humans; Liver Neoplasms; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Survival Rate; Tamoxifen | 1998 |
Long-term follow-up of a randomized trial on adjuvant chemotherapy and hormonal therapy in locally advanced breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate; Vincristine | 1998 |
Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patients. Austrian Breast Cancer Study Group.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome; Vincristine | 1998 |
Radiotherapy at tumor recurrence in primary CNS lymphoma.
Topics: Adult; Central Nervous System Diseases; Combined Modality Therapy; Dose-Response Relationship, Drug; Humans; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies | 1998 |
[A randomized controlled trial with methotrexate (MTX), 5-fluorouracil (5-FU) and pirarubicin (THP) vs 5-FU alone in advanced or recurrent gastric carcinoma. Tokai Hokuriku THP Study Group].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Stomach Neoplasms; Survival Analysis | 1998 |
Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Regression Analysis; Survival Rate; Vincristine | 1999 |
Prospective evaluation of high-dose ifosfamide-related nephrotoxicity in young adult patients with recurrent osteosarcoma previously treated with cisplatin, methotrexate and standard-dose ifosfamide.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Bone Neoplasms; Cisplatin; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Ifosfamide; Kidney; Kidney Diseases; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Prospective Studies | 1999 |
Cervical adenocarcinoma, a novel combination chemotherapy with mitomycin C, etoposide, and cisplatin for advanced or recurrent disease.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Etoposide; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Uterine Cervical Neoplasms | 1999 |
High dose chemotherapy for refractory urothelial carcinoma supported by peripheral blood stem cell transplantation.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Urologic Neoplasms; Vinblastine | 1999 |
Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Recurrence; Survival Rate; Tamoxifen; Vincristine | 1999 |
Three new active cisplatin-containing combinations in the neoadjuvant treatment of locally advanced and locally recurrent breast carcinoma: a randomized phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Epirubicin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Vincristine | 1999 |
Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Humans; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Rate; Treatment Failure; Vincristine | 1999 |
A bladder preservation regimen using intra-arterial chemotherapy and radiotherapy for invasive bladder cancer: a prospective study.
Topics: Aged; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Female; Humans; Injections, Intra-Arterial; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Treatment Failure; Urinary Bladder Neoplasms | 2000 |
[Consolidation radiotherapy after high-dose chemotherapy and autologous bone marrow transplantation in patients with advanced breast cancer].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Retrospective Studies; Time Factors | 2000 |
Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cell Division; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Italy; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Mitotic Index; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Prospective Studies; Receptors, Estrogen; Survival Analysis; Treatment Outcome | 2000 |
Intra-arterial chemotherapy in locally advanced or recurrent carcinomas of the penis and anal canal: an active treatment modality with curative potential.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Anus Neoplasms; Arteries; Bleomycin; Cisplatin; Fluorouracil; Follow-Up Studies; Humans; Injections; Male; Methotrexate; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neutropenia; Penile Neoplasms; Skin Diseases; Treatment Outcome | 2000 |
[Randomized study of cisplatin-based combination chemotherapy for the treatment of planocellular cancer of the head and neck region].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Analysis; Treatment Outcome; Vincristine | 2000 |
Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Extremities; Female; Fertility; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Osteosarcoma; Patient Compliance; Plastic Surgery Procedures; Postoperative Complications; Radiography; Reoperation; Survival Rate | 2000 |
Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Leukopenia; Lymph Nodes; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Premenopause; Survival Analysis; Time Factors; Treatment Outcome | 2000 |
Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Eye Neoplasms; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nervous System Diseases; Salvage Therapy; Thiotepa | 2001 |
A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Extremities; Female; Humans; Ifosfamide; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Survival Rate | 2001 |
Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cisplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Proportional Hazards Models; Risk Assessment | 2001 |
Thymidine kinase and thymidylate synthase in advanced breast cancer: response to tamoxifen and chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Tamoxifen; Thymidine Kinase; Thymidylate Synthase | 2001 |
Intra-arterial plus i.v. chemotherapy for advanced bulky squamous cell carcinoma of the buccal mucosa.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Drug Eruptions; Dyspnea; Fluorouracil; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Stomatitis; Survival Rate; Treatment Outcome | 2001 |
Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lomustine; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Vulvar Neoplasms | 2001 |
Long-term prognosis of breast cancer patients with 10 or more positive lymph nodes treated with CMF.
Topics: Adult; Age Distribution; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Prognosis | 2001 |
Vinorelbine, epirubicin, and methotrexate (VEM) as primary treatment in locally advanced breast cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Epirubicin; Female; Humans; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Survival Rate; Treatment Outcome; Vinblastine; Vinorelbine | 2001 |
Locally advanced primary breast cancer: medium-term results of a randomised trial of multimodal therapy versus initial hormone therapy.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Mastectomy; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Metastasis; Neoplasm Recurrence, Local; Postoperative Care; Prospective Studies; Receptors, Estrogen; Survival Analysis; Treatment Outcome | 2001 |
Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2001 |
Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lomustine; Male; Methotrexate; Neoplasm Recurrence, Local; Neuroectodermal Tumors; Radiotherapy Dosage; Supratentorial Neoplasms; Survival Rate; Treatment Outcome; Vincristine | 2002 |
Result of two randomized trials comparing nolatrexed (Thymitaq) versus methotrexate in patients with recurrent head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Diarrhea; Enzyme Inhibitors; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Quinazolines; Thymidylate Synthase; Treatment Outcome | 2001 |
Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia.
Topics: Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2002 |
Multimodal therapy for histological stage-II breast cancer. Multicentre Breast Cancer Chemotherapy Group.
Topics: Adult; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; United Kingdom; Vincristine | 1977 |
Adjvant treatment of tongue and floor of the mouth cancers.
Topics: Antigens, Bacterial; Bleomycin; Carcinoma, Squamous Cell; Drug Therapy, Combination; Humans; Leucovorin; Methotrexate; Mouth Floor; Mouth Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Propionibacterium acnes; Random Allocation; Tongue Neoplasms | 1978 |
Effects of continuous or discontinuous maintenance therapy on subsequent remission maintenance in childhood leukemia.
Topics: Acute Disease; Antineoplastic Agents; Child; Clinical Trials as Topic; Cyclophosphamide; Drug Resistance; Follow-Up Studies; Humans; Leukemia; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Remission, Spontaneous | 1977 |
Adjuvant combination chemotherapy in primary mammary carcinoma: the CMF program.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Fluorouracil; Humans; Leukopenia; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Time Factors | 1977 |
[Polychemotherapy of advanced breast cancer. Triple combination with doxorubicin. Analysis of 209 observation].
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Vincristine | 1977 |
Adjuvant therapy for osteosarcoma: preoperative and postoperative treatment.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Doxorubicin; Female; Humans; Leucovorin; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Postoperative Care; Preoperative Care; Time Factors | 1978 |
Adjuvant therapy for nonmetastatic osteogenic sarcoma: an evaluation of transfer factor versus combination chemotherapy.
Topics: Bone Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Osteosarcoma; Transfer Factor; Vincristine | 1978 |
Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients. Intermediate report of a randomized trial in 242 patients.
Topics: Administration, Oral; Aged; BCG Vaccine; Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Neoplasm Recurrence, Local | 1978 |
A controlled study of combined methotrexate, BCG, and INH therapy for squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; BCG Vaccine; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Hypersensitivity, Delayed; Isoniazid; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1977 |
High dose methotrexate as a preoperative adjuvant in the treatment of epidermoid carcinoma of the head and neck. A feasibility study and clinical trial.
Topics: Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Leucovorin; Methotrexate; Neoplasm Recurrence, Local; Postoperative Complications | 1975 |
[Neoadjuvant chemotherapy in combined treatment of breast cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy, Radical; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Preoperative Care; Prospective Studies; Radiotherapy Dosage; Remission Induction; Thiotepa | 1992 |
Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Ear, Middle; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Hypertension; Kidney; Leukopenia; Male; Methotrexate; Middle Aged; Nausea; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Time Factors | 1992 |
Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: a South-Eastern Cancer Study Group (SEG) Trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Prospective Studies; Survival Analysis | 1992 |
Evaluation of systemic chemotherapy with methotrexate, vinblastine, adriamycin, and cisplatin for advanced bladder cancer. The Japanese Urological Cancer Research Group for Adriamycin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1992 |
Randomized trial of adjuvant chemotherapy for operable breast cancer comparing i.v. CMF to an epirubicin-containing regimen [see comment].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Injections, Intravenous; Methotrexate; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Thiotepa; Vincristine; Vindesine | 1992 |
M4 protocol for cerebellar medulloblastoma: supratentorial radiotherapy may not be avoided.
Topics: Adolescent; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy; Radiotherapy Dosage; Survival Rate | 1992 |
[Second cessation of therapy in children with acute lymphoblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Infant; Male; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Time Factors; Vincristine | 1992 |
Swiss adjuvant trials in women with node-negative breast cancer. OSAKO.
Topics: Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Chemotherapy, Adjuvant; Chlorambucil; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Recurrence, Local; Risk Factors; Switzerland | 1992 |
West Midlands Oncology Association trial of adjuvant chemotherapy in node-negative breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Chlorambucil; England; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Odds Ratio; Prognosis; Risk Factors; Survival Rate | 1992 |
Chemotherapy versus observation in high-risk node-negative breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Neoplasm Recurrence, Local; Postoperative Care; Prednisone; Receptors, Estrogen; Risk Factors; Survival Rate | 1992 |
Small-cell carcinoma of the head and neck. A novel treatment regimen.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Laryngeal Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Radiotherapy Dosage; Remission Induction; Tongue Neoplasms; Vincristine | 1991 |
The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Diseases; Clinical Trials as Topic; Cyclophosphamide; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Survival Analysis; Time Factors; Vincristine | 1990 |
The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Tamoxifen; Vincristine | 1992 |
A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Family; Female; Graft vs Host Disease; HLA Antigens; Humans; Incidence; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Prednisolone; Prospective Studies; Survival Analysis; Treatment Outcome | 1991 |
Systemic adjuvant therapy in women with resected node-negative breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Prognosis; Receptors, Estrogen; Tamoxifen; Time Factors | 1991 |
The dose of total body irradiation (TBI), and GvHD prophilaxis have a crucial role on relapse risk and survival after BMT for leukaemia.
Topics: Bone Marrow Transplantation; Cyclophosphamide; Cyclosporins; Graft vs Host Disease; Humans; Italy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methotrexate; Neoplasm Recurrence, Local; Prospective Studies; Radiotherapy Dosage; Risk Factors; Survival Rate; Whole-Body Irradiation | 1991 |
Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Protocols; Epirubicin; Female; Humans; Lymph Node Excision; Mastectomy; Methotrexate; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Thiotepa; Vincristine; Vindesine | 1991 |
A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Drug Administration Schedule; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pyrimidines | 1991 |
Perioperative chemotherapy in oral cancer.
Topics: Adult; Aged; Combined Modality Therapy; Humans; Methotrexate; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Postoperative Period; Time Factors | 1991 |
Local failure in patients treated with radiotherapy and multidrug chemotherapy for small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy Dosage; Survival Analysis; Vincristine | 1990 |
Treatment of relapsed acute lymphocytic leukemia in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Germany, West; Humans; Ifosfamide; Leucovorin; Life Tables; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Spinal Cord Neoplasms; Teniposide; Testicular Neoplasms; Vindesine | 1990 |
Risk of CNS relapse after systemic relapse of childhood acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Female; Germany, West; Humans; Infusions, Intravenous; Injections, Spinal; Life Tables; Male; Methotrexate; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Spinal Cord Neoplasms | 1990 |
Neoadjuvant chemotherapy or chemotherapy and endocrine therapy in locally advanced breast carcinoma. A prospective, randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Estrogen; Remission Induction; Tamoxifen; Time Factors | 1990 |
A randomized trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in stage II breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Randomized Controlled Trials as Topic; Tamoxifen; Vincristine | 1990 |
Pediatric osteosarcoma: therapeutic strategies, results, and prognostic factors derived from a 10-year experience.
Topics: Child; Cisplatin; Follow-Up Studies; Humans; Leucovorin; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis | 1990 |
The prognostic value of testicular biopsy in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Child; Combined Modality Therapy; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Radiotherapy Dosage; Remission Induction; Testicular Neoplasms; Testis; Time Factors; Vincristine | 1990 |
Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An Eastern Cooperative Oncology Group trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prednisone; Prevalence; Prognosis; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen | 1990 |
Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Double-Blind Method; Female; Head and Neck Neoplasms; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Placebos; Prospective Studies; Randomized Controlled Trials as Topic; Remission Induction | 1990 |
Methotrexate in advanced endometrial carcinoma. A phase II trial of the Gynecologic Oncology Group.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Drug Evaluation; Female; Humans; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Remission Induction; Uterine Neoplasms | 1990 |
A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis | 1985 |
A prospective study of preoperative chemotherapy and split-course irradiation for locally advanced or recurrent oral/pharyngeal squamous carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Humans; Methotrexate; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Pharyngeal Neoplasms; Premedication; Radiotherapy Dosage; Random Allocation; Time Factors | 1985 |
A randomized study of methotrexate, bleomycin, hydroxyurea with versus without cisplatin in patients with previously untreated and recurrent squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Hydroxyurea; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Random Allocation | 1987 |
Factors predicting response of end stage squamous cell carcinoma of the head and neck to cisplatinum.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Recurrence, Local; Random Allocation | 1987 |
A randomized study of radiation treatment in small cell bronchial carcinoma treated with two types of four-drug chemotherapy regimens.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Autopsy; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Random Allocation; Vincristine | 1988 |
Distant recurrence in breast cancer. Survival expectations and first choice of chemotherapy regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Palliative Care; Random Allocation | 1988 |
[Intra-arterial chemotherapy with methotrexate and 5-fluorouracil in extensive locoregional recurrences of cervix cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Methotrexate; Neoplasm Recurrence, Local; Palliative Care; Prospective Studies; Random Allocation; Uterine Cervical Neoplasms | 1988 |
Effect of methotrexate on relapse after bone-marrow transplantation for acute lymphoblastic leukaemia. International Bone Marrow Transplant Registry.
Topics: Actuarial Analysis; Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporins; Drug Evaluation; Graft vs Host Disease; Humans; Methotrexate; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies | 1989 |
Conservation therapy of breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Recurrence, Local; Pilot Projects; Random Allocation; Tamoxifen | 1989 |
Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin's lymphoma of children: a report from the Childrens Cancer Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Humans; Infant; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Random Allocation; Vincristine | 1989 |
Three versus five years of maintenance therapy are equivalent in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Child; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Radiotherapy Dosage; Random Allocation; Remission Induction; Sex Factors; Testis; Time Factors; Vincristine | 1989 |
A comparison of carboplatin plus methotrexate versus methotrexate alone in patients with recurrent and metastatic head and neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Organoplatinum Compounds; Random Allocation | 1989 |
The relationship between hormone receptor content and the effect of adjuvant tamoxifen in operable breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Random Allocation; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1989 |
Salvage treatments in relapsing resectable breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Fluorouracil; Humans; Mastectomy; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Randomized Controlled Trials as Topic; Tamoxifen | 1989 |
Endocrine versus endocrine plus five-drug chemotherapy in postmenopausal women with stage II estrogen receptor-positive breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Mastectomy, Modified Radical; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Receptors, Estrogen; Survival Analysis; Tamoxifen; Vincristine | 1989 |
Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma, Small Cell; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Random Allocation; Transplantation, Autologous; Vincristine | 1987 |
Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Follow-Up Studies; Humans; Italy; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Patient Compliance; Prognosis; Random Allocation; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1988 |
A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood. A Pediatric Oncology Group Study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Humans; Hydrocortisone; Infant; Infant, Newborn; Infections; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prospective Studies; Random Allocation; Remission Induction; Vincristine | 1989 |
Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy, Radical; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Random Allocation; Receptors, Estrogen; Risk Factors | 1989 |
Chemotherapy for advanced urothelial tract tumors: the M-VAC regimen.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials as Topic; Doxorubicin; Follow-Up Studies; Humans; Infusions, Intravenous; Methotrexate; Neoplasm Recurrence, Local; Remission Induction; Urinary Bladder Neoplasms; Vinblastine | 1988 |
Isolated central nervous system relapse in acute lymphocytic leukemia (ALL) in children. Experiences of the Swiss Pediatric Oncology Group (SPOG/SAKK) 1976-1986.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Female; Humans; Hydrocortisone; Infant; Injections, Intravenous; Injections, Spinal; Male; Methotrexate; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Switzerland | 1988 |
Sequential methotrexate, 5-fluorouracil, and cisplatin in the treatment of recurrent squamous-cell carcinoma of the head and neck: failure of hypertonic saline to reduce the nephrotoxicity of cisplatin.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Kidney Diseases; Male; Mannitol; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Random Allocation; Sodium Chloride | 1986 |
Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Prognosis; Prospective Studies; Receptors, Estrogen; Time Factors | 1988 |
The application of a two-stage design for clinical trials in patients with recurrent head and neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Clinical Trials as Topic; Drug Evaluation; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Recurrence, Local; Organoplatinum Compounds; Random Allocation; Research Design | 1988 |
Recurrence patterns in a prospective study of patients with stage II breast cancer treated with endocrine-chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Random Allocation; Tamoxifen | 1987 |
Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Menstrual Cycle; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ovariectomy; Prognosis; Prospective Studies; Random Allocation; Receptors, Estrogen; Time Factors | 1987 |
Major prognostic factors of adult patients with advanced B-cell lymphoma treated with vincristine, cyclophosphamide, prednisone and doxorubicin (VEPA) or VEPA plus methotrexate (VEPA-M).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Japan; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Prognosis; Prospective Studies; Vincristine | 1988 |
The relationship of various aspects of surgical management to outcome in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Doxorubicin; Female; Femoral Neoplasms; Humans; Humerus; Lung Neoplasms; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Pelvic Neoplasms; Prognosis; Radius; Random Allocation; Tibia; Vincristine | 1988 |
Comparison of methotrexate and sequential methotrexate-5-fluorouracil for patients with recurrent squamous cell carcinoma of the oral cavity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Prospective Studies; Random Allocation | 1987 |
Treatment of metastatic and recurrent cervix cancer with chemotherapy: a randomised trial comparing hydroxyurea with cisdiamminedichloro-platinum plus methotrexate.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Female; Humans; Hydroxyurea; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Random Allocation; South Africa; Uterine Cervical Neoplasms | 1986 |
Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Body Weight; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Random Allocation; Time Factors | 1986 |
Local control and survival in early breast cancer: the Milan trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Italy; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Random Allocation; Time Factors | 1986 |
Age as a prognostic factor in recurrent breast cancer.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovariectomy; Prednisone; Prognosis; Time Factors; Vincristine | 1986 |
Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Diabetes Mellitus, Type 1; Female; Fluorouracil; Hematologic Diseases; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Obesity; Prednisone; Prognosis; Random Allocation; Receptors, Estrogen; Risk; Tamoxifen | 1985 |
Adjuvant systemic therapy for resectable breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Immunotherapy; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Prognosis; Research Design; Tamoxifen | 1985 |
A randomized controlled trial of prophylactic cytotoxic chemotherapy in potentially curable breast cancer.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Female; Fluorouracil; Humans; Melphalan; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Patient Compliance; Random Allocation | 1985 |
[Cooperative studies in the treatment of acute lymphoblastic leukemia in children in Austria--report of 10 years' experience].
Topics: Asparaginase; Austria; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Infant; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Risk; Vincristine | 1985 |
Methotrexate for superficial bladder cancer.
Topics: Carcinoma, Transitional Cell; Clinical Trials as Topic; Humans; Methotrexate; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms | 1985 |
Preoperative irradiation with and without chemotherapy as adjunct to radical cystectomy.
Topics: Antineoplastic Agents; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Recurrence, Local; Postoperative Care; Preoperative Care; Radiotherapy, High-Energy; Time Factors; Urinary Bladder Neoplasms | 1985 |
659 other study(ies) available for methotrexate and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Comparison of chidamide-contained treatment modalities versus chemotherapy in the second-line treatment for relapsed or refractory peripheral T-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Deoxycytidine; Doxorubicin; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, T-Cell, Peripheral; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Platinum; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate | 2021 |
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Female; Humans; Injections, Spinal; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome; Young Adult | 2022 |
A Retrospective Analysis of R-MPV Plus Response-adapted Whole-brain Radiotherapy for Elderly Patients with Primary Central Nervous System Lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System; Central Nervous System Neoplasms; Combined Modality Therapy; Humans; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome | 2022 |
Rituximab, Methotrexate, Carmustine, Etoposide, and Prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: a retrospective single-center study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System; Central Nervous System Neoplasms; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Retrospective Studies; Rituximab | 2022 |
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Retrospective Studies; Rituximab; Vincristine | 2022 |
[A Case of Malignant Thyroid Lymphoma That Was Difficult to Differentiate from Methotrexate-Associated Lymphoproliferative Disorders(MTX-LPD)].
Topics: Antirheumatic Agents; Female; Humans; Lymphoma; Lymphoproliferative Disorders; Methotrexate; Neoplasm Recurrence, Local; Thyroid Neoplasms | 2021 |
Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Central Nervous System; Dexamethasone; Etoposide; Humans; Ifosfamide; Killer Cells, Natural; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies | 2022 |
Role of upfront autologous stem cell transplantation in patients newly diagnosed with primary CNS lymphoma treated with R-MVP: real-world data from a retrospective single-center analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Rituximab; Transplantation, Autologous | 2022 |
Burkitt lymphoma - no impact of HIV status on outcomes with rituximab-based chemoimmunotherapy.
Topics: Adult; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; HIV Infections; Humans; Methotrexate; Neoplasm Recurrence, Local; Rituximab; Vincristine | 2023 |
Predictive factors associated with resistance to initial methotrexate treatment in women with low-risk gestational trophoblastic neoplasia.
Topics: Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies | 2022 |
Long-term remission of primary refractory ALK-positive anaplastic large cell lymphoma after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Brentuximab Vedotin; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Neoplasm Recurrence, Local; Receptor Protein-Tyrosine Kinases | 2022 |
High efficacy of intensive immunochemotherapy for primary mediastinal B-cell lymphoma with prolonged follow up.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Rituximab; Vincristine | 2022 |
Diffuse Large B-cell Lymphoma with Adrenal Involvement Presenting as Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorders: Sustained Remission with Methotrexate Termination Alone in Two Cases.
Topics: Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Iatrogenic Disease; Immunologic Deficiency Syndromes; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Methotrexate; Neoplasm Recurrence, Local | 2023 |
Fulminant elderly adult-onset Still disease effectively treated with tocilizumab and methotrexate: A case report.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Disseminated Intravascular Coagulation; Female; Humans; Interleukin-18; Macrophage Activation Syndrome; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Still's Disease, Adult-Onset; Treatment Outcome | 2022 |
Post-Transplantation Cyclophosphamide Versus Tacrolimus and Methotrexate Graft-Versus-Host Disease Prophylaxis for HLA-Matched Donor Transplantation.
Topics: Cyclophosphamide; Graft vs Host Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies; Tacrolimus | 2022 |
Analysis of Key Factors Associated with Response to Salvage High-Dose Methotrexate Rechallenge in Primary Central Nervous System Lymphoma with First Relapse.
Topics: Central Nervous System; Central Nervous System Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Quality of Life; Retrospective Studies; Salvage Therapy | 2022 |
Osteosarcoma and causes of death: A report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cause of Death; Cisplatin; Doxorubicin; Female; Humans; Ifosfamide; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma | 2022 |
Relapsing subcutaneous panniculitis-like T-cell lymphoma with B symptoms, remitting on low dose methotrexate.
Topics: Humans; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Methotrexate; Neoplasm Recurrence, Local; Panniculitis; Skin Neoplasms | 2022 |
About time: why central nervous system prophylaxis timing in diffuse large B-cell lymphoma matters and does the protocol need updating?
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cyclophosphamide; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Rituximab | 2022 |
Flat-dose versus weight or body surface area-based methotrexate dosing in low-risk gestational trophoblastic neoplasia.
Topics: Body Surface Area; Dactinomycin; Drug-Related Side Effects and Adverse Reactions; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies | 2023 |
Long-term outcomes of combined intravitreal methotrexate and systemic high-dose methotrexate therapy in vitreoretinal lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Eye Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Retinal Neoplasms; Retrospective Studies; Treatment Outcome; Vitreous Body | 2023 |
EMACO for treatment of gestational trophoblastic neoplasia: A multinational multicenter study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies; Vincristine | 2023 |
Diagnosis, treatment, and prognosis of primary intraocular lymphoma: Single-center real-world clinical experience.
Topics: Central Nervous System Neoplasms; Humans; Interleukin-10; Interleukin-6; Intraocular Lymphoma; Methotrexate; Neoplasm Recurrence, Local; Prospective Studies; Retrospective Studies; Treatment Outcome | 2023 |
Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L-asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T-cell lymphoma: A French retrospective study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome | 2023 |
Cost-Effectiveness of Brentuximab Vedotin Versus Physician's Choice of Methotrexate or Bexarotene for the Treatment of Cutaneous T-cell Lymphoma in Canada.
Topics: Bexarotene; Brentuximab Vedotin; Canada; Cost-Benefit Analysis; Humans; Immunoconjugates; Lymphoma, T-Cell, Cutaneous; Methotrexate; Neoplasm Recurrence, Local; Physicians; Skin Neoplasms | 2023 |
[Methotrexate-related lymphoproliferative disease showing different histological findings at recurrence].
Topics: Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 2023 |
Diffuse large B-cell lymphoma at risk of secondary CNS involvement: The inefficacy of intravenous high-dose methotrexate CNS prophylaxis and the importance of baseline cerebrospinal fluid analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies | 2023 |
[A single-center, retrospective analysis of relapse and progression patterns of primary central nervous system lymphoma: can whole brain radiotherapy be replaced?]
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Combined Modality Therapy; Humans; Lymphoma; Methotrexate; Neoplasm Recurrence, Local; Prospective Studies; Retrospective Studies | 2023 |
Management of primary and secondary CNS lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Methotrexate; Neoplasm Recurrence, Local; Prospective Studies; Transplantation, Autologous | 2023 |
Post-transplantation Cyclophosphamide-based Graft-versus-host-disease Prophylaxis Compared to Methotrexate-cyclosporine a in Matched-related Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Adult; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies | 2023 |
[Risk assessment and prophylactic treatment strategies for central nervous system relapse of diffuse large B-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Chronic Disease; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Risk Assessment; Rituximab; Vincristine | 2023 |
Factors Influencing Physician Discretion to Administer CNS Prophylaxis in Diffuse Large B Cell Lymphoma: A Single Institution Retrospective Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies | 2023 |
A case of classic Hodgkin lymphoma arising after remission of methotrexate-associated follicular lymphoma.
Topics: Aged; Hodgkin Disease; Humans; Lymphoma, Follicular; Lymphoproliferative Disorders; Male; Methotrexate; Neoplasm Recurrence, Local; Rituximab | 2023 |
High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Humans; Lymphoma; Lymphoma, B-Cell; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Young Adult | 2023 |
Clinical, histological features, and predictors of relapse in patients with idiopathic granulomatous mastitis.
Topics: Breast; Breast Neoplasms; Chronic Disease; Female; Granulomatous Mastitis; Humans; Methotrexate; Neoplasm Recurrence, Local | 2023 |
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Child, Preschool; DNA-Binding Proteins; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Transcription Factors; Treatment Outcome; Tumor Cells, Cultured | 2020 |
Patient selection and tolerability of high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma.
Topics: Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Maximum Tolerated Dose; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Patient Selection; Prognosis; Retrospective Studies; Survival Rate | 2020 |
Lateral intraventricular primary central nervous system lymphoma (LIPCNSL): a review.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; China; Craniotomy; Disease Progression; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Young Adult | 2020 |
Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H&N study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Australia; Brazil; Bridged-Ring Compounds; Canada; Cetuximab; Confidence Intervals; Europe; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Platinum Compounds; Republic of Korea; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taiwan; Taxoids; Treatment Outcome | 2020 |
Isolated Central Nervous System Relapse Following Treatment Reduction in Low-risk Acute Lymphoblastic Leukemia at the Children's Cancer Center of Lebanon.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Central Nervous System Neoplasms; Child; Child, Preschool; Dexamethasone; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Incidence; Infant; Lebanon; Male; Methotrexate; Neoplasm Recurrence, Local; Non-Randomized Controlled Trials as Topic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Prospective Studies; Survival Rate | 2020 |
Composite tumor of the larynx: A Case Report.
Topics: Administration, Metronomic; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Chemoradiotherapy; Fatal Outcome; Humans; Laryngeal Neoplasms; Larynx; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Complex and Mixed; Palliative Care; Positron-Emission Tomography; Tracheostomy | 2020 |
Effects of germline DHFR and FPGS variants on methotrexate metabolism and relapse of leukemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Genome-Wide Association Study; Humans; Infant; Infant, Newborn; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Peptide Synthases; Polyglutamic Acid; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Tetrahydrofolate Dehydrogenase; Young Adult | 2020 |
Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the ABCSG Trial 5.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Goserelin; Humans; Ki-67 Antigen; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Premenopause; Progression-Free Survival; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 2020 |
[Effect of Modified LMB 89± Rituximab Regimen on Long-Term Benefits for Patients's with Burkitt Lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Humans; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies; Rituximab; Treatment Outcome | 2020 |
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP delivery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies; Rituximab; Vincristine | 2020 |
Clinical factors affecting prognosis of limb osteosarcoma in China: a multicenter retrospective analysis.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; China; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis; Retrospective Studies; Young Adult | 2020 |
Serial changes in the aqueous IL-10 level after intravitreal methotrexate injection as an indicator of primary vitreoretinal lymphoma recurrence.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Interleukin-10; Intraocular Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retinal Neoplasms; Retrospective Studies; Vitreous Body | 2020 |
Outcomes for relapsed versus resistant low risk gestational trophoblastic neoplasia following single-agent chemotherapy.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Prognosis; Remission Induction; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2020 |
Desmoid-type fibromatosis in children. Clinical features, treatment response, and long-term follow-up
Topics: Child; Fibromatosis, Aggressive; Follow-Up Studies; Gaucher Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies | 2020 |
Outcomes of intravitreal methotrexate to salvage eyes with relapsed primary intraocular lymphoma.
Topics: Humans; Intraocular Lymphoma; Intravitreal Injections; Male; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome | 2022 |
Metronomic therapy using Methotrexate and Celecoxib: A Boon for Oral Cancer patients during COVID-19 Pandemic.
Topics: Carcinoma; Celecoxib; Cisplatin; COVID-19; Humans; Methotrexate; Mouth Neoplasms; Neoplasm Recurrence, Local; Pandemics; SARS-CoV-2 | 2021 |
Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: a retrospective, multi-center descriptive study.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Lymphoproliferative Disorders; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies | 2022 |
Lomustine, methotrexate and cytarabine chemotherapy as a rescue treatment for feline lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cat Diseases; Cats; Cyclophosphamide; Cytarabine; Lomustine; Lymphoma; Methotrexate; Neoplasm Recurrence, Local | 2021 |
Overall survival and post-spontaneous regression relapse-free survival of patients with lymphoproliferative disorders associated with rheumatoid arthritis: a multi-center retrospective cohort study.
Topics: Aged; Arthritis, Rheumatoid; Hodgkin Disease; Humans; Longitudinal Studies; Lymphoproliferative Disorders; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies | 2022 |
Central nervous system relapse of primary cutaneous CD8
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Autografts; CD8-Positive T-Lymphocytes; Central Nervous System; Cranial Nerve Diseases; Cytarabine; Humans; Lymphoma, T-Cell, Cutaneous; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Recurrence; Referral and Consultation; Remission Induction; Skin Neoplasms; Spinal Puncture; Stem Cell Transplantation; T-Lymphocytes, Cytotoxic; Treatment Outcome | 2021 |
Cessation of methotrexate and a small intestinal resection provide a good clinical course for a patient with a jejunum perforation induced by a methotrexate-associated lymphoproliferative disorder: a case report.
Topics: Aged, 80 and over; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Intestinal Perforation; Jejunum; Lymphoproliferative Disorders; Methotrexate; Neoplasm Recurrence, Local; Prognosis | 2021 |
An intrathecal limited postoperative chemotherapy regimen for the treatment of young children with nodular/desmoplastic medulloblastoma and medulloblastoma with extensive nodularity.
Topics: Cerebellar Neoplasms; Child; Child, Preschool; Female; Humans; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Progression-Free Survival | 2021 |
Ineffectiveness of high-dose methotrexate for prevention of CNS relapse in diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Risk Factors; Treatment Outcome; Young Adult | 2021 |
Therapeutic drug monitoring guides the management of patients with chronic non-infectious uveitis treated with adalimumab: a retrospective study.
Topics: Adalimumab; Antirheumatic Agents; Drug Monitoring; Humans; Iridocyclitis; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome; Uveitis | 2022 |
Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent-based analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies | 2021 |
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Internationality; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Muscle, Smooth; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Risk Factors; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms; Vinblastine | 2021 |
Effect assessment of methotrexate in combination with other chemotherapeutic agents for osteosarcoma in children: A protocol for systematic review and meta-analysis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Disease-Free Survival; Humans; Meta-Analysis as Topic; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Randomized Controlled Trials as Topic; Survival Rate; Systematic Reviews as Topic; Time Factors | 2021 |
Interpretation of retrospective data evaluating high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma; caution required.
Topics: Central Nervous System; Central Nervous System Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies | 2021 |
Small intestinal follicular lymphoma induced by methotrexate: a case report.
Topics: Aged; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Jejunum; Lymphoma, Follicular; Lymphoproliferative Disorders; Methotrexate; Neoplasm Recurrence, Local | 2021 |
High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma.
Topics: Aged; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies | 2021 |
Comparison of Efficacy of Adjuvant MEC (Methotrexate, Epirubicin and Cisplatin) and GC (Gemcitabine and Cisplatin) in Advanced Upper Tract Urothelial Carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Risk Factors; Survival Rate; Urologic Neoplasms | 2017 |
Gamma-delta T-cell lymphoma of skin, eye and brain presenting with visual loss.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain; Cyclophosphamide; Doxorubicin; Fatal Outcome; Humans; Lymphoma, T-Cell; Male; Methotrexate; Neoplasm Recurrence, Local; Salvage Therapy; Skin; Vincristine; Vision, Low; Young Adult | 2017 |
Immunochemotherapy using rituximab (RTX) and high-dose methotrexate (HD-MTX): an evaluation of the addition of RTX to HD-MTX in recurrent primary central nervous system lymphoma (PCNSL).
Topics: Aged; Central Nervous System Neoplasms; Humans; Immunotherapy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Rituximab | 2017 |
Debulking Surgery for Pelvic Recurrence After Surgically-treated Tubal Gestational Choriocarcinoma - A Case Report and Literature Review.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Choriocarcinoma; Cytoreduction Surgical Procedures; Dactinomycin; Fallopian Tube Neoplasms; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy, Ectopic; Salpingectomy; Young Adult | 2018 |
Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Eye Neoplasms; Female; Flow Cytometry; Humans; Intraocular Lymphoma; Intravitreal Injections; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Procarbazine; Prognosis; Retinal Neoplasms; Retrospective Studies; Rituximab; Survival Rate; Time Factors; Vincristine; Visual Acuity; Vitreous Body | 2018 |
Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: report of the Dutch Cutaneous Lymphoma Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Netherlands; Prednisone; Retrospective Studies; Skin; Skin Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2018 |
Nivolumab maintenance after salvage autologous stem cell transplantation results in long-term remission in multiple relapsed primary CNS lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Exome Sequencing; Female; Gene Expression; Hematopoietic Stem Cell Transplantation; Humans; Magnetic Resonance Imaging; Methotrexate; Neoplasm Recurrence, Local; Nivolumab; Programmed Cell Death 1 Receptor; Remission Induction; T-Lymphocytes; Transplantation, Autologous; Treatment Outcome | 2018 |
Methotrexate-associated Intravascular Large B-cell Lymphoma in a Patient with Rheumatoid Arthritis: A Very Rare Case.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Chromones; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Neoplasm Recurrence, Local; Rare Diseases; Rituximab; Sulfonamides; Treatment Outcome | 2018 |
ALL relapse with multiple cranial nerve palsies and toxic leukoencephalopathy: treatment failure with treatment toxicity.
Topics: Adult; Cranial Nerve Diseases; Female; Humans; Immunosuppressive Agents; Leukoencephalopathies; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Failure | 2018 |
The Prosigna gene expression assay and responsiveness to adjuvant cyclophosphamide-based chemotherapy in premenopausal high-risk patients with breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Gene Expression Profiling; Humans; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Premenopause; Prognosis; Receptor, ErbB-2; Retrospective Studies; Risk Assessment | 2018 |
Hypothalamic relapse of a cardiac large B-cell lymphoma presenting with memory loss, confabulation, alexia-agraphia, apathy, hypersomnia, appetite disturbances and diabetes insipidus.
Topics: Adult; Antimetabolites, Antineoplastic; Cerebral Ventricle Neoplasms; Diabetes Insipidus; Heart Neoplasms; Humans; Hyperphagia; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Memory Disorders; Methotrexate; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Third Ventricle; Treatment Outcome | 2018 |
Treatment results of the second-line chemotherapy regimen for patients with low-risk gestational trophoblastic neoplasia treated with 5-day methotrexate and 5-day etoposide.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Japan; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Remission Induction; Retrospective Studies; Risk Factors; Treatment Outcome | 2018 |
Outcomes of Low-Intensity Treatment of Acute Lymphoblastic Leukemia at Butaro Cancer Center of Excellence in Rwanda.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cancer Care Facilities; Child; Cyclophosphamide; Developing Countries; Dexamethasone; Female; Humans; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Rwanda; Treatment Outcome; Vincristine | 2018 |
Intraocular involvement is associated with a high risk of disease relapse in primary central nervous system lymphoma.
Topics: Adult; Aged; Brain; Central Nervous System Neoplasms; Disease Progression; Eye; Eye Neoplasms; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Progression-Free Survival; Prospective Studies; Risk; Young Adult | 2019 |
Experience in Intra-arterial Chemotherapy using Two Protocols for the Treatment of OSCC over Two Decades at the University Hospital Vienna.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Treatment Outcome; Young Adult | 2018 |
[Primary central nervous system lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; France; Humans; Lymphoma; Methotrexate; Neoplasm Recurrence, Local | 2016 |
Safety and efficacy of high-dose methotrexate for osteosarcoma in adolescents compared with young adults.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Female; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Treatment Outcome; Young Adult | 2019 |
Is there uniformity in definitions and treatment of gestational trophoblastic disease in Europe?
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Europe; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Prognosis; Vincristine | 2019 |
Cetuximab and methotrexate in recurrent or metastatic head and neck squamous cell carcinoma-A single institution analysis of 54 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Michigan; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Survival Rate | 2019 |
[A Case of Carcinomatous Meningitis Due to Gastric Cancer].
Topics: Adult; Cytarabine; Humans; Male; Meningeal Carcinomatosis; Methotrexate; Neoplasm Recurrence, Local; Stomach Neoplasms | 2019 |
Childhood acute lymphoblastic leukaemia relapse with atypical localised presentation mimicking ankle trauma in a 28-year-old man.
Topics: Adult; Ankle; Diagnosis, Differential; Humans; Leucovorin; Male; Methotrexate; Neoplasm Recurrence, Local; Pain; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tomography, X-Ray Computed; Vincristine | 2019 |
It's not all about the CNS. High dose methotrexate in DLBCL.
Topics: Central Nervous System Neoplasms; Freedom; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local | 2019 |
Efficacy and Toxicity of Pembrolizumab in Pediatric Metastatic Recurrent Melanoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antirheumatic Agents; Arthritis, Juvenile; Child; Female; Humans; Melanoma; Methotrexate; Neoplasm Recurrence, Local; Soft Tissue Neoplasms; Steroids; Treatment Outcome; Uveitis | 2019 |
Brentuximab Vedotin and High-dose Methotrexate Administrated Alternately for Refractory Anaplastic Large-cell Lymphoma With Central Nervous System Disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Central Nervous System Diseases; Child; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Neoplasm Recurrence, Local; Prognosis | 2020 |
Oral metronomic chemotherapy in recurrent, metastatic and locally advanced head and neck cancers.
Topics: Administration, Metronomic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Celecoxib; Head and Neck Neoplasms; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pyrazoles; Sulfonamides | 2013 |
Rituximab is associated with improved survival for aggressive B cell CNS lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Cytarabine; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Prognosis; Radiotherapy Dosage; Retrospective Studies; Rituximab; Survival Rate; Young Adult | 2013 |
Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Female; Fluorouracil; Humans; Ki-67 Antigen; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Survival Rate; Taxoids | 2013 |
Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: a 9-year single institute experience in the Northern Region of Thailand.
Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Retrospective Studies; Risk Factors; Survival; Survival Rate; Thailand; Treatment Outcome | 2013 |
Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cyclophosphamide; Cytarabine; Dasatinib; Dexamethasone; Doxorubicin; Female; Flow Cytometry; Follow-Up Studies; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Immunoglobulin Heavy Chains; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Pyrimidines; Real-Time Polymerase Chain Reaction; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Thiazoles; Vincristine; Young Adult | 2013 |
Combination of low-dose mycophenolate mofetil with cyclosporine and methotrexate as GVHD prophylaxis in unrelated donor allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Child; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Morbidity; Mycophenolic Acid; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Transplantation, Homologous; Unrelated Donors; Young Adult | 2013 |
Treatment outcome of relapsed/refractory primary central nervous system diffuse large B-cell lymphoma: a single-center experience of autologous stem cell transplantation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Young Adult | 2013 |
High-dose chemotherapy with autologous stem cell support as salvage therapy in recurrent gestational trophoblastic disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Prognosis; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Vincristine | 2013 |
Effect of variation of ABCB1 and ABCC3 genotypes on the survival of bone tumor cases after chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Dactinomycin; Doxorubicin; Female; Follow-Up Studies; Genotype; Humans; Male; Methotrexate; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Polymorphism, Single Nucleotide; Prognosis; Survival Rate; Vincristine; Young Adult | 2013 |
Patterns of failure after radiosurgery to two different target volumes of enhancing lesions with and without FLAIR abnormalities in recurrent glioblastoma multiforme.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Glioblastoma; Humans; Leucovorin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Complications; Radiosurgery; Retrospective Studies; Treatment Outcome | 2014 |
Drug-drug interaction between methotrexate and levetiracetam resulting in delayed methotrexate elimination.
Topics: Anticonvulsants; Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Interactions; Humans; Levetiracetam; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Osteosarcoma; Piracetam | 2014 |
Primary CNS lymphoma treated with radiotherapy in Japan: a survey of patients treated in 2005-2009 and a comparison with those treated in 1985-2004.
Topics: Adult; Aged; Central Nervous System; Central Nervous System Neoplasms; Female; Humans; Japan; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Surveys and Questionnaires; Survival Rate | 2014 |
Dexamethasone, methotrexate, ifosfamide, L-asparaginase and etoposide (SMILE) chemotherapy for relapsed or refractory adult lymphoblastic lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Etoposide; Humans; Ifosfamide; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2014 |
Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: influence on cure rates and risk of second cancer.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cohort Studies; Cytogenetic Analysis; DNA, Neoplasm; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Genotype; Humans; Infant; Male; Mercaptopurine; Methotrexate; Methyltransferases; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pharmacogenetics; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Risk Factors | 2014 |
Methotrexate re-challenge for recurrent primary central nervous system lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retreatment; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2014 |
Salvage therapy with bendamustine for methotrexate refractory recurrent primary CNS lymphoma: a retrospective case series.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Central Nervous System Neoplasms; Disease-Free Survival; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2014 |
Identification of patients with node-negative, triple-negative breast cancer who benefit from adjuvant cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Survival Rate; Triple Negative Breast Neoplasms | 2014 |
[Relapsed primary intraocular lymphoma treated with intravitreal methotrexate and high-dose chemotherapy followed by autologous stem cell rescue].
Topics: Eye Neoplasms; Female; Humans; Intravitreal Injections; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome | 2014 |
Is it important to maintain high-dose intensity chemotherapy in the treatment of adults with osteosarcoma?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Prognosis; Retrospective Studies; Survival Rate; Time Factors; Young Adult | 2014 |
Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Female; Humans; Injections, Spinal; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2015 |
Impact of SLCO1B1 521T > C variant on leucovorin rescue and risk of relapse in childhood acute lymphoblastic leukemia treated with high-dose methotrexate.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Genotype; Humans; Leucovorin; Liver-Specific Organic Anion Transporter 1; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Organic Anion Transporters; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Prospective Studies; Risk Factors | 2014 |
Medication errors on oral chemotherapy in children with acute lymphoblastic leukemia in a developing country.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cross-Sectional Studies; Developing Countries; Dexamethasone; Drug Prescriptions; Female; Follow-Up Studies; Humans; Infant; Male; Medication Errors; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Prospective Studies | 2014 |
Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Mammaplasty; Mastectomy; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Receptor, ErbB-2; Retrospective Studies; Survival Rate | 2014 |
Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Prognosis; Survival Rate; Time Factors | 2014 |
Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Methotrexate; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Prospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium; Vinblastine | 2015 |
Testicular germ cell tumors in adolescents - results of the protocol MAHO 98 and the identification of good risk patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prognosis; Risk Adjustment; Testicular Neoplasms; Vinblastine; Young Adult | 2014 |
The analysis of treatment of aggressive fibromatosis using oral methotrexate chemotherapy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Child; Female; Fibromatosis, Aggressive; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Young Adult | 2014 |
A case of clonally distinct relapse of Burkitt lymphoma 9 years after complete remission.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Genes, Immunoglobulin; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunoglobulin Heavy Chains; Male; Methotrexate; Molecular Sequence Data; Neoplasm Recurrence, Local; Remission Induction; V(D)J Recombination; Vincristine | 2015 |
Cyclophosphamide, hydroxyurea, actinomycin D, methotrexate, and vincristine in the treatment of gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Hydroxyurea; Methotrexate; Neoplasm Recurrence, Local; Neutropenia; Pregnancy; Retrospective Studies; Salvage Therapy; Stomatitis; Survival Rate; Treatment Outcome; Vincristine; Vomiting | 2015 |
Inoperable inflammatory myofibroblastic tumour of the para-nasal sinuses and orbit with recurrence responding to methotrexate and prednisolone: a case report.
Topics: Adult; Antimetabolites, Antineoplastic; Drug Therapy, Combination; Glucocorticoids; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasms, Muscle Tissue; Paranasal Sinus Neoplasms; Paranasal Sinuses; Prednisolone | 2015 |
Predictors of local recurrence after rituximab-based chemotherapy alone in stage III and IV diffuse large B-cell lymphoma: guiding decisions for consolidative radiation.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Prednisone; Recurrence; Regression Analysis; Risk; Rituximab; Treatment Failure; Tumor Burden; Vincristine; Young Adult | 2015 |
EGFR inhibition for recurrent or metastatic HNSCC.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Quinazolines | 2015 |
Stereotactic radiosurgery in combination with up-front high-dose methotrexate as a first-line treatment for newly diagnosed primary central nervous system lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiosurgery; Radiotherapy Dosage; Retrospective Studies; Salvage Therapy; Survival Rate | 2015 |
Survival of Mexican Children with Acute Lymphoblastic Leukaemia under Treatment with the Protocol from the Dana-Farber Cancer Institute 00-01.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Female; Humans; Infant; Male; Methotrexate; Mexico; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk Factors; Treatment Outcome; United States; Vincristine | 2015 |
Head and neck cancer: second-line afatinib shows promise.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Quinazolines | 2015 |
High-dose methotrexate, etoposide, dexamethasone and pegaspargase (MEDA) combination chemotherapy is effective for advanced and relapsed/refractory extranodal natural killer/T cell lymphoma: a retrospective study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Polyethylene Glycols; Retrospective Studies; Treatment Outcome | 2015 |
Methotrexate administration directly into the fourth ventricle in children with malignant fourth ventricular brain tumors: a pilot clinical trial.
Topics: Adolescent; Antineoplastic Agents; Cerebral Ventricle Neoplasms; Child; Child, Preschool; Ependymoma; Female; Fourth Ventricle; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Pilot Projects; Rhabdoid Tumor; Spinal Cord; Young Adult | 2015 |
Comparison of 5-day MTX and 5-day ETP treatment results and early predictors of drug resistance to 5-day MTX in patients with post-molar low-risk gestational trophoblastic neoplasia.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Chorionic Gonadotropin; Drug Administration Schedule; Drug Resistance, Neoplasm; Drug Substitution; Etoposide; Female; Humans; Hydatidiform Mole; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies; Treatment Outcome; Uterine Neoplasms; Young Adult | 2015 |
The influence of lung metastases on the clinical course of gestational trophoblastic neoplasia: a historical cohort study.
Topics: Adult; Antimetabolites, Antineoplastic; Cohort Studies; Databases, Factual; Disease-Free Survival; Female; Gestational Trophoblastic Disease; Humans; Induction Chemotherapy; Lung Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Netherlands; Pregnancy; Treatment Outcome | 2016 |
[Angioimmunoblastic T-cell lymphoma suspected to recur in the cranium after complete remission: A case report].
Topics: Brain; Brain Neoplasms; Combined Modality Therapy; Female; Humans; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, T-Cell; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy; Remission Induction; Treatment Outcome | 2016 |
Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study.
Topics: Adalimumab; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Azathioprine; Breast Neoplasms; Cohort Studies; Etanercept; Female; Humans; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Infliximab; Medicare; Mercaptopurine; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Proportional Hazards Models; Retrospective Studies; Risk Factors; Tumor Necrosis Factor-alpha; United States | 2016 |
Combination chemotherapy with methotrexate and vinblastine for surgically unresectable, aggressive fibromatosis.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Female; Fever; Fibromatosis, Aggressive; Humans; Kaplan-Meier Estimate; Liver; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Retrospective Studies; Transaminases; Treatment Outcome; Vinblastine; Young Adult | 2016 |
A case of primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Eyelid Neoplasms; Humans; Interferon-alpha; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Skin Neoplasms | 2016 |
[Pediatric ependymomas: Current diagnosis and therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Ependymoma; Humans; Infant; Leucovorin; Methotrexate; Neoplasm Recurrence, Local; Procarbazine; Prognosis; Rare Diseases; Vincristine | 2016 |
Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Rituximab | 2017 |
Dismal outcome of therapy-related myeloid neoplasm associated with complex aberrant karyotypes and monosomal karyotype: a case report.
Topics: Abnormal Karyotype; Antineoplastic Combined Chemotherapy Protocols; Humans; Idarubicin; In Situ Hybridization, Fluorescence; Karyotyping; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Tretinoin | 2016 |
Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Fatal Outcome; Humans; Language Development Disorders; Lung Neoplasms; Mercaptopurine; Methotrexate; Mitoxantrone; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Nephrectomy; Pneumonectomy; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2017 |
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis.
Topics: Aged; Calcineurin Inhibitors; Cohort Studies; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 2017 |
Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Case-Control Studies; Cisplatin; Doxorubicin; Female; Humans; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Nephrectomy; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 2008 |
Methotrexate and leucovorin double-modulated 5-fluorouracil combined with cisplatin (MPFL) in metastatic/recurrent head and neck cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Treatment Outcome; Vitamin B Complex | 2008 |
New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
Topics: Adult; Age Factors; Aged; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Denmark; Disease Susceptibility; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Heart; Heart Failure; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Severity of Illness Index; Tamoxifen; Vindesine | 2008 |
[Treatment of advanced penile cancer. Do we need new methods for chemotherapy?].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Disease Progression; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Palliative Care; Penile Neoplasms | 2008 |
COX-2 expression correlates with survival in patients with osteosarcoma lung metastases.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclooxygenase 2; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Proteins; Neoplasm Recurrence, Local; Osteosarcoma; Pneumonectomy; Prognosis; Retrospective Studies; Salvage Therapy; Survival Analysis | 2008 |
No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy Dosage; Remission Induction; Salvage Therapy; Thiotepa; Vincristine; Young Adult | 2009 |
Initial results of retrospective study: preoperative transurethral excision plus chemotherapy and radiation therapy and trial of bladder preservation.
Topics: Adult; Aged; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Preoperative Care; Prognosis; Radiotherapy Dosage; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2007 |
First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX plus (125)IUdR.
Topics: Adult; Antibiotics, Antineoplastic; Antigens, Tumor-Associated, Carbohydrate; Brain Neoplasms; Combined Modality Therapy; Drug Resistance, Neoplasm; Fatal Outcome; Female; Humans; Idoxuridine; Injections, Spinal; Iodine Radioisotopes; Meningeal Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Radiopharmaceuticals | 2008 |
Poor treatment compliance in children with down syndrome and acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Down Syndrome; Female; Guideline Adherence; Humans; Infant; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Patient Compliance; Physician's Role; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome | 2009 |
Tacrolimus with mini-methotrexate as prophylaxis for graft-versus-host disease in pediatric patients after allogeneic peripheral blood stem cell transplant or bone marrow transplant.
Topics: Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Survival Rate; Tacrolimus; Transplantation, Homologous; Treatment Outcome; Young Adult | 2008 |
Successful salvage chemotherapy for isolated central nervous system (CNS) relapse in Burkitt lymphoma: monocentric experience of 3 pediatric patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Central Nervous System Neoplasms; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Treatment Outcome | 2008 |
[Pulmonary resection in the management of gestational trophoblastic neoplasia: a clinical study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Pregnancy; Prognosis; Retrospective Studies | 2008 |
Benefit of radiation boost after whole-breast radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retreatment; Retrospective Studies | 2009 |
Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study.
Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chorionic Gonadotropin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hysterectomy; Kaplan-Meier Estimate; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Pregnancy; Prognosis; Proportional Hazards Models; Retrospective Studies; ROC Curve; Survival Rate; Treatment Outcome; Trophoblastic Tumor, Placental Site; United Kingdom; Uterine Neoplasms; Vincristine | 2009 |
Chemotherapy: Adjuvant chemotherapy in older patients with breast cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Drug Therapy; Female; Fluorouracil; Humans; Meta-Analysis as Topic; Methotrexate; Neoplasm Recurrence, Local; Neutropenia; Patient Compliance; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Estrogen; Survival Analysis; Therapeutic Equivalency | 2009 |
[Therapeutic management of central nervous system lymphomas in a single hematological institute].
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Doxorubicin; Drug Administration Schedule; Epidural Space; Female; Humans; Hungary; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prednisone; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2009 |
Aggressive fibromatosis in children and adolescents: the Italian experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Female; Fibromatosis, Aggressive; Humans; Infant; Male; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Vinblastine; Vinorelbine | 2010 |
[Clinical impact of extracapsular extension of axillary lymph node metastases in breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Postmenopause; Proportional Hazards Models; Retrospective Studies; Risk Factors; Survival Rate | 2009 |
[Therapeutic effects of vinorelbine-based chemotherapy--retrospective study of 65 patients with metastatic or relapsed breast cancer].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Retrospective Studies; Trastuzumab; Vinblastine; Vinorelbine | 2010 |
The degree of myelosuppression during maintenance therapy of adolescents with B-lineage intermediate risk acute lymphoblastic leukemia predicts risk of relapse.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Female; Humans; Infant; Leukocyte Count; Male; Mercaptopurine; Methotrexate; Methyltransferases; Neoplasm Recurrence, Local; Neutrophils; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; Survival Rate; Treatment Outcome | 2010 |
Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type.
Topics: Adult; Antineoplastic Agents; Asparaginase; Combined Modality Therapy; Cyclosporine; Drug Resistance, Neoplasm; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphoma, T-Cell; Male; Methotrexate; Natural Killer T-Cells; Neoplasm Recurrence, Local; Nose Neoplasms; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation, Homologous; Treatment Outcome; Young Adult | 2010 |
[Adjuvant chemotherapy in older women with breast cancer. CALGB Study (The Cancer and Leukemia Group B Study)].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Deoxycytidine; Doxorubicin; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Receptors, Estrogen; Survival Analysis | 2010 |
Moyamoya in a child treated with interferon for recurrent osteosarcoma.
Topics: Antineoplastic Agents; Bone Neoplasms; Carotid Artery Diseases; Cerebral Arterial Diseases; Cerebral Infarction; Chemotherapy, Adjuvant; Child; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Interferon-alpha; Lung Neoplasms; Magnetic Resonance Angiography; Methotrexate; Moyamoya Disease; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Thyroiditis, Autoimmune | 2010 |
The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up.
Topics: Adult; Amenorrhea; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Premenopause; Survival Rate; Tamoxifen; Treatment Outcome | 2010 |
Overt testicular disease at diagnosis in childhood acute lymphoblastic leukemia: prognostic significance and role of testicular irradiation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Humans; Male; Methotrexate; Multivariate Analysis; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Testicular Neoplasms | 2010 |
[Primary neurolymphomatosis of the cervical nerve root].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cervical Vertebrae; Cyclophosphamide; Doxorubicin; Fatal Outcome; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Neurosurgical Procedures; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Prednisolone; Rituximab; Spinal Nerve Roots; Vincristine | 2010 |
Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionated cyclophosphamide, doxorubicin, vincristine, dexamethasone/methotrexate, cytarabine: results from an Australian population.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Australia; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2011 |
[Clinical analysis of patients with relapsed and chemo-resistant gestational trophoblastic neoplasia].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Prognosis; Retrospective Studies; Time Factors; Treatment Outcome; Vincristine; Young Adult | 2010 |
Tumor volume increase during preoperative chemotherapy as a novel predictor of local recurrence in extremity osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Doxorubicin; Extremities; Female; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Preoperative Care; Survival Rate; Treatment Outcome; Tumor Burden; Young Adult | 2011 |
[A successful case of tanshinone II A treatment for relapsed acute promyelocytic leukemia after maintainance therapy of all-trans retinoic acid and arsenic trioxide].
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Oxides; Tretinoin; Young Adult | 2010 |
Exclusive alternating chemotherapy and radiotherapy in nonmetastatic inflammatory breast cancer: 20 years of follow-up.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachial Plexus Neuropathies; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Combined Modality Therapy; Cyclophosphamide; Dose Fractionation, Radiation; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fibrosis; Fluorouracil; Follow-Up Studies; Heart; Humans; Inflammatory Breast Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Radiation Injuries; Radiation Pneumonitis; Survival Rate; Tamoxifen; Time Factors; Vincristine | 2012 |
Late relapse in primary central nervous system lymphoma: clonal persistence.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome | 2011 |
Treatment outcome of Korean patients with localized Ewing sarcoma family of tumors: a single institution experience.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Confounding Factors, Epidemiologic; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Odds Ratio; Prognosis; Republic of Korea; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Time Factors; Treatment Outcome; Vincristine; Young Adult | 2011 |
Classical CMF regimen as adjuvant chemotherapy for triple-negative breast cancer may be more effective compared with anthracycline or taxane-based regimens.
Topics: Adolescent; Adult; Aged; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Immunoenzyme Techniques; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Survival Rate; Taxoids; Young Adult | 2012 |
Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Infant; Leucovorin; Magnetic Resonance Imaging; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Radiotherapy; Remission Induction; Survival Rate; Vincristine | 2011 |
Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Disease-Free Survival; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine; Vindesine | 2011 |
Prophylactic intrathecal chemotherapy in primary CNS lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cohort Studies; Disease-Free Survival; Female; Follow-Up Studies; Humans; Injections, Spinal; Karnofsky Performance Status; Lomustine; Lymphoma; Male; Methotrexate; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Neuroprotective Agents; Procarbazine; Retrospective Studies; Young Adult | 2012 |
Intravitreal methotrexate for retinoblastoma.
Topics: Antimetabolites, Antineoplastic; Humans; Intravitreal Injections; Methotrexate; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma | 2011 |
Rituximab for the treatment of adult relapsed/refractory CD20 positive B-ALL patients: a pilot series.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Pilot Projects; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Risk Factors; Rituximab; Salvage Therapy; Survival Rate; Vincristine; Young Adult | 2012 |
Clinical correlates of 'BRCAness' in triple-negative breast cancer of patients receiving adjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Taxoids; Treatment Outcome; Young Adult | 2012 |
Panniculitis associated with dermatomyositis and recurrent ovarian cancer.
Topics: Adenocarcinoma; Administration, Oral; Dermatologic Agents; Dermatomyositis; Female; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Panniculitis; Treatment Outcome | 2012 |
EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Prognosis; Retrospective Studies; Uterine Neoplasms; Young Adult | 2012 |
Analysis of Intravesical Recurrence After Bladder-preserving Therapy for Muscle-invasive Bladder Cancer.
Topics: Administration, Intravesical; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Biomarkers, Tumor; Cancer Vaccines; Cell Proliferation; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Drug Administration Schedule; Female; Humans; Immunohistochemistry; Infusions, Intra-Arterial; Ki-67 Antigen; Male; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Odds Ratio; Proportional Hazards Models; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retrospective Studies; Urinary Bladder Neoplasms | 2012 |
SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Clinical Trials, Phase II as Topic; Cohort Studies; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Survival Rate; Young Adult | 2012 |
Post-treatment T1 shortening in primary CNS lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Female; Follow-Up Studies; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Survival Rate; Young Adult | 2013 |
Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: a retrospective analysis from the University of Southern California.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Cystectomy; Deoxycytidine; Doxorubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Proportional Hazards Models; Retrospective Studies; Urinary Bladder Neoplasms; Vinblastine | 2013 |
Towards rational graft-versus-host disease prophylaxis.
Topics: Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Sirolimus; Tacrolimus | 2012 |
Early relapses in patients with primary CNS lymphoma treated with methotrexate-based chemotherapy without consolidating whole brain irradiation.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Cranial Irradiation; Dexamethasone; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Remission Induction; Retrospective Studies; Rituximab; Survival Rate | 2013 |
Fibrous soft tissue tumors: factors predictive of recurrence.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Fibroma; Follow-Up Studies; Humans; Infant; Infant, Newborn; Logistic Models; Male; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies; Risk Factors; Soft Tissue Neoplasms; Treatment Outcome; Vinblastine; Young Adult | 2013 |
Sequential administration of methotrexate and asparaginase in relapsed or refractory pediatric acute myeloid leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Female; Humans; Infant; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy | 2013 |
Malignant urothelial carcinoma of urinary bladder in a young child: a rare case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Child, Preschool; Cisplatin; Doxorubicin; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms; Vinblastine | 2013 |
The role of combined method in organ-sparing treatment of muscle-invasive bladder cancer recurrences.
Topics: Aged; BCG Vaccine; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Disease Progression; Doxorubicin; Female; Humans; Life Tables; Male; Methotrexate; Middle Aged; Muscle, Smooth; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Radiotherapy, High-Energy; Remission Induction; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2002 |
Local recurrence in the breast after conservative surgery--a study of prognosis and prognostic factors in 391 women.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prognosis; Survival Analysis | 2002 |
Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Female; Follow-Up Studies; Humans; Hydrocortisone; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome | 2002 |
Efficacy of a primary chemotherapy regimen combining vinorelbine, epirubicin, and methotrexate (VEM) as neoadjuvant treatment in 89 patients with operable breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Epirubicin; Female; Humans; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Treatment Outcome; Vinblastine; Vinorelbine | 2002 |
Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Follow-Up Studies; Humans; Leucovorin; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Survival Analysis; Treatment Outcome | 2002 |
Optimal therapy of primary ocular lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Eye Neoplasms; Functional Laterality; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Radiotherapy; Vincristine | 2002 |
Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Brain Damage, Chronic; Brain Neoplasms; Calcinosis; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disabled Children; Epilepsy; Etoposide; Female; Humans; Hydrocephalus; Infant; Intellectual Disability; Learning Disabilities; Lomustine; Magnetic Resonance Imaging; Male; Methotrexate; Movement Disorders; Neoplasm Recurrence, Local; Prevalence; Procarbazine; Radiation Injuries; Slovenia; Survivors; Tomography, X-Ray Computed; Unemployment; Vincristine; Vision Disorders | 2003 |
Value of P-glycoprotein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremities.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Arm; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Doxorubicin; Female; Humans; Ifosfamide; Immunohistochemistry; Leg; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Prognosis; Risk Factors | 2003 |
[Ocular relapse of acute lymphoblastic leukemia].
Topics: Administration, Topical; Adrenal Cortex Hormones; Anterior Chamber; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cyclophosphamide; Cytarabine; Dexamethasone; Eye Neoplasms; Fatal Outcome; Humans; Methotrexate; Neoplasm Recurrence, Local; Paracentesis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy, Adjuvant; Vincristine | 2002 |
Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Child, Preschool; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Thrombocytopenia; Vincristine | 2003 |
Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Doxorubicin; Female; Humans; Infant; Infant, Newborn; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Osteosarcoma; Patient Compliance; Prognosis; Salvage Therapy; Survival Analysis | 2003 |
S-1 in the treatment of advanced and recurrent gastric cancer: current state and future prospects.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Forecasting; Humans; Japan; Liver Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Pyridines; Severity of Illness Index; Stomach Neoplasms; Survival Analysis; Tegafur; Time Factors; Treatment Outcome | 2003 |
Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Disease-Free Survival; Eye Neoplasms; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 2003 |
Paradigm shift in adjuvant treatment of receptor positive premenopausal breast cancer patients? Not yet!
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Goserelin; Humans; Infant; Methotrexate; Neoplasm Recurrence, Local; Ovariectomy; Premenopause; Survival Rate; Tamoxifen | 2003 |
Combined endocrine blockade in premenopausal breast cancer: a superior therapeutic option for adjuvant management?
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Goserelin; Humans; Methotrexate; Neoplasm Recurrence, Local; Ovariectomy; Premenopause; Survival Rate; Tamoxifen | 2003 |
Long-term remission of primary central nervous system lymphoma by intensified methotrexate chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Combined Modality Therapy; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Time Factors | 2003 |
[Retroperitoneal fibrosarcoma. Apropos of a case].
Topics: Antineoplastic Combined Chemotherapy Protocols; Back Pain; Calcinosis; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Fatal Outcome; Fibrosarcoma; Hematuria; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pulmonary Embolism; Retroperitoneal Neoplasms | 2003 |
CLOSED PELVIC PERFUSION: A NEW APPROACH TO THE PROBLEM OF ADVANCED GYNECOLOGIC MALIGNANCY.
Topics: Chemotherapy, Cancer, Regional Perfusion; Cyclophosphamide; Drug Therapy; Female; Fluorouracil; Genital Neoplasms, Female; Geriatrics; Humans; Methotrexate; Neoplasm Recurrence, Local; Neoplasms; Palliative Care; Pelvis; Prognosis; Uracil Mustard; Uterine Cervical Neoplasms; Vulvar Neoplasms | 1965 |
Reduced folate carrier protein expression in osteosarcoma: implications for the prediction of tumor chemosensitivity.
Topics: Actins; Adolescent; Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neoplasms; Carrier Proteins; Child; Drug Resistance, Neoplasm; Humans; Male; Membrane Proteins; Membrane Transport Proteins; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Osteosarcoma; Reduced Folate Carrier Protein; Tumor Cells, Cultured | 2003 |
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Safety; Salvage Therapy; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2003 |
Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma: the experience of the Gruppo Italiano Studio Linfomi.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Female; Hodgkin Disease; Humans; Lung; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome; Vincristine | 2003 |
Chemotherapy for bladder cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Clinical Protocols; Cystectomy; Doxorubicin; Humans; Methotrexate; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms; Vinblastine | 2003 |
Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Chi-Square Distribution; Cisplatin; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies; Statistics, Nonparametric; Survival Analysis | 2003 |
Low-risk persistent gestational trophoblastic disease treated with low-dose methotrexate: efficacy, acute and long-term effects.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Drug Resistance, Neoplasm; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Pregnancy; Treatment Outcome; Vitamin B Complex | 2003 |
CNS-directed therapy in young children with T-lineage acute lymphoblastic leukemia: High-dose methotrexate versus cranial irradiation.
Topics: Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Child, Preschool; Cohort Studies; Cranial Irradiation; Female; Humans; Infant; Leukemia, T-Cell; Male; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Survival Rate | 2004 |
Using loco-regional recurrence as an indicator of the quality of breast cancer treatment.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 2004 |
Lymphomatoid papulosis associated with recurrent cutaneous T-cell lymphoma.
Topics: Adult; Dermatologic Agents; Humans; Lymphomatoid Papulosis; Male; Methotrexate; Mycosis Fungoides; Neoplasm Recurrence, Local; Skin Neoplasms; Ultraviolet Therapy | 2004 |
Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chi-Square Distribution; Cisplatin; Cystectomy; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic; Scandinavian and Nordic Countries; Survival Analysis; Urinary Bladder Neoplasms | 2004 |
Clonal evolution as pathogenetic mechanism in relapse of primary CNS lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Base Sequence; Breast Neoplasms; Clone Cells; Combined Modality Therapy; Cytarabine; DNA, Neoplasm; Embryonal Carcinoma Stem Cells; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Genes, Immunoglobulin; Germinal Center; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Methotrexate; Molecular Sequence Data; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neoplastic Stem Cells; Parietal Lobe; Remission Induction; Sequence Alignment; Sequence Homology, Nucleic Acid; Supratentorial Neoplasms; Temporal Lobe | 2004 |
Multimodal treatment of children with unresectable or recurrent desmoid tumors: an 11-year longitudinal observational study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Diclofenac; Female; Fibromatosis, Aggressive; Humans; Infant; Longitudinal Studies; Magnetic Resonance Imaging; Male; Methotrexate; Neoplasm Recurrence, Local; Surgical Procedures, Operative; Tamoxifen; Vinblastine | 2004 |
Treatment of relapsed central nervous system lymphoma with high-dose methotrexate.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Cranial Irradiation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome | 2004 |
Placental site trophoblastic tumor: an overview.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Fertility; Humans; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Placenta Diseases; Pregnancy; Retrospective Studies; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2004 |
Tumor excision and reconstruction of the upper cervical spine: a multidisciplinary approach.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axis, Cervical Vertebra; Bone Transplantation; Cervical Atlas; Chemotherapy, Adjuvant; Chondrosarcoma; Chordoma; Combined Modality Therapy; Cranial Fossa, Posterior; Etoposide; Fatal Outcome; Female; Femoral Neoplasms; Humans; Ifosfamide; Interdisciplinary Communication; Internal Fixators; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Palliative Care; Patient Care Team; Proton Therapy; Remission Induction; Skull Base Neoplasms; Spinal Fusion; Spinal Neoplasms; Surgical Flaps | 2004 |
The 2000 Burkitt lymphoma trial in Malawi.
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Female; Humans; Malawi; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Vincristine | 2005 |
[Efficacy of modified BFM-90 regimen on children and adolescents with T cell lymphoblastic lymphoma: a report of 20 cases].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Stem Cell Transplantation; Survival Rate; Treatment Outcome; Vincristine | 2004 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 1-2005. A 35-year-old woman with difficulty walking, headache, and nausea.
Topics: Adult; Antimetabolites, Antineoplastic; Biopsy; Brain Neoplasms; Corpus Callosum; Diagnosis, Differential; Female; Headache; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Methotrexate; Movement Disorders; Nausea; Neoplasm Recurrence, Local; Parietal Lobe; Stereotaxic Techniques; Tomography, X-Ray Computed | 2005 |
Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Aspartic Acid; Central Nervous System Neoplasms; Choline; Creatine; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Immunocompetence; Lactic Acid; Lipid Metabolism; Lymphoma; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Protons; Survival Analysis | 2005 |
Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Cohort Studies; Disease-Free Survival; Feasibility Studies; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction | 2005 |
Chemosensitivity in pediatric dermatofibrosarcoma protuberans.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Child; Dermatofibrosarcoma; Female; Humans; Methotrexate; Neoplasm Recurrence, Local; Skin Neoplasms; Vinblastine | 2005 |
[Case of central nervous system lymphoma metastasized to breast after remission by methotrexate chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cytarabine; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Pulse Therapy, Drug; Radiotherapy, Adjuvant; Remission Induction; Vincristine | 2005 |
Survival of adults treated for medulloblastoma using paediatric protocols.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Cranial Irradiation; Disease-Free Survival; Humans; Infusions, Intravenous; Lomustine; Medulloblastoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome; Vincristine | 2005 |
Relapse of primary CNS lymphoma after more than 10 years in complete remission.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Dacarbazine; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Recurrence, Local; Procarbazine; Temozolomide; Vincristine | 2005 |
[Personal experiences with methotrexate in tumor therapy].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma; Combined Modality Therapy; Disease Progression; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Treatment Outcome | 1966 |
Expression profiles of osteosarcoma that can predict response to chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Nuclear Proteins; Osteosarcoma; Predictive Value of Tests; Prognosis; Razoxane; Reverse Transcriptase Polymerase Chain Reaction; Survival Rate; Twist-Related Protein 1 | 2005 |
Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group.
Topics: Adolescent; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Humans; Idarubicin; Incidence; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Risk Factors; Survival Rate; Tretinoin | 2005 |
Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma.
Topics: Administration, Oral; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Brain Abscess; Carboplatin; Cerebral Ventricle Neoplasms; Child; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Cyclophosphamide; Diagnostic Errors; Etoposide; Humans; Immunocompromised Host; Infusions, Intravenous; Lomustine; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Neuroaspergillosis; Pyrimidines; Surgical Wound Infection; Triazoles; Vincristine; Voriconazole | 2007 |
Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Breast; Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Lobular; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Dose Fractionation, Radiation; Doxorubicin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Risk Factors; Taxoids; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Multifocal motor neuropathy with conduction block associated with metastatic lymphoma of the nervous system.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Demyelinating Diseases; Female; Head and Neck Neoplasms; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Motor Neuron Disease; Neoplasm Recurrence, Local; Nervous System Neoplasms; Neural Conduction; Peripheral Nervous System Diseases; Scalp; Skin Neoplasms; Thiotepa; Vincristine | 2006 |
Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Disease-Free Survival; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Proton Therapy; Salvage Therapy; Survival Rate; Urinary Bladder; Urinary Bladder Neoplasms; Vinblastine | 2006 |
Primary central nervous system lymphomas (PCNSL): MRI response criteria revised.
Topics: Central Nervous System Neoplasms; Follow-Up Studies; Humans; Lymphoma; Magnetic Resonance Imaging; Methotrexate; Neoplasm Recurrence, Local; Remission Induction; Retrospective Studies | 2006 |
Persistent trophoblast disease following partial molar pregnancy.
Topics: Adult; Australia; Biomarkers, Tumor; Chorionic Gonadotropin; Female; Follow-Up Studies; Gestational Age; Humans; Hydatidiform Mole; Maternal Age; Methotrexate; Neoplasm Recurrence, Local; Parity; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Registries; Retrospective Studies; Risk Assessment; Trophoblastic Neoplasms; Uterine Neoplasms | 2006 |
Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Karnofsky Performance Status; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Salvage Therapy; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Female; Humans; Hydrocortisone; Incidence; Lactate Dehydrogenases; Male; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis | 2006 |
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cisplatin; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Linear Models; Lymphatic Metastasis; Methotrexate; Middle Aged; Mitomycins; Neoplasm Proteins; Neoplasm Recurrence, Local; Odds Ratio; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; Risk Assessment; Risk Factors; Secondary Prevention; Tamoxifen | 2006 |
Recurrent gestational trophoblastic tumor: management and risk factors for recurrence.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Etoposide; Female; Fluorouracil; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Retrospective Studies; Risk Factors; Vincristine | 2006 |
Acute lymphoblastic leukemia in adolescents between 10 and 19 years of age in Denmark--secondary publication.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Doxorubicin; Female; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Retrospective Studies; Stem Cell Transplantation; Treatment Outcome; Vincristine | 2006 |
Spontaneously relapsing and remitting primary CNS lymphoma in an immunocompetent 45-year-old man.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Central Nervous System Neoplasms; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Regression, Spontaneous; Procarbazine; Treatment Outcome; Vincristine | 2006 |
[Acute lymphoblastic leukaemia in Danish children and young people 10 to 19 years of age. Should young adults with acute lymphoblastic leukaemia be treated in the same way as children?].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Daunorubicin; Doxorubicin; Female; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Stem Cell Transplantation; Treatment Outcome; Vincristine | 2006 |
Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences.
Topics: Antineoplastic Combined Chemotherapy Protocols; China; Drug Resistance, Neoplasm; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Analysis; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms | 2006 |
Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Ependymoma; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Methotrexate; Neoplasm Recurrence, Local; Thiotepa; Transplantation, Autologous; Treatment Outcome; Vincristine | 2007 |
Local recurrence and distant metastasis of supratentorial primitive neuro-ectodermal tumor in an adult patient successfully treated with intensive induction chemotherapy and maintenance temozolomide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Humans; Liver Neoplasms; Male; Methotrexate; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Prednisone; Remission Induction; Supratentorial Neoplasms; Temozolomide; Treatment Outcome; Vincristine | 2007 |
Gene expression profilers and conventional clinical markers to predict distant recurrences for premenopausal breast cancer patients after adjuvant chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; DNA, Complementary; Female; Fluorouracil; Gene Expression Profiling; Humans; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Premenopause; RNA; ROC Curve | 2006 |
A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms, Male; Chemotherapy, Adjuvant; Cyclophosphamide; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; SEER Program | 2007 |
Proteomic analysis identifies candidate proteins associated with distant recurrences in breast cancer after adjuvant chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Combined Modality Therapy; DNA, Complementary; Electrophoresis, Gel, Two-Dimensional; Female; Fluorouracil; Gels; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Molecular Weight; Neoplasm Proteins; Neoplasm Recurrence, Local; Oligonucleotide Array Sequence Analysis; Proteomics | 2007 |
Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; England; Female; Fluorouracil; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Magnetic Resonance Imaging; Mastectomy; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Preoperative Care; Retrospective Studies; Treatment Outcome | 2007 |
DHFR and MSH3 co-amplification in childhood acute lymphoblastic leukaemia, in vitro and in vivo.
Topics: Cell Line, Transformed; Cell Line, Tumor; Child; DNA-Binding Proteins; Gene Amplification; Gene Dosage; Humans; Methotrexate; MutS Homolog 3 Protein; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tetrahydrofolate Dehydrogenase | 2007 |
[Diagnostic problems in case of primary central nervous system lymphoma].
Topics: Adult; Biopsy; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Diagnosis, Differential; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy; Stereotaxic Techniques; Treatment Outcome | 2006 |
HER-2/neu status and response to CMF: retrospective study in a series of operable breast cancer treated with primary CMF chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Gene Amplification; Genes, erbB-2; Humans; Mammography; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Survival Analysis | 2007 |
Neoadjuvant chemotherapy in advanced penile carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Penile Neoplasms; Treatment Outcome; Vincristine | 2007 |
Editorial comment on: Neoadjuvant chemotherapy in advanced penile carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Penile Neoplasms; Treatment Outcome; Vincristine | 2007 |
[Outcome of gestational trophoblastic neoplasia patients with residual lung tumor after completion of treatment].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Female; Fluorouracil; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Pregnancy; Prognosis; Retrospective Studies | 2007 |
CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: a 15-year monocentric experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leukemia; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Risk Factors; Survival Rate; Treatment Outcome; Vincristine | 2007 |
What is the best salvage therapy for treatment of isolated CNS relapse in elderly patients with imatinib-responsive Ph(+) ALL?
Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Marrow; Cytarabine; Humans; Hydrocortisone; Imatinib Mesylate; Injections, Spinal; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiotherapy; Salvage Therapy | 2007 |
Resumption of high-dose methotrexate after methotrexate-induced nephrotoxicity and carboxypeptidase G2 use.
Topics: Adolescent; Antimetabolites, Antineoplastic; gamma-Glutamyl Hydrolase; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Renal Insufficiency; Retreatment | 2007 |
Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Contraindications; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Extremities; Female; Humans; Limb Salvage; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Treatment Outcome | 2007 |
One more change of paradigm in breast cancer treatment. Postmastectomy radiotherapy for patients with one to three lymph node metastases?
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prognosis; Survival Rate; Tamoxifen | 2007 |
An increase in cell number at completion of therapy may develop as an indicator of early relapse: quantification of circulating epithelial tumor cells (CETC) for monitoring of adjuvant therapy in breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Cell Count; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Epirubicin; Epithelial Cells; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Prognosis; Remission Induction; Survival Rate; Tamoxifen; Taxoids | 2008 |
Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Ependymoma; Female; Humans; Infant; Male; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Treatment Outcome; Vincristine | 2007 |
Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cryptogenic Organizing Pneumonia; Cyclophosphamide; Cyclosporine; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Methotrexate; Neoplasm Recurrence, Local; Palatal Neoplasms; Remission Induction; Salvage Therapy; Transplantation, Homologous; Vincristine | 2007 |
Methotrexate concentrations in cerebrospinal fluid and serum, and the risk of central nervous system relapse in children with acute lymphoblastic leukaemia.
Topics: Adolescent; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Logistic Models; Male; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk | 2007 |
[Diagnosis and prognosis study of breast carcinoma with micropapillary component].
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Liver Neoplasms; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Tamoxifen | 2007 |
18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Central Nervous System Neoplasms; Cohort Studies; Female; Fluorodeoxyglucose F18; HIV Seronegativity; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Rituximab | 2007 |
Effect of radiation dose on local control in breast cancer.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Radiation; Female; Fluorouracil; Humans; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy; Radiotherapy Dosage; Risk | 2008 |
[Postoperative radiotherapy of the chest wall in patients with male breast cancer].
Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms, Male; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Mastectomy, Modified Radical; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radioisotope Teletherapy; Radiotherapy, Adjuvant; Tamoxifen; Thoracic Wall | 2007 |
Management of high-risk hydatidiform mole and persistent gestational trophoblastic neoplasia: the Korean experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Korea; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pregnancy; Prospective Studies; Registries; Retrospective Studies; Risk Factors; Salvage Therapy; Severity of Illness Index; Uterine Neoplasms | 2007 |
Multiple cutaneous relapses in an adolescent in anaplastic large cell lymphoma diagnosed by FNAC.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Fine-Needle; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Mitoguazone; Neoplasm Recurrence, Local; Prednisone; Skin Neoplasms; Vincristine | 2008 |
Multimodality treatment of osteosarcoma: radiation in a high-risk cohort.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Cohort Studies; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Medical Records; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Survival Rate | 2008 |
Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcome.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Drug Monitoring; Estrogens; Female; Fluorouracil; Follow-Up Studies; Humans; Japan; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Paclitaxel; Progesterone; Prognosis; Retrospective Studies; Taxoids; Trastuzumab; Treatment Outcome | 2009 |
Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia--feasibility and safety study.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Feasibility Studies; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Leukemia; Lymphocyte Transfusion; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Tissue Donors | 2008 |
Interdisciplinary combined treatment of craniofacial osteosarcoma with neoadjuvant and adjuvant chemotherapy and excision of the tumour: a retrospective study.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Mandibular Neoplasms; Maxillary Neoplasms; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Young Adult | 2008 |
[Treatment of advanced maxillary sinus squamous carcinoma: an analysis of 92 cases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Maxillary Sinus; Maxillary Sinus Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Radiotherapy, High-Energy; Retrospective Studies; Survival Rate; Young Adult | 2008 |
Disseminated melanoma. Biologic behavior and treatment.
Topics: Antineoplastic Agents; Chlorambucil; Cyclophosphamide; Dactinomycin; Fluorouracil; Humans; Hydrazines; Hydroxyurea; Lymph Node Excision; Lymphatic Metastasis; Melanoma; Melphalan; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Perfusion; Vincristine | 1967 |
[Drug therapy in advanced squamous cell carcinoma of the ORL region].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Fluorouracil; Head and Neck Neoplasms; Humans; Leucovorin; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Prognosis | 1984 |
Reevaluation of 5-fluorouracil as a single therapeutic agent for gestational trophoblastic neoplasms.
Topics: Choriocarcinoma; Diarrhea; Female; Fluorouracil; Follow-Up Studies; Humans; Hydatidiform Mole, Invasive; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Uterine Neoplasms | 1984 |
Comparison of three methods of central-nervous-system prophylaxis in childhood acute lymphoblastic leukaemia.
Topics: Adolescent; Child; Child, Preschool; Hodgkin Disease; Humans; Infant; Infusions, Parenteral; Injections, Spinal; Leukemia, Lymphoid; Meningeal Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies; Risk | 1980 |
Combined intraarterial chemotherapy, radiation therapy, and surgery for advanced squamous-cell carcinoma of the head and neck.
Topics: Adult; Aged; Bleomycin; Carcinoma, Squamous Cell; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Maxillary Sinus; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paranasal Sinus Neoplasms; Prospective Studies; Tongue Neoplasms | 1980 |
[Chemotherapy of advanced head and neck cancer with a combination of bleomycin, vincristine, methotrexate and hydroxyuree or cis-dichloro-diamino-platinium. Analysis of local and general parameters of prognosis (author's transl)].
Topics: Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Drug Therapy, Combination; Head and Neck Neoplasms; Humans; Hydroxyurea; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Vincristine | 1980 |
Advanced recurrent squamous cell carcinoma of the head and neck. Results of a chemotherapeutic regimen with adriamycin, bleomycin, 5-fluorouracil, methotrextate, and vitamin A.
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Doxorubicin; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Vitamin A | 1980 |
Chemotherapy for head and neck cancer relapsing after radiotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Time Factors | 1981 |
Methotrexate as salvage or adjunctive therapy for primary invasive carcinoma of the bladder.
Topics: Bone Neoplasms; Carcinoma, Transitional Cell; Drug Evaluation; Humans; Methotrexate; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Pilot Projects; Urinary Bladder Neoplasms | 1981 |
Multidrug chemotherapy (vincristine-bleomycin-methotrexate) followed by radiotherapy in inoperable carcinomas of the head and neck: a pilot study of the Radiation Therapy Oncology Group.
Topics: Bleomycin; Drug Therapy, Combination; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pilot Projects; Prognosis; Radiotherapy Dosage; Vincristine | 1982 |
Twelve years of experience with cytotoxic therapy in malignant tumors of the neck and head.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Head and Neck Neoplasms; Hodgkin Disease; Humans; Infusions, Intra-Arterial; Leucovorin; Mechlorethamine; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine | 1982 |
Chemotherapy of cervical carcinoma.
Topics: Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Methotrexate; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms; Vincristine | 1982 |
Non-platinum-containing combination chemotherapy for stage III-IV head and neck squamous carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cyclophosphamide; Doxorubicin; Fluorouracil; Head and Neck Neoplasms; Humans; Methotrexate; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Neoplasm Staging; Time Factors; Vincristine | 1983 |
Hydroxyurea fails to improve the results of MBD chemotherapy in cancer of the head and neck, but reduces toxicity.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Evaluation; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Hydroxyurea; Leukopenia; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Thrombocytopenia | 1983 |
Effective chemotherapy for advanced carcinoma of the cervix with bleomycin, cisplatin, vincristine, and methotrexate.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Uterine Cervical Neoplasms; Vincristine | 1983 |
[What may be expected of palliative chemotherapy of recurrent tumors of the upper airways and the digestive tract?].
Topics: Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Digestive System Neoplasms; Drug Therapy, Combination; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Respiratory Tract Neoplasms | 1983 |
Advanced squamous carcinoma of the head and neck. A preliminary report of neoadjuvant chemotherapy with cisplatin, bleomycin, and methotrexate.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Child; Cisplatin; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 1984 |
The role of chemotherapy for advanced carcinoma of the supraglottic and glottic larynx.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Glottis; Humans; Laryngeal Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Platinum | 1984 |
Bleomycin, vincristine, and methotrexate with citrovorum factor rescue in the treatment of advanced squamous cell carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Female; Humans; Leucovorin; Lung Diseases; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms; Vincristine | 1984 |
Methotrexate in the treatment of metastatic and recurrent primary transitional cell carcinoma.
Topics: Aged; Carcinoma, Transitional Cell; Drug Eruptions; Humans; Kidney Diseases; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms | 1984 |
Chemotherapy for adenocystic carcinoma.
Topics: Alkylating Agents; Antineoplastic Agents; Carcinoma, Adenoid Cystic; Fluorouracil; Humans; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Time Factors; Vinca Alkaloids | 1980 |
[Cessation of treatment in childhood acute lymphatic leukemia. Long-term observations after meningosis prevention with intrathecal gold colloid radioisotopes and methotrexate].
Topics: Adolescent; Child; Child, Preschool; Female; Gold Colloid, Radioactive; Humans; Infant; Leukemia, Lymphoid; Male; Meningeal Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Time Factors | 1981 |
Methotrexate in the chemotherapy of lung cancer.
Topics: Brain Neoplasms; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Humans; Infusions, Parenteral; Lomustine; Lung Neoplasms; Methotrexate; Neoplasm Recurrence, Local | 1981 |
CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma.
Topics: Administration, Oral; Adult; Aged; Carcinoma, Small Cell; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injections, Intravenous; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Procarbazine; Vincristine | 1982 |
[Prevention of recurrence of small-cell lung cancer by adjuvant polychemotherapy (author's transl)].
Topics: Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Vincristine | 1982 |
Treatment of small cell lung cancer: intensive remission induction, radiation therapy, and maintenance chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Small Cell; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Procarbazine; Prognosis; Vincristine | 1982 |
Small-cell bronchogenic carcinoma--primary and relapse therapy with etoposide (VP-16), methotrexate and CCNU.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Drug Therapy, Combination; Etoposide; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin | 1982 |
High-dose methotrexate in small cell lung cancer. Lack of efficacy in preventing CNS relapse.
Topics: Aged; Carcinoma, Small Cell; Drug Therapy, Combination; Female; Humans; Leucovorin; Leukopenia; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nervous System Neoplasms; Paraneoplastic Syndromes; Smoking; Thrombocytopenia | 1983 |
Prognostic significance of hormone receptors in early recurrence of breast cancer.
Topics: Adenocarcinoma; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Receptors, Cell Surface; Retrospective Studies; Time Factors | 1983 |
[Cytologic studies in relation to the effect of treatment of lung cancer].
Topics: Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Chromatin; Cyclophosphamide; Cytodiagnosis; Humans; Lung Neoplasms; Male; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy Dosage | 1982 |
[Triple biphasic chemotherapy in the treatment of small-cell bronchial cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lomustine; Male; Methotrexate; Neoplasm Recurrence, Local; Procarbazine; Vincristine | 1983 |
[Combination chemotherapy with mitomycin C, methotrexate, and vincristine (MMV) for metastatic breast cancer refractory to adriamycin].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Humans; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Neoplasm Recurrence, Local; Vincristine | 1983 |
[Simultaneous combined radio-/chemotherapy of locally recurring breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cobalt Radioisotopes; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Radioisotope Teletherapy; Radiotherapy Dosage; Vincristine | 1984 |
Intravesical methotrexate in the treatment of superficial bladder cancer.
Topics: Carcinoma, Transitional Cell; Cystoscopy; Humans; Methotrexate; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms | 1984 |
A phase I-II trial of cisplatin and dichloromethotrexate in squamous cell cancer of the head and neck.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 1984 |
Comparison of melphalan with cyclophosphamide, methotrexate, and 5-fluorouracil in patients with ovarian cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Probability; Random Allocation; Time Factors | 1984 |
[Use of adriamycin in the treatment of metastatic breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Castration; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lung Neoplasms; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Time Factors | 1984 |
Non-Hodgkin lymphoma following Hodgkin's disease. A case report.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Hodgkin Disease; Humans; Laparotomy; Lomustine; Lymphoma; Male; Mechlorethamine; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Vincristine | 1984 |
Prolonged second remissions in childhood acute lymphocytic leukemia: a report from the Childrens Cancer Study Group.
Topics: Asparaginase; Bone Marrow Examination; Child; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukemia, Lymphoid; Male; Methotrexate; Neoplasm Recurrence, Local; Pilot Projects; Prednisone; Vincristine | 1983 |
[Efficacy and toxicity of preventive treatment with cranial irradiation and intrathecal methotrexate on the central nervous system in childhood lymphoblastic leukemia].
Topics: Adolescent; Child; Child, Preschool; Humans; Infant; Injections, Spinal; Leukemia, Lymphoid; Meningeal Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy; Radiotherapy Dosage | 1983 |
Effect on immunologic and other indices of adjuvant cytotoxic chemotherapy including melphalan in breast cancer.
Topics: Adult; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; B-Lymphocytes; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Immunity, Cellular; Immunity, Innate; Isoantibodies; Mastectomy; Melphalan; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; T-Lymphocytes; Time Factors | 1984 |
Psychosocial implications of adjuvant chemotherapy. A two-year follow-up.
Topics: Antineoplastic Combined Chemotherapy Protocols; Attitude; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Neoplasm Recurrence, Local; Quality of Life | 1983 |
Multimodal treatment of locoregionally advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis | 1983 |
[Survival and factors related to the survival of recurrent breast cancer patients--a study with quantification theory].
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Tamoxifen | 1983 |
Tumor cell kinetics-directed chemotherapy for advanced squamous carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Cell Cycle; Dianhydrogalactitol; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 1984 |
Primary lymphoma of the brain: a case report and review of the literature.
Topics: Brain Neoplasms; Cytarabine; Female; Humans; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis | 1984 |
Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-up.
Topics: Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Estrogen Antagonists; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Random Allocation; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1984 |
Response to secondary therapy in patients with adenocarcinoma of the breast previously treated with adjuvant chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Receptors, Estrogen; Tamoxifen; Time Factors; Vincristine | 1983 |
Recurrent medulloblastoma. Lack of response to high-dose methotrexate.
Topics: Adolescent; Blood Cell Count; Blood Urea Nitrogen; Cerebellar Neoplasms; Child; Child, Preschool; Creatinine; Drug Administration Schedule; Electrolytes; Humans; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Prognosis | 1983 |
Adjuvant CMF effect on site of first recurrence, and appropriate follow-up intervals, in operable breast cancer with positive axillary nodes.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Random Allocation; Soft Tissue Neoplasms; Thoracic Neoplasms; Time Factors | 1981 |
Multiple-drug chemotherapy for the primary treatment of osteosarcoma of the extremities.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Child; Doxorubicin; Drug Therapy, Combination; Extremities; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Osteosarcoma; Vincristine | 1980 |
Leukemic infiltration of the cerebellum in acute myelomonocytic leukemia.
Topics: Adult; Cerebellar Ataxia; Cerebellar Neoplasms; Cerebellum; Cytarabine; Drug Therapy, Combination; Female; Humans; Injections, Intraventricular; Leukemia, Myeloid, Acute; Methotrexate; Neoplasm Recurrence, Local; Tomography, X-Ray Computed | 1982 |
Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia in Norway. Preliminary results of a national treatment program.
Topics: Antineoplastic Agents; Brain Neoplasms; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Injections, Spinal; Leucovorin; Leukemia, Lymphoid; Male; Methotrexate; Neoplasm Recurrence, Local; Norway; Pilot Projects | 1981 |
Adjuvant chemotherapy of adult high-grade soft tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leucovorin; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Radiography; Sarcoma; Vincristine | 1982 |
[Results of chemotherapy with cyclophosphamide, vincristine, methotrexate and prednisone in recurring or disseminated non-Hodgkin lymphomas in the University of Kiel Radiology Clinic].
Topics: Cyclophosphamide; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Vincristine | 1981 |
Increased survival of cancer-bearing mice treated with inhibitors of prostaglandin synthesis alone or with chemotherapy.
Topics: Adenocarcinoma; Animals; Biological Availability; Body Weight; Drug Therapy, Combination; Female; Flurbiprofen; Indomethacin; Male; Mammary Neoplasms, Experimental; Melphalan; Methotrexate; Mice; Neoplasm Recurrence, Local; Propionates; Prostaglandin Antagonists | 1982 |
Management of childhood leukemia.
Topics: Adolescent; Brain; Child; Child, Preschool; Humans; Leukemia, Lymphoid; Methotrexate; Neoplasm Recurrence, Local | 1982 |
The medical management of breast cancer.
Topics: Adjuvants, Pharmaceutic; Adult; Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Castration; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Hypophysectomy; Melphalan; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Receptors, Estrogen; Tamoxifen | 1982 |
Patterns of failure in patients with medulloblastoma.
Topics: Adolescent; Adult; Aged; Cerebellar Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dose-Response Relationship, Radiation; Female; Humans; Infant; Lomustine; Male; Medulloblastoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Retrospective Studies; Vincristine | 1982 |
Chemotherapy for advanced recurrent carcinoma of the cervix. A report on the treatment of 22 patients.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Doxorubicin; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Survival; Uterine Cervical Neoplasms | 1982 |
[Ancillary chemotherapy with trofosfamid, methotrexate and fluoro-uracil in cancer of the breast (author's transl)].
Topics: Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1981 |
The effect of chemotherapy on occult metastases after surgical removal of a non-immunogenic mouse carcinoma.
Topics: Animals; Drug Therapy, Combination; Female; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Melphalan; Methotrexate; Mice; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1980 |
Prophylactic oral methotrexate therapy for multiple superficial bladder carcinoma.
Topics: Administration, Oral; Carcinoma, Transitional Cell; Humans; Methotrexate; Neoplasm Recurrence, Local; Stomatitis, Aphthous; Thrombocytopenia; Urinary Bladder Neoplasms | 1981 |
Oral methotrexate therapy for multiple superficial bladder carcinomata.
Topics: Administration, Oral; Follow-Up Studies; Humans; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Time Factors; Urinary Bladder Neoplasms | 1981 |
Methotrexate in advanced bladder cancer.
Topics: Bone Neoplasms; Drug Administration Schedule; Humans; Lung Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Urinary Bladder Neoplasms | 1981 |
Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexate.
Topics: Cerebellar Neoplasms; Female; Humans; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 1980 |
Adverse effect of radiotherapy on adjuvant chemotherapy for carcinoma of the breast.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Vincristine | 1980 |
[Adjuvant chemotherapy in breast neoplasms. Clinical and immunologic results].
Topics: Adult; Aged; Breast Neoplasms; Concanavalin A; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Lymphocyte Activation; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis | 1980 |
Improved anticancer effect by combining cytotoxic drugs with an inhibitor of prostaglandin synthesis.
Topics: Adenocarcinoma; Animals; Drug Evaluation, Preclinical; Female; Flurbiprofen; Mammary Neoplasms, Experimental; Melphalan; Methotrexate; Mice; Neoplasm Recurrence, Local; Propionates; Prostaglandin Antagonists | 1980 |
[Treatment of recurrent cervical cancer with doxorubicin in combination with methotrexate].
Topics: Doxorubicin; Drug Therapy, Combination; Female; Humans; Methotrexate; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 1980 |
Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocol.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Female; Fluorouracil; Humans; Leucovorin; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms | 1994 |
The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Genital Neoplasms, Male; Germinoma; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Time Factors; Vinblastine; Vincristine | 1994 |
Long-term results of two VAB-like regimens (vinblastine + actinomycin-D + bleomycin + cyclophosphamide + cisplatin) in malignant germ cell tumours of the ovary.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Cyclophosphamide; Dactinomycin; Female; Germinoma; Humans; Methotrexate; Neoplasm Recurrence, Local; Neoplasm, Residual; Ovarian Neoplasms; Salvage Therapy; Vinblastine; Vincristine | 1994 |
Long-term results with M-VAC for advanced urothelial cancer: high relapse rate and low survival in patients with a complete response.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Treatment Outcome; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 1995 |
Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fibroblast Growth Factor 3; Fibroblast Growth Factors; Fluorouracil; Gene Amplification; Genetic Markers; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Oncogenes; Progestins; Prognosis; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-myc; Receptor, ErbB-2; Risk Factors; Survival Rate; Tamoxifen; Treatment Outcome | 1995 |
Breast cancer: are imaging studies cost effective following breast cancer and adjuvant therapy?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cost-Benefit Analysis; Cyclophosphamide; Diagnostic Imaging; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Mastectomy, Segmental; Methotrexate; Neoplasm Recurrence, Local; Treatment Outcome | 1995 |
[Pleomorphic T-cell lymphoma. The diagnostic problems, therapeutic possibilities and infection-induced complications].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Humans; Interferon-alpha; Lymphoma, T-Cell, Peripheral; Male; Mercaptopurine; Methotrexate; Mitoxantrone; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Remission Induction; Time Factors; Vincristine | 1993 |
MACOP-B +/- radiation therapy for diffuse large cell lymphoma. Analysis of the Stanford results according to prognostic indices.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Risk Factors; Survival Rate; Vincristine | 1993 |
Cisplatin (P), bleomycin (B), and methotrexate (M) preoperative chemotherapy in locally advanced vulvar carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Preoperative Care; Survival Analysis; Vulvar Neoplasms | 1993 |
Treatment of locally recurrent male breast cancer by regional chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms, Male; Chemotherapy, Cancer, Regional Perfusion; Humans; Male; Methotrexate; Mitomycins; Mitoxantrone; Neoplasm Recurrence, Local | 1995 |
[Intra-arterial chemotherapy with cisplatin, vincristine, methotrexate and adriamycin for recurrent penile cancer: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Humans; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Penile Neoplasms; Vincristine | 1995 |
[The use of endolymphatic chemotherapy in patients with metastatic stomach cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Signet Ring Cell; Cisplatin; Female; Fluorouracil; Humans; Injections, Intralymphatic; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Stomach Neoplasms | 1994 |
Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Mastectomy, Modified Radical; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Preoperative Care; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome | 1995 |
Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Extremities; Female; Follow-Up Studies; Humans; Ifosfamide; Leucovorin; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Vindesine | 1994 |
Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome.
Topics: Adult; Aged; Aged, 80 and over; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Female; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy Dosage; Remission Induction; Survival Rate; Treatment Outcome | 1994 |
Bilateral breast cancer in a male? Case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Fatal Outcome; Humans; Male; Mammography; Mastectomy, Modified Radical; Methotrexate; Neoplasm Recurrence, Local; Tamoxifen | 1993 |
[Simultaneous radiochemotherapy in locoregional recurrent breast carcinoma after mastectomy. Results in patients with macroscopic residual tumor R2].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy Dosage; Retrospective Studies; Time Factors | 1994 |
Diffusion of methotrexate from surgical acrylic cement.
Topics: Acrylates; Bone Cements; Bone Neoplasms; Chemotherapy, Adjuvant; Diffusion; Humans; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Pharmaceutical Vehicles | 1993 |
Adjuvant interferon treatment in human osteosarcoma.
Topics: Bone Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxorubicin; Follow-Up Studies; Humans; Immunologic Factors; Interferon-alpha; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Survival Rate | 1993 |
Intralesional implant for treatment of primary oral malignant melanoma in dogs.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Delayed-Action Preparations; Dog Diseases; Dogs; Drug Implants; Female; Gels; Injections, Intralesional; Linear Models; Male; Melanoma; Methotrexate; Mouth Neoplasms; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Survival Rate; Treatment Outcome | 1994 |
Carboquone combined with methotrexate and 5-fluorouracil for recurrent and advanced ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms | 1993 |
Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Extremities; Female; Femur; Humans; Humerus; Infusions, Intravenous; Injections, Intra-Arterial; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Postoperative Complications; Preoperative Care; Remission Induction; Survival Rate; Tibia | 1993 |
[Successful treatment of recurrent multiple lung metastasis from colon cancer with combination chemotherapy using methotrexate, 5-fluorouracil, and high-dose leucovorin: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Lung Neoplasms; Male; Methotrexate; Neoplasm Recurrence, Local; Remission Induction; Sigmoid Neoplasms | 1993 |
Methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy for the treatment of advanced bladder carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Urinary Bladder Neoplasms; Vinblastine | 1993 |
[MEP (methotrexate, etoposide and cisplatin) and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced uroepithelial cancer--a preliminary report of MEP as second line chemotherapy for recurrence after M-VAC].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 1994 |
Multiagent chemotherapy in the salvage cure of ocular lymphoma relapsing after radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Eye Neoplasms; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Salvage Therapy; Vincristine | 1993 |
Case report of acquired piritrexim resistance and collateral methotrexate sensitivity in recurrent squamous cell carcinoma of the head and neck.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Resistance; Folic Acid Antagonists; Head and Neck Neoplasms; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Pyrimidines | 1993 |
Recurrent cervical cancer treated with cisplatin and methotrexate.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Survival Rate; Uterine Cervical Neoplasms | 1993 |
Lomustine, etoposide, methotrexate and prednisone (LEMP) therapy for relapsed and refractory non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Remission Induction | 1993 |
CMV front-line chemotherapy in transitional bladder carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Cystectomy; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1993 |
[Quandrantectomy in the conservative treatment of breast carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Italy; Lymph Node Excision; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Care; Radiotherapy Dosage; Tamoxifen | 1993 |
Fatal brain stem necrosis after standard posterior fossa radiation and aggressive chemotherapy for metastatic medulloblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Stem; Cerebellar Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Female; Humans; Medulloblastoma; Methotrexate; Necrosis; Neoplasm Recurrence, Local; Radiotherapy, High-Energy | 1993 |
Neoadjuvant chemotherapy in locally advanced breast cancer.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Mastectomy, Modified Radical; Mastectomy, Radical; Mastectomy, Segmental; Methotrexate; Nausea; Neoplasm Recurrence, Local; Vomiting | 1996 |
Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy.
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Feasibility Studies; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy Dosage; Remission Induction; Risk Factors; Survival Rate; Treatment Failure; Vincristine | 1995 |
c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; DNA, Neoplasm; Female; Fluorouracil; Gene Expression; Genes, erbB-2; Humans; Methotrexate; Neoplasm Recurrence, Local; Premenopause; Receptor, ErbB-2 | 1995 |
Cisplatin-based neoadjuvant chemotherapy and combined resection for ethmoid sinus adenocarcinoma reaching and/or invading the skull base.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Ethmoid Sinus; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Paranasal Sinus Neoplasms; Retrospective Studies; Skull Neoplasms | 1996 |
Results of treatment of inoperable recurrences of laryngeal cancer after total laryngectomy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Disease-Free Survival; Humans; Laryngeal Neoplasms; Laryngectomy; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neutrons; Radiotherapy Dosage; Time Factors; Vincristine | 1996 |
Carboxypeptidase G2 rescue after high-dose methotrexate.
Topics: Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Female; gamma-Glutamyl Hydrolase; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects | 1996 |
Chemotherapy for ovarian germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Germinoma; Humans; Leucovorin; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Salvage Therapy; Survival Rate; Vincristine | 1996 |
[Extirpation of total urinary tract as a final treatment for asynchronous multicentric urothelial cancer: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Humans; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Remission Induction; Renal Dialysis; Urinary Bladder Neoplasms; Urinary Tract; Vinblastine | 1996 |
Conservative management of stage T2 or T3a bladder cancer with deep transurethral resection followed by four cycles of chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Epirubicin; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 1996 |
Pediatric leptomeningeal metastases: outcome following combined therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebrospinal Fluid; Chemotherapy, Cancer, Regional Perfusion; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Female; Humans; Injections, Intraventricular; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Survival Rate; Thiotepa; Treatment Outcome | 1997 |
Endoscopic local injection of a new drug delivery formulation, anticancer drug bound to carbon particles, for digestive cancers: pilot study.
Topics: Adenocarcinoma; Adsorption; Aged; Aged, 80 and over; Antineoplastic Agents; Carbon; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Humans; Injections, Intralesional; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Peplomycin; Pilot Projects; Stomach Neoplasms; Survival Rate | 1997 |
[Combined breast-preserving surgery, chemotherapy and radiotherapy in the treatment of breast carcinoma. Effect of the interval between surgery and the beginning of radiotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prognosis; Radiotherapy Dosage; Retrospective Studies; Time Factors | 1997 |
Treatment of isolated testicular recurrence of acute lymphoblastic leukemia without radiotherapy. Report from the Dutch Late Effects Study Group.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Testicular Neoplasms | 1997 |
Anterior segment recurrence of acute myelogenous leukemia: treatment with subconjunctival injections of methotrexate and triamcinolone acetonide.
Topics: Anterior Eye Segment; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Conjunctiva; Fatal Outcome; Glucocorticoids; Humans; Immunosuppressive Agents; Injections; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Tomography, X-Ray Computed; Triamcinolone | 1997 |
Neoadjuvant chemotherapy for osseous malignant fibrous histiocytoma of the extremity: results in 18 cases and comparison with 112 contemporary osteosarcoma patients treated with the same chemotherapy regimen.
Topics: Adolescent; Adult; Amputation, Surgical; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Histiocytoma, Benign Fibrous; Humans; Ifosfamide; Leg; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Osteosarcoma | 1997 |
Effectiveness of selective neck dissection for management of the clinically negative neck.
Topics: Adult; Aged; Aged, 80 and over; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Decision Making; Disease-Free Survival; Elective Surgical Procedures; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Leucovorin; Lymph Node Excision; Lymph Nodes; Methotrexate; Middle Aged; Neck; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome | 1997 |
[Preoperative irradiation and interstitial radiotherapy-hyperthermia boost in breast tumors > or = 3 cm. The Düsseldorf experience].
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Hyperthermia, Induced; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Preoperative Care; Radiotherapy Dosage; Surgical Flaps; Time Factors | 1997 |
Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cisplatin; Disease Progression; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Treatment Outcome | 1998 |
Conservative surgery and radiotherapy in early stage breast cancer: a comparison between tumourectomy and quadrantectomy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate | 1998 |
[Successful chemotherapy based on in vitro chemosensitivity testing in a case of recurrent thymic carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Adenosquamous; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Recurrence, Local; Thymus Neoplasms; Tumor Cells, Cultured | 1998 |
Neoadjuvant chemotherapy for extremity osteosarcoma--preliminary results of the Rizzoli's 4th study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Disease-Free Survival; Doxorubicin; Extremities; Female; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Osteosarcoma; Preoperative Care | 1998 |
Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Follow-Up Studies; Humans; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Premedication; Radiotherapy Dosage; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 1998 |
Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Prospective Studies; Survival Analysis; Tamoxifen; Time Factors; Treatment Outcome | 1997 |
Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms | 1998 |
[Conservative treatment of locally advanced bladder carcinoma: neoadjuvant chemotherapy, TUR and radiotherapy. Results in 40 patients].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Evaluation Studies as Topic; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm, Residual; Preoperative Care; Radiotherapy, Adjuvant; Remission Induction; Urinary Bladder Neoplasms; Vinblastine | 1998 |
Ewing's sarcoma treatment in Scandinavia 1984-1990--ten-year results of the Scandinavian Sarcoma Group Protocol SSGIV.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Orthopedic Procedures; Radiotherapy, Adjuvant; Sarcoma, Ewing; Scandinavian and Nordic Countries; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Estrogen Replacement Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Hyperplasia; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Precancerous Conditions; Radiotherapy Dosage; Survival Analysis | 1998 |
High-dose sequential chemotherapy with autologous blood stem cell rescue for relapsed or resistant lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Stem Cells | 1998 |
[Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms; Vinblastine | 1998 |
Successful chemotherapy in a patient with recurrent carcinoma of the urachus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Doxorubicin; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome; Urachus; Urologic Neoplasms; Vinblastine | 1998 |
Radical transurethral resection and chemotherapy in the treatment of muscle-invasive bladder cancer: a long-term follow-up.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystectomy; Disease Progression; Disease-Free Survival; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms | 1999 |
[Primary lymphoma of the thyroid with contralateral recurrence--case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Citrates; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Female; Gallium; Gallium Radioisotopes; Humans; Ifosfamide; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Radiopharmaceuticals; Remission Induction; Technetium; Thallium; Thyroid Neoplasms; Thyroidectomy; Vincristine | 1999 |
[A case of liver metastases from gastric cancer responding to induced hypertensive chemotherapy with angiotensin II].
Topics: Aged; Angiotensin II; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Drug Administration Schedule; Fluorouracil; Gastrectomy; Humans; Injections, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Methotrexate; Mitomycin; Neoplasm Recurrence, Local; Stomach Neoplasms; Vasoconstrictor Agents | 1999 |
Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Eye Neoplasms; Female; Humans; Injections; Interleukin-10; Interleukin-6; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 1999 |
Sixty percent salvage rate for germ-cell tumours using sequential m-BOP, surgery and ifosfamide-based chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Disease Progression; Germinoma; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Vincristine | 1999 |
Estradiol receptor and prognostic parameters of human breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Receptors, Estradiol; Tamoxifen | 1999 |
[A case of adriamycin and methotrexate-resistant recurrent breast cancer treated with doxifluridine and mitomycin C].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Female; Floxuridine; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Mitomycin; Neoplasm Recurrence, Local | 1999 |
Osteosarcoma of the pelvis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Child; Cisplatin; Doxorubicin; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Pelvic Neoplasms; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Salvage Therapy; Survival Rate | 1999 |
The establishment of sublines with opposite chemosensitivity from a patient with pulmonary large cell carcinoma and the implementation of treatment based on tumor heterogeneity.
Topics: Aged; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Cisplatin; Drug Screening Assays, Antitumor; Genetic Heterogeneity; Humans; Lung; Lung Neoplasms; Male; Methotrexate; Mice; Mice, Nude; Neoplasm Recurrence, Local; Tumor Cells, Cultured | 1999 |
Outcome of radiation-related osteosarcoma after treatment of childhood and adolescent cancer: a study of 23 cases.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasms; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Osteosarcoma; Radiotherapy Dosage; Rhabdomyosarcoma; Sarcoma, Ewing | 1999 |
Treatment of mammographically detected minimal breast cancer in an older woman.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Mammography; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy; Tamoxifen | 2000 |
Malignant fibrous histiocytoma of the scalp. Multidisciplinary treatment.
Topics: Adult; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Histiocytoma, Benign Fibrous; Humans; Methotrexate; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Retrospective Studies; Scalp; Skin Neoplasms; Skin Transplantation; Tomography, X-Ray Computed | 1999 |
Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic plac
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cisplatin; Cohort Studies; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Placenta; Pregnancy; Remission Induction; Risk Factors; Survival Rate; Trophoblastic Neoplasms; Uterine Neoplasms | 2000 |
[The efficacy of BFM-90 program in the treatment of acute lymphoblastic leukemia in children in the studies of Polish pediatric leukemia/lymphoma group].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Poland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 1998 |
Extramedullary relapse in a child with mixed lineage acute lymphoblastic leukemia: chylous pleuropericardial effusion.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Chyle; Chylothorax; Follow-Up Studies; Humans; Leukemia, Biphenotypic, Acute; Male; Methotrexate; Neoplasm Recurrence, Local; Pericardial Effusion; Pleural Effusion, Malignant; Remission Induction | 2000 |
The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystectomy; Disease-Free Survival; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Muscle Neoplasms; Muscle, Smooth; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Risk Factors; Treatment Failure; Urinary Bladder Neoplasms; Vinblastine | 2000 |
Incidence and time of occurrence of regional recurrence in stage I-II breast cancer: value of adjuvant irradiation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cisplatin; Female; Fluorouracil; Follow-Up Studies; Humans; Incidence; Lymph Node Excision; Lymph Nodes; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Time Factors; Treatment Failure | 1999 |
Treatment of persistent trophoblastic disease later than 6 months after diagnosis of molar pregnancy.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Databases as Topic; England; Etoposide; Female; Follow-Up Studies; Humans; Hydatidiform Mole; Leucovorin; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Prognosis; Registries; Salvage Therapy; Time Factors; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms | 2000 |
Wide-field radiation as adjunct to adjuvant chemotherapy in high-risk cases with early breast cancer: do it or not?
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cause of Death; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy, Modified Radical; Meta-Analysis as Topic; Methotrexate; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Risk; Treatment Failure; Treatment Outcome | 2000 |
Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dactinomycin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Teratoma; Testicular Neoplasms; Treatment Outcome; Vinblastine; Vincristine | 2000 |
Local recurrence after mastectomy and adjuvant CMF: implications for adjuvant radiation therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy, Radical; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Treatment Outcome | 2000 |
Experience of neoadjuvant chemotherapy for breast cancer at a public hospital: retrospective study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Hong Kong; Hospitals, Public; Humans; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Treatment Outcome | 2000 |
Methotrexate infusion in low-risk gestational trophoblastic disease.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Female; Humans; Hydatidiform Mole; Infusions, Intravenous; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Prospective Studies; Remission Induction; Risk Factors | 2000 |
Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Biomarkers, Tumor; Colorectal Neoplasms; Fluorouracil; Humans; Immunohistochemistry; Leucovorin; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Survival Rate; Treatment Outcome; Tumor Suppressor Protein p53 | 2001 |
Angiogenesis sustains tumor dormancy in patients with breast cancer treated with adjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Methotrexate; Microcirculation; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Prognosis; Risk Factors | 2001 |
Delay of the diagnostic lumbar puncture and intrathecal chemotherapy in children with acute lymphoblastic leukemia who undergo routine corticosteroid testing: Tokyo Children's Cancer Study Group study L89-12.
Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Child, Preschool; Disease-Free Survival; Drug Screening Assays, Antitumor; Female; Follow-Up Studies; Glucocorticoids; Humans; Infant; Injections, Spinal; Japan; Life Tables; Male; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Proportional Hazards Models; Risk; Sensitivity and Specificity; Spinal Puncture; Time Factors; Treatment Outcome | 2001 |
Prognostic factors for survival and bladder recurrence in transitional cell carcinoma of the upper urinary tract.
Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Survival Analysis; Urinary Bladder Neoplasms; Vinblastine | 2001 |
Primary central nervous system T-cell lymphoma.
Topics: Adult; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Cytarabine; Fatal Outcome; Humans; Lymphoma, T-Cell; Male; Methotrexate; Neoplasm Recurrence, Local; Prognosis | 2001 |
Leiomyosarcoma, rheumatoid arthritis and methotrexate: an association?
Topics: Aged; Arm; Arthritis, Rheumatoid; Bone Neoplasms; Fatal Outcome; Humans; Leiomyosarcoma; Lung Neoplasms; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm Recurrence, Local | 2001 |
Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Ifosfamide; Immunologic Factors; Immunotherapy; Interferon-alpha; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Vincristine | 2001 |
Fatal hemorrhage after radiochemotherapy for leptomeningeal dissemination of glioma: report of two cases.
Topics: Adolescent; Antineoplastic Agents; Astrocytoma; Combined Modality Therapy; Fatal Outcome; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy; Subarachnoid Hemorrhage; Time Factors; Tomography, X-Ray Computed | 2002 |
Successful autologous peripheral blood stem cell transplantation in transformed follicular lymphoma previously treated with radioimmunotherapy (iodine (131)I tositumomab).
Topics: Antibodies, Monoclonal; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Hematopoietic Stem Cell Transplantation; Humans; Iodine Radioisotopes; Leucovorin; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Radioimmunotherapy; Remission Induction; Transplantation, Autologous; Treatment Outcome; Vincristine | 2002 |
Multimodal therapy including neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) for stage IIB to IV cervical cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neutropenia; Retrospective Studies; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms; Vinblastine | 2002 |
[Regional chemotherapy of stomach cancers].
Topics: Adult; Aged; Antineoplastic Agents; Catheterization; Dactinomycin; Female; Humans; Male; Methotrexate; Middle Aged; Mitomycins; Neoplasm Recurrence, Local; Postoperative Complications; Stomach; Stomach Neoplasms; Vinblastine | 1975 |
Seven-drug polychemotherapy in the treatment of advanced and recurrent squamous carcinoma of the female genital tract.
Topics: Adult; Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms; Vincristine | 1975 |
Adjuvant chemotherapy in embryonal carcinoma of the testis.
Topics: alpha-Fetoproteins; Antineoplastic Agents; Bleomycin; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Gonadotropins; Humans; Luteinizing Hormone; Male; Methotrexate; Neoplasm Recurrence, Local; Plicamycin; Teratoma; Testicular Neoplasms; Testis | 1978 |
Adjuvant chemotherapy or chemoimmunotherapy in the management of primary malignant melanoma of level III, IV, or V.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Bacterial Vaccines; BCG Vaccine; Dacarbazine; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Procarbazine; Propionibacterium acnes; Streptonigrin; Thiotepa; Vinblastine | 1978 |
Adjuvant chemoimmunotherapy in advanced lesions of the head and neck.
Topics: Adjuvants, Immunologic; Adult; Aged; BCG Vaccine; Carcinoma, Squamous Cell; Drug Therapy, Combination; Head and Neck Neoplasms; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy Dosage; Skin Tests | 1976 |
Brain tumors in children.
Topics: Adolescent; Astrocytoma; Brain; Brain Neoplasms; Child; Diagnosis, Differential; Ependymoma; Female; Glioblastoma; Glioma; Humans; Lomustine; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Procarbazine; Radiotherapy Dosage; Vincristine | 1978 |
Combination chemotherapy of malignant glioma. Effect of postoperative treatment with CCNU, vincristine, amethopterine and procarbazine.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Drug Therapy, Combination; Glioma; Humans; Lomustine; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Peripheral Nervous System Diseases; Postoperative Period; Procarbazine; Vincristine | 1978 |
High-dose methotrexate with citrovorum factor rescue for the treatment of central nervous system tumors in children.
Topics: Brain Neoplasms; Child; Child, Preschool; Drug Therapy, Combination; Female; Glioma; Humans; Leucovorin; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Pons | 1977 |
Phase II study of combined vincristine, adriamycin, cyclophosphamide, and methotrexate with citrovorum factor factor rescue in metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Remission, Spontaneous; Vincristine | 1977 |
Combination chemotherapy of advanced squamous carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Injections, Intra-Arterial; Injections, Intravenous; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Vincristine | 1977 |
Adjuvant methotrexate and leucovorin in head and neck squamous cancer. Two-year follow-up of a pilot project.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1978 |
[Juvenile reticulosarcoma].
Topics: Adolescent; Braces; Child; Cortisone; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Vincristine | 1978 |
[Treatment of relapses in juvenile acute lymphoblastic leukemia].
Topics: Asparaginase; Blood-Brain Barrier; Blood-Testis Barrier; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Resistance; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Meningoencephalitis; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Vincristine | 1978 |
Chemotherapy in recurrent noncystic low-grade astrocytomas of the cerebrum in children.
Topics: Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Carmustine; Child; Child, Preschool; Dexamethasone; Drug Therapy, Combination; Female; Humans; Infant; Male; Methotrexate; Neoplasm Recurrence, Local; Remission, Spontaneous; Vincristine | 1978 |
[How could the results of surgical treatment of bronchogenic carcinoma be improved? (authors transl)].
Topics: Angiography; Carcinoma, Bronchogenic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Time; Vinblastine | 1978 |
[Cytostatic therapy in metastasizing breast cancer].
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Remission, Spontaneous; Vincristine | 1978 |
[Surgical and radiotherapeutic possibilities of treatment of mouth neoplasms].
Topics: Adult; Aged; Carcinoma, Squamous Cell; Diagnostic Errors; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Papilloma; Tongue Neoplasms | 1978 |
[Chemotherapy of malignant scalp angioendothelioma].
Topics: Antineoplastic Agents; Cyclophosphamide; Doxorubicin; Female; Hemangioendothelioma; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Scalp; Skin Neoplasms; Vincristine | 1978 |
Chemoimmunotherapy of syngeneic mouse mammary carcinomas employing methanol extraction residue.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; BCG Vaccine; Cyclophosphamide; Female; Fluorouracil; Immunotherapy; Mammary Neoplasms, Experimental; Methanol; Methotrexate; Mice; Mice, Inbred BALB C; Mycobacterium bovis; Neoplasm Recurrence, Local; Solvents | 1976 |
[Chemotherapy of bronchial carcinomas (author's transl)].
Topics: Antineoplastic Agents; Bronchial Neoplasms; Carcinoma, Bronchogenic; Cyclophosphamide; Drug Therapy, Combination; Fluorouracil; Humans; Long-Term Care; Lung Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies; Vinblastine | 1975 |
Clinical chemistry and breast cancer.
Topics: Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Mastectomy; Melphalan; Methotrexate; Neoplasm Recurrence, Local; Risk | 1976 |
Long-term second remissions in acute lymphatic leukemia.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Prednisolone; Prednisone; Remission, Spontaneous; Vincristine | 1975 |
[Association of radical surgery and cyclic polychemotherapy (with vincristine, methotrexate and adriamycin) in the treatment of some forms of osteosarcoma. Preliminary results].
Topics: Adolescent; Adult; Amputation, Surgical; Bone Neoplasms; Child; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Osteosarcoma; Postoperative Care; Vincristine | 1975 |
Combined chemotherapy and cryosurgery for oral cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryosurgery; Drug Therapy, Combination; Fluorouracil; Humans; Leucovorin; Male; Methods; Methotrexate; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Ohio; Tongue Neoplasms | 1975 |
Perfusion therapy for skin cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Perfusion; Drug Therapy, Combination; Extremities; Female; Head and Neck Neoplasms; Humans; Injections, Intra-Arterial; Leucovorin; Male; Melanoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Sarcoma; Sarcoma, Kaposi; Skin Neoplasms | 1975 |
T-cell rosette test in squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; BCG Vaccine; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Immune Adherence Reaction; Isoniazid; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; T-Lymphocytes | 1976 |
Chemotherapy in the treatment strategy of breast cancer.
Topics: Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prednisone | 1975 |
Aspects of radiation biology and radiation pathology observed during the treatment of cancer in man. The Mackenzie Davidson memorial lecture delivered at the British Institute of Radiology on May 16, 1974.
Topics: Carcinoma, Squamous Cell; Female; Humans; Lip Neoplasms; Lymphoma, Non-Hodgkin; Male; Methotrexate; Microscopy, Electron; Mitosis; Models, Biological; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasms; Radiobiology; Radiotherapy Dosage; Tonsillar Neoplasms | 1975 |
Combination chemotherapy as an adjuvant treatment in operable breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Recurrence; Time Factors | 1976 |
The treatment of locally advanced cancer of the head and neck, with special reference to upper jaw tumours.
Topics: Adult; Age Factors; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Esophageal Neoplasms; Female; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Male; Maxillary Neoplasms; Methotrexate; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Paranasal Sinus Neoplasms; Sex Factors; South Africa; Tongue Neoplasms; Vinblastine | 1976 |
New attitudes in cancer treatment: breast cancer and adjuvant therapy.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Recurrence, Local | 1976 |
Results of chemotherapy plus external reirradiation in the treatment of locally advanced recurrences of nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chi-Square Distribution; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Retrospective Studies; Survival Rate; Vincristine | 1992 |
[The efficacy of polychemotherapy with cisplatin, methotrexate and 5-fluorouracil in inoperable forms of squamous cell cancer of the head and neck area].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Time Factors | 1992 |
Comparison of partial and modified radical mastectomy in the community setting--"10 years later".
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy, Modified Radical; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate | 1992 |
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Global Health; Humans; Immunotherapy; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Ovariectomy; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen; Time Factors; Treatment Outcome | 1992 |
Clinical and prognostic significance of monoclonal small cells in the peripheral blood and bone marrow of various B-cell lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Flow Cytometry; Humans; Leucovorin; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Prognosis; Remission Induction; Vincristine | 1992 |
Surgery for local recurrences following deficient radical mastectomy for breast cancer: a selected series of 39 cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Radical; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Reoperation | 1992 |
Neoadjuvant chemotherapy in the treatment of recurrent glioblastomas (GBM).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Fluorouracil; Glioma; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Reoperation | 1992 |
Metastatic breast cancer: higher versus low dose maintenance treatment when only a partial response or a no change status is obtained following doxorubicin induction treatment. An Eastern Cooperative Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Fluoxymesterone; Humans; Methotrexate; Mitolactol; Neoplasm Recurrence, Local; Prednisone; Prospective Studies; Remission Induction; Survival Rate; Tamoxifen | 1992 |
[The effectiveness of anal submucosal injection of methotrexate for relapsed prostatic cancer--a case report].
Topics: Adenocarcinoma; Aged; Anal Canal; Antineoplastic Agents; Castration; Combined Modality Therapy; Humans; Injections; Male; Methotrexate; Neoplasm Recurrence, Local; Prostatic Neoplasms | 1992 |
Intravenous or oral adjuvant CMF for node-positive breast cancer.
Topics: Adjuvants, Pharmaceutic; Administration, Oral; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Leukopenia; Lymph Node Excision; Lymphatic Metastasis; Mastectomy, Simple; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; New South Wales; Prognosis; Survival Analysis; Survival Rate | 1992 |
[Late recurrence (11 years) in a case of ALL. Recurrence or a second disease?].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System Neoplasms; Diagnosis, Differential; Humans; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Time Factors; Vincristine | 1992 |
Maintenance chemotherapy and cure of childhood acute lymphoblastic leukaemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bone Marrow; Child; Humans; Long-Term Care; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Analysis | 1991 |
MACOP-B chemotherapy for the treatment of high grade and intermediate grade non Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Vincristine | 1990 |
Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Humans; Hysterectomy; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Survival Rate; Uterine Cervical Neoplasms | 1991 |
Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Remission Induction; Survival Rate; Vincristine | 1991 |
Stage IIB osteogenic sarcoma.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Clinical Protocols; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; New York City; Osteosarcoma; Osteotomy; Postoperative Care; Predictive Value of Tests; Preoperative Care; Survival Analysis; Survival Rate | 1991 |
Response of brain metastases from breast cancer to systemic chemotherapy.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Survival Analysis; Tomography, X-Ray Computed | 1992 |
Recurrent disseminated retinoblastoma treated by high-dose chemotherapy, total body irradiation, and autologous bone marrow rescue.
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Bone Marrow Purging; Bone Marrow Transplantation; Bone Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Gangliosides; Humans; Mandibular Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Remission Induction; Retinoblastoma; Transplantation, Autologous; Vincristine; Whole-Body Irradiation | 1991 |
[The fate of children after discontinuation of treatment for acute lymphoblastic leukemia].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Infant; Male; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Sex Factors; Time Factors; Vincristine | 1991 |
IIB osteosarcoma. Current management, local control, and survival statistics--the Australian experience.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Australia; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Humans; Injections, Intra-Arterial; Life Tables; Male; Methotrexate; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Osteotomy; Postoperative Complications; Radiotherapy; Remission Induction; Survival Rate | 1991 |
The management of IIB osteosarcoma. Experience from 1976 to 1985.
Topics: Adolescent; Adult; Amputation, Surgical; Austria; Bone Neoplasms; Bone Transplantation; Child; Child, Preschool; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Osteotomy; Postoperative Complications; Prostheses and Implants; Surgical Flaps; Survival Analysis; Survival Rate | 1991 |
Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. A pilot trial.
Topics: Adjuvants, Pharmaceutic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Esthetics; Female; Fluorouracil; Fluoxymesterone; Hematologic Diseases; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Prednisone; Radiotherapy; Survival Rate; Thiotepa; Vinblastine; Vincristine | 1991 |
Zürich experience with preoperative, high dose methotrexate-containing chemotherapy in patients with extremity osteosarcomas (OSA).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Necrosis; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis; Retrospective Studies; Survival Rate | 1991 |
[Adjuvant chemotherapy in premenopausal women].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Quality of Life | 1991 |
[Results of treatment following breast-saving therapy: analysis of intramammary recurrence].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Survival Rate | 1990 |
Salvage therapy with PROMACE in relapsed non-Hodgkin malignant lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone | 1991 |
Second-line chemotherapy of advanced colorectal cancer with sequential high-dose methotrexate and 5-fluorouracil.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1991 |
Primary non-Hodgkin's lymphoma of the brain revisited.
Topics: Adult; Aged; Biopsy; Brain Neoplasms; Combined Modality Therapy; Craniotomy; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; New York; Radiotherapy; Tomography, X-Ray Computed | 1991 |
Treatment of metastatic gastric carcinoma with a modified FAMTX chemotherapy regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prospective Studies; Stomach Neoplasms; Survival Rate | 1990 |
[Intra-arterial infusion of high dose methotrexate therapy in recurrent gliomas].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Drug Evaluation; Female; Glioma; Humans; Infusions, Intra-Arterial; Leucovorin; Male; Mannitol; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction | 1990 |
Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Female; Humans; Infusions, Intravenous; Leucovorin; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms | 1990 |
Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Drug Evaluation; Etoposide; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Remission Induction; Stomatitis; Testicular Neoplasms; Time Factors | 1990 |
[Acute coronary thrombosis and myocardial ischemia following chemotherapy of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Coronary Disease; Coronary Thrombosis; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Male; Methotrexate; Myocardial Infarction; Neoplasm Recurrence, Local | 1990 |
Extended experience of neo-adjuvant M-VAC chemotherapy for T1-4 N0 M0 transitional cell carcinoma of the urinary bladder.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Survival Rate; Time Factors; Urinary Bladder Neoplasms; Vinblastine | 1990 |
Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy.
Topics: Adult; Aged; Brain Neoplasms; Combined Modality Therapy; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 1990 |
Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Cytarabine; Doxorubicin; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Methotrexate; Neoplasm Recurrence, Local; Prednisolone; Probability; Remission Induction; Vincristine | 1990 |
Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial ci
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Extremities; Humans; Infusions, Intravenous; Injections, Intra-Arterial; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Survival Rate | 1990 |
Methotrexate plus L-asparaginase. An active combination for children with acute nonlymphocytic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Drug Hypersensitivity; Female; Humans; Infant; Injections, Intravenous; Leukemia, Myeloid, Acute; Male; Methotrexate; Neoplasm Recurrence, Local; Remission Induction | 1990 |
Primary transitional cell carcinoma of prostate: case with lymph node metastasis eradicated by neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prostatic Neoplasms; Vinblastine | 1990 |
[Intra-arterial chemotherapy of relapsed and hormone-resistant prostate cancer using reservoir system].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Resistance; Hormones; Humans; Infusion Pumps; Infusions, Intra-Arterial; Male; Methotrexate; Neoplasm Recurrence, Local; Prostatic Neoplasms; Survival Rate | 1990 |
CNS minimal disease therapy in childhood leukaemia: the place for irradiation.
Topics: Brain Neoplasms; Child; Child, Preschool; Humans; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy; Spinal Cord Neoplasms | 1990 |
[Burkitt's lymphoma in HIV-infected patients].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Recurrence, Local; Remission Induction | 1990 |
[Cases of the regression of advanced bladder tumors (T2-T4) after the use of chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Care; Remission Induction; Urinary Bladder Neoplasms; Vinblastine | 1990 |
The treatment of recurrent and metastatic cervical carcinoma. Evaluation of an antiblastic combination of methotrexate-adriamycin-bleomycin (MAB).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 1985 |
Carcinoma of the base of the tongue. A review of 45 cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Tongue Neoplasms; Vincristine | 1985 |
Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Fluorouracil; Head and Neck Neoplasms; Humans; Leucovorin; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Time Factors | 1985 |
Nasopharyngeal cancer: study III. A review of 1206 patients treated with combined modalities.
Topics: Bleomycin; Carcinoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Humans; Methotrexate; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local | 1985 |
[The question of polychemotherapy of oral tumors with curative and palliative objectives].
Topics: Adult; Aged; Bleomycin; Cisplatin; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Palliative Care; Prognosis; Vincristine | 1985 |
Carcinoma of the nasopharynx. An analysis of 91 cases and a comparison of differing treatment approaches.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclophosphamide; Endoscopy; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Palpation; Random Allocation; Retrospective Studies | 1986 |
Chemotherapy in buccal mucosa cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Male; Methotrexate; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neoplasm Recurrence, Local | 1986 |
Neoadjuvant chemotherapy for osteogenic sarcoma: a model for the treatment of other highly malignant neoplasms.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma | 1986 |
Chemotherapy for recurrent and metastatic cervical cancer with standard-dose methotrexate-leucovorin, bleomycin and cis-platinum.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Time Factors; Uterine Cervical Neoplasms | 1986 |
Therapy of recurrent squamous cell carcinoma of the head and neck using combination vincristine, bleomycin, and methotrexate. A Southwest Oncology Group Study.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Vincristine | 1986 |
[Cisplatin, methotrexate and peplomycin in the treatment of esophageal carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Administration Schedule; Esophageal Neoplasms; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Peplomycin | 1986 |
[Combined chemotherapy and radiotherapy in recurrent tumors of the head and neck region].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy Dosage; Tegafur; Uracil | 1987 |
CDDP and 5-FU after prior VBM or VBM after prior CDDP and 5-FU in the management of recurrent squamous cell carcinoma of the head and neck?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Vincristine | 1986 |
Alternating regimens in recurrent and metastatic squamous cell carcinoma of the head and neck.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Vincristine | 1987 |
Metastatic spread of floor of the mouth squamous cell carcinoma via pectoralis major myocutaneous flap.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Combined Modality Therapy; Humans; Male; Methotrexate; Mouth Floor; Mouth Neoplasms; Neck Dissection; Neoplasm Recurrence, Local; Palliative Care; Radiotherapy Dosage; Surgical Flaps; Thoracic Neoplasms; Time Factors; Vincristine | 1988 |
Response-oriented therapy with CHOP and VIM-Bleo in high-grade malignant non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Vincristine | 1988 |
Neoadjuvant chemotherapy in locally advanced cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Female; Humans; Italy; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Prognosis; Uterine Cervical Neoplasms | 1989 |
Treatment of disseminated germ cell tumours of the testis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Leukocyte Count; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms; Testis; Vinblastine; Vincristine | 1989 |
Antiblastic treatment of advanced cervical carcinoma and its recurrences: assessment of four different polychemotherapies used for a decade.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Tegafur; Uterine Cervical Neoplasms; Vincristine | 1989 |
[Factors modifying remission in cytostatic chemotherapy of squamous cell carcinoma recurrence in the area of the head and neck].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Prognosis | 1989 |
Improved results in the treatment of nasopharyngeal carcinoma using combined radiotherapy and chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclophosphamide; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Tegafur; Uracil | 1989 |
[Two cases of gastrointestinal cancers with major responses to sequential methotrexate 5-FU plus 5'-DFUR].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Colonic Neoplasms; Drug Administration Schedule; Female; Floxuridine; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Stomach Neoplasms | 1989 |
[Effect of sequential MTX/5-FU therapy for a case of disseminated intravascular coagulation syndrome associated with recurrence of gastric cancer--a case report].
Topics: Adenocarcinoma, Scirrhous; Adult; Disseminated Intravascular Coagulation; Fluorouracil; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Stomach Neoplasms | 1989 |
Early recurrence following induction chemotherapy for stage IV head and neck cancers: rationale for additional therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Recurrence, Local; Prognosis | 1985 |
Postcricoid carcinoma: a retrospective study of 13 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Hydroxyurea; Laryngeal Neoplasms; Male; Mercaptopurine; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Vincristine | 1985 |
Impact of administration-related factors on outcome of adjuvant chemotherapy for primary breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Prognosis; Prospective Studies | 1989 |
Long-term follow-up in patients treated with methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) for transitional cell carcinoma of urinary bladder: cause for concern.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Urinary Bladder Neoplasms; Vinblastine | 1989 |
Factors associated with local recurrence as a first site of failure following the conservative treatment of early breast cancer.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Risk Factors; Time Factors | 1989 |
[Recurrence of choriocarcinoma following methotrexate monotherapy].
Topics: Adult; Choriocarcinoma; Drug Administration Schedule; Female; Humans; Hysterectomy; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Uterine Neoplasms; Uterus | 1989 |
[Adjuvant chemotherapy with biocisplatin, methotrexate and biocarbazine in advanced bladder tumors].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Dacarbazine; Drug Evaluation; Epirubicin; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Urinary Bladder Neoplasms; Vinblastine | 1989 |
[Kaposi's sarcoma after kidney transplantation].
Topics: Adult; Cyclosporins; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Methotrexate; Neoplasm Recurrence, Local; Postoperative Complications; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Time Factors | 1989 |
The significance of an isolated central nervous system relapse, occurring as first relapse in children with acute lymphoblastic leukemia.
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Meningeal Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Retrospective Studies; Time Factors | 1989 |
[Combination chemotherapy of CPM-MTX-5-FU in non-resectable and recurrent cancer patients].
Topics: Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Drug Evaluation; Fatigue; Fluorouracil; Humans; Leukopenia; Methotrexate; Nausea; Neoplasm Recurrence, Local; Neoplasms; Remission Induction; Stomach Neoplasms | 1989 |
The effect of sequential methotrexate and 5-fluorouracil in patients with recurrent head and neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Hematologic Diseases; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis | 1989 |
Low-dose chemotherapy of desmoid tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arm; Female; Fibroma; Humans; Leg; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pelvic Neoplasms; Remission Induction; Thoracic Neoplasms; Vinblastine | 1989 |
Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Mastectomy, Segmental; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Risk Factors | 1989 |
Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Infusions, Intravenous; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Seizures | 1989 |
Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Boston; Child; Clinical Protocols; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Ontario; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Risk Factors; Survival Rate; Vincristine | 1989 |
Use of serum CA-125 levels to monitor therapy of patients with advanced or recurrent endometrial carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antigens, Tumor-Associated, Carbohydrate; Doxorubicin; Drug Therapy, Combination; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Progesterone; Uterine Neoplasms | 1989 |
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Female; Humans; Kidney Neoplasms; Liver Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1989 |
High-dose methotrexate for non-AIDS primary central nervous system lymphoma. Report of 13 cases.
Topics: Adult; Aged; Brain Neoplasms; Combined Modality Therapy; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 1989 |
Treatment of refractory and relapsed non-Hodgkin's lymphoma with ifosfamide, methotrexate and etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Time Factors | 1989 |
Intensive alternating chemotherapy regimen in small cell carcinoma of the lung.
Topics: Actuarial Analysis; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Brain Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gastrointestinal Hemorrhage; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Thrombocytopenia; Vincristine | 1985 |
Combined methotrexate and high-dose vincristine chemotherapy with radiation therapy for small cell bronchogenic carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Brain; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Evaluation Studies as Topic; Female; Humans; Lung Neoplasms; Male; Mediastinum; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radionuclide Imaging; Tomography, X-Ray Computed; Vincristine | 1985 |
Chemotherapy for gestational trophoblastic tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Choriocarcinoma; Chorionic Gonadotropin; Cisplatin; Dactinomycin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Humans; Hydatidiform Mole; Luteinizing Hormone; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Prognosis; Trophoblastic Neoplasms; Uterine Neoplasms | 1987 |
Recurrent glioblastoma treated by chemotherapy alone.
Topics: Brain Neoplasms; Child; Female; Glioblastoma; Humans; Methotrexate; Neoplasm Recurrence, Local | 1987 |
Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Estrogens, Conjugated (USP); Fluorouracil; Heart Failure; Humans; Leucovorin; Leukopenia; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Tamoxifen | 1987 |
Phase II study of the three-drug combination of mitomycin C, CCNU, and methotrexate (MCM) in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Neoplasm Recurrence, Local; Time Factors | 1986 |
Radiotherapy for the prevention of local-regional recurrence in high risk patients post mastectomy receiving adjuvant chemotherapy.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prednisone; Radiotherapy, High-Energy; Retrospective Studies; Risk Factors | 1988 |
42-hour methotrexate infusions as relapse therapy for childhood malignancies: toxicity and efficacy of 109 infusions.
Topics: Adolescent; Adult; Child; Child, Preschool; Combined Modality Therapy; Drug Evaluation; Humans; Infusions, Intravenous; Leucovorin; Methotrexate; Neoplasm Recurrence, Local; Neoplasms | 1987 |
Physician compliance and relapse rates of acute lymphoblastic leukemia in children.
Topics: Administration, Oral; Brain Neoplasms; Child; Humans; Injections, Spinal; Leukemia, Lymphoid; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Practice Patterns, Physicians'; Radiotherapy Dosage; Remission Induction | 1988 |
Adjuvant chemotherapy with and without radiotherapy in stage II breast cancer.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Period; Retrospective Studies | 1988 |
A phase II study of sequential methotrexate and 5-fluorouracil in colorectal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Drug Evaluation; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1988 |
Neoadjuvant chemotherapy in the treatment of osteosarcoma of the extremities: preliminary results in 131 cases treated preoperatively with methotrexate and cisdiamminoplatinum.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis; Random Allocation; Time Factors | 1988 |
[Evaluation of the results of treatment of non-Hodgkin's lymphoma in children by the Wollner method].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Daunorubicin; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Time Factors; Vincristine | 1988 |
[Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Thioguanine; Time Factors; Vincristine | 1988 |
The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Receptors, Estrogen; Retrospective Studies; Tamoxifen; Vincristine | 1988 |
Integration of full-dose adjuvant chemotherapy with definitive radiotherapy for primary breast cancer: four-year update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Recurrence, Local; Prednisone | 1988 |
The eye in acute leukaemia. 2. The management of solitary anterior chamber relapse.
Topics: Anterior Chamber; Bone Neoplasms; Child; Combined Modality Therapy; Eye Neoplasms; Humans; Leukemia, Lymphoid; Methotrexate; Neoplasm Recurrence, Local | 1987 |
[Chemotherapy of advanced and recurrent colorectal cancer].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Hyperthermia, Induced; Infusions, Intra-Arterial; Leucovorin; Methotrexate; Neoplasm Recurrence, Local; Rectal Neoplasms | 1986 |
[Successful chemotherapy in a primary cerebral centroblastic non-Hodgkin's lymphoma in childhood].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cobalt Radioisotopes; Combined Modality Therapy; Cytarabine; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Recurrence, Local; Radioisotope Teletherapy; Tomography, X-Ray Computed | 1986 |
Intermittent central nervous system irradiation and intrathecal chemotherapy for central nervous system leukemia in children.
Topics: Adolescent; Central Nervous System; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Infant; Injections, Spinal; Leukemia; Male; Meningeal Neoplasms; Methotrexate; Neoplasm Recurrence, Local | 1987 |
[Therapy of advanced hypopharyngeal carcinoma].
Topics: Combined Modality Therapy; Humans; Hypopharyngeal Neoplasms; Hypopharynx; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Pharyngeal Neoplasms; Postoperative Care; Preoperative Care; Radiotherapy | 1987 |
[Ovarian function and recurrence in adjuvant chemotherapy of breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Methotrexate; Neoplasm Recurrence, Local; Ovarian Function Tests; Receptors, Estrogen; Receptors, Progesterone | 1987 |
Significance of plasma retinol binding protein levels in recurrence of breast tumors in women.
Topics: Antineoplastic Combined Chemotherapy Protocols; beta Carotene; Breast Neoplasms; Carotenoids; Cisplatin; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Proteins; Neoplasm Recurrence, Local; Prealbumin; Retinol-Binding Proteins; Retinol-Binding Proteins, Plasma; Vitamin A | 1987 |
Methotrexate as relapse therapy for rhabdomyosarcoma.
Topics: Child; Child, Preschool; Female; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Orbital Neoplasms; Rhabdomyosarcoma; Soft Tissue Neoplasms; Thoracic Neoplasms | 1986 |
[Results of the chemotherapy of patients with recurrence of cervical cancer after radiotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 1986 |
[Chemotherapy of recurrent squamous cell carcinomas in the ENT area with cisplatin/adriamycin (DDP/ADM) and methotrexate/5-fluorouracil (MTX/5-Flu): a retrospective comparison of 2 protocols].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Otorhinolaryngologic Neoplasms; Retrospective Studies | 1986 |
Salvage treatment of patients suffering relapse after adjuvant CMF chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Ovariectomy; Retrospective Studies; Tamoxifen | 1986 |
Controversy over combination chemotherapy in advanced ovarian cancer: what we learn from reports of matured data.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Reoperation; Time Factors | 1986 |
A reappraisal of oophorectomy in carcinoma of the breast.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Evaluation Studies as Topic; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovariectomy; Prognosis; Receptors, Estrogen; Time Factors | 1987 |
[Repeated irradiation of recurrent head and neck tumors using hyperthermia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclophosphamide; Head and Neck Neoplasms; Humans; Hyperthermia, Induced; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy Dosage; Vinblastine | 1987 |
Combined cryosurgical, chemotherapeutic, and radiotherapeutic management of T1-4N0M0 oral cavity cancers.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cobalt Radioisotopes; Combined Modality Therapy; Cryosurgery; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Mouth Neoplasms; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radioisotope Teletherapy | 1985 |
Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Leukopenia; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Prognosis; Receptors, Estrogen; Retrospective Studies; Tamoxifen | 1985 |
Our experience regarding precautional chemotherapy in breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis | 1985 |
Management of inflammatory carcinoma of the breast. A combined modality approach.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy Dosage | 1985 |
Carcinoma of the tongue and floor of the mouth. Preliminary results of a multidisciplinary approach.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Cryosurgery; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Mouth Floor; Mouth Neoplasms; Neoplasm Recurrence, Local; Tongue Neoplasms | 1985 |
[Therapy of recurrent squamous cell cancers in the ENT area with the sequential methotrexate (MTX)/5-fluorouracil (5-Fu) protocol].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Otorhinolaryngologic Neoplasms; Prognosis | 1985 |
Response of astrocytoma to high-dose methotrexate with citrovorum factor rescue.
Topics: Adolescent; Adult; Angiography; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Female; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neurologic Examination; Seizures; Tomography, X-Ray Computed | 1985 |
Control of primary osteosarcoma with chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Femoral Neoplasms; Follow-Up Studies; Humans; Ilium; Infusions, Intra-Arterial; Leucovorin; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Tibia | 1985 |
Maintenance chemotherapy for high-risk patients. A preliminary report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Leucovorin; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Patient Compliance; Prospective Studies; Risk; Sex Ratio | 1985 |
The cyclophosphamide, hexamethylmelamine, 5 fluorouracil (CHF) regimen in the treatment of advanced and recurrent ovarian cancer.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Humans; Hysterectomy; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Reoperation | 1985 |
Treatment of persistent or recurrent ovarian carcinoma with sequential methotrexate and 5-fluorouracil.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms | 1986 |
Patterns of recurrence in patients with high-grade soft-tissue sarcomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Sarcoma; Soft Tissue Neoplasms | 1985 |
Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies | 1985 |
[Chemotherapy for recurrent breast carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Vincristine | 1985 |
Evaluation of the efficacy of oral methotrexate in the prevention of recurrence of superficial bladder tumours.
Topics: Administration, Oral; Carcinoma, Transitional Cell; Humans; Methotrexate; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms | 1985 |
Weight gain during adjuvant chemotherapy for breast cancer.
Topics: Adult; Aged; Body Weight; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Prognosis; Risk | 1985 |
A phase II study of sequential methotrexate and fluorouracil in advanced colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Colonic Neoplasms; Drug Evaluation; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Rectal Neoplasms | 1985 |
Cis-platinum, doxorubicin, and methotrexate treatment for recurrent cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Uterine Cervical Neoplasms | 1985 |
[Combined therapy of bladder cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Cisplatin; Combined Modality Therapy; Dacarbazine; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Urinary Bladder; Urinary Bladder Neoplasms | 1985 |
Chemotherapy of head and neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Head and Neck Neoplasms; Humans; Immunotherapy; Infusions, Intra-Arterial; Methotrexate; Neoplasm Recurrence, Local | 1985 |
[Effects of combination chemotherapy M-VEMFH including mitoxantrone in advanced breast cancer].
Topics: Adult; Aged; Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Prednisolone; Vincristine | 1985 |
Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.
Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Creatinine; Dehydration; Drug Evaluation; Female; Hematologic Diseases; Humans; Male; Methotrexate; Middle Aged; Nausea; Neoplasm Metastasis; Neoplasm Recurrence, Local; Urologic Neoplasms; Vinblastine | 1985 |
[Therapy of bronchial carcinoma. Intermittent high-dosage polychemotherapy of bronchial carcinoma in combination with radical surgery for the prevention of recurrences and in primarily inoperable patients].
Topics: Adult; Aged; Antineoplastic Agents; Austria; Bronchial Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Palliative Care | 1973 |
Cancer of the tongue.
Topics: Bleomycin; Carcinoma, Squamous Cell; Dental Caries; Electrocoagulation; Fluorides, Topical; Fluorouracil; Glossectomy; Humans; Lymphatic Metastasis; Methotrexate; Neck Dissection; Neoplasm Metastasis; Neoplasm Recurrence, Local; Preoperative Care; Radiotherapy Dosage; Tongue Neoplasms | 1973 |
[Testicular tumors].
Topics: Adult; Dactinomycin; Diagnosis, Differential; Dysgerminoma; Humans; Male; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Teratoma; Testicular Diseases; Testicular Neoplasms | 1973 |
Bleomycin--a new approach in cancer chemotherapy.
Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Bleomycin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Ear Neoplasms; Esophageal Neoplasms; Female; Humans; Lung Neoplasms; Male; Mandibular Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Nose Neoplasms; Penile Neoplasms; Pulmonary Fibrosis; Remission, Spontaneous; Skin Neoplasms | 1973 |
[Intra-arterial chemotherapy of head and neck tumors: statistical study of 129 cases treated at the Institut Gustave Roussy].
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Facial Neoplasms; Fluorouracil; Head and Neck Neoplasms; Humans; Imidazoles; Jaw Neoplasms; Mannomustine; Melanoma; Methotrexate; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Pharyngeal Neoplasms; Prognosis; Sarcoma; Thiotepa; Vinblastine | 1973 |
[Chemotherapy of cancers of the larynx and hypopharynx].
Topics: Adult; Aminocaproates; Antineoplastic Agents; Bleomycin; Cyclophosphamide; Drug Therapy, Combination; Female; Glutathione; Humans; Injections, Intravenous; Laryngeal Neoplasms; Laryngectomy; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pharyngeal Neoplasms; Postoperative Care; Time Factors; Vinblastine | 1973 |
Chemotherapy in recurrent heat and neck cancer.
Topics: Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Fluorouracil; Head; Head and Neck Neoplasms; Humans; Hydroxyurea; Injections, Intra-Arterial; Injections, Intramuscular; Methotrexate; Neoplasm Recurrence, Local; Neoplasms; Vinblastine; Vincristine | 1974 |
The place of chemotherapy in the treatment of advanced squamous carcinoma of the head and neck and in other situations.
Topics: Adult; Aged; Bleomycin; Carcinoma, Squamous Cell; Drug Therapy, Combination; Esophageal Neoplasms; Female; Forearm; Head; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Injections, Intravenous; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms | 1974 |
Combined chemotherapy, radiotherapy, and surgery in the treatment of advanced but localized solid malignant tumours.
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cystadenocarcinoma; Drug Therapy, Combination; Esophageal Neoplasms; Female; Head and Neck Neoplasms; Humans; Hydroxyurea; Infusions, Parenteral; Injections, Intravenous; Male; Methotrexate; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Skin Neoplasms; Tongue Neoplasms; Vincristine | 1974 |
[FSH and steroid hormone excretion in breast cancer during chemotherapy].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Breast Neoplasms; Cyclophosphamide; Estrogens; Female; Fluorouracil; Follicle Stimulating Hormone; Glucocorticoids; Humans; Menopause; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pregnanediol; Thiotepa; Time Factors; Vinblastine | 1972 |
Malignant trophoblastic neoplasia. Monitoring of therapy.
Topics: Adolescent; Adult; Choriocarcinoma; Chorionic Gonadotropin; Dactinomycin; Drug Combinations; Evaluation Studies as Topic; Female; Humans; Hydatidiform Mole; Hydatidiform Mole, Invasive; Luteinizing Hormone; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pregnancy; Radioimmunoassay; Time Factors; Trophoblastic Neoplasms; Uterine Neoplasms; Vinblastine | 1972 |
Burkitt's lymphoma: cell kinetics, treatment and immunology.
Topics: Antibodies, Neoplasm; Antibodies, Viral; Burkitt Lymphoma; Culture Techniques; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Herpesvirus 4, Human; Humans; Hypersensitivity, Delayed; Injections, Spinal; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Thymidine; Tritium; Vincristine | 1973 |
Immunological studies on a case of recurrent Burkitt's lymphoma during immune stimulant treatment.
Topics: Antibodies, Neoplasm; Antigen-Antibody Reactions; Antigens, Neoplasm; Antigens, Viral; BCG Vaccine; Burkitt Lymphoma; Cell Membrane; Child, Preschool; Complement Fixation Tests; Cytarabine; Diphtheria Antitoxin; Facial Neoplasms; Herpesvirus 4, Human; Humans; Kidney Neoplasms; Male; Methotrexate; Neoplasm Recurrence, Local; Pertussis Vaccine; Tetanus Antitoxin | 1973 |
Recurrent head and neck cancer: the results of treatment.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Ear Neoplasms; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lip Neoplasms; Lymphatic Metastasis; Methotrexate; Mouth Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paranasal Sinus Neoplasms; Pharyngeal Neoplasms; Skin Neoplasms; Surgery, Plastic | 1974 |
Clinical and immunological recovery of children with acute lymphocytic leukemia admitted to "total therapy" studies.
Topics: Antibody Formation; Drug Therapy, Combination; Evaluation Studies as Topic; Humans; Immunoglobulin G; Immunoglobulin M; Leukemia, Lymphoid; Lymphocytes; Meningitis; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Radiotherapy Dosage; Remission, Spontaneous; Time Factors; Vincristine | 1973 |
[Ewing's sarcoma localized to the mandible. 2 cases].
Topics: Adolescent; Asparaginase; Child; Chlorambucil; Cobalt Radioisotopes; Cyclophosphamide; Female; Humans; Lung Neoplasms; Male; Mandible; Mandibular Neoplasms; Mercaptopurine; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pregnenolone; Radiography; Sarcoma, Ewing; Vinblastine | 1974 |
Arterial infusion and radiation therapy in the treatment of advanced cancer of the nasal cavity and paranasal sinuses.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Carotid Artery, External; Carotid Artery, Internal; Chemotherapy, Cancer, Regional Perfusion; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphatic Metastasis; Maxillary Artery; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nose Neoplasms; Paranasal Sinus Neoplasms | 1973 |
Pontine glioma. High-dose methotrexate and leucovorin rescue.
Topics: Administration, Oral; Brain Neoplasms; Calcium; Child; Drug Evaluation; Glioma; Humans; Infusions, Parenteral; Leucovorin; Male; Methotrexate; Neoplasm Recurrence, Local; Pons; Remission, Spontaneous | 1974 |
Intra-arterial infusion for head and neck cancers.
Topics: Aged; Antineoplastic Agents; Brachiocephalic Trunk; Carcinoma, Squamous Cell; Carotid Arteries; Catheterization; Female; Fluoresceins; Fluorouracil; Head; Head and Neck Neoplasms; Humans; Injections, Intra-Arterial; Leukocyte Count; Male; Methods; Methotrexate; Neoplasm Recurrence, Local; Neoplasms; Vinblastine | 1973 |
Cancer chemotherapy. I. Methods, agents and overall results in 400 patients.
Topics: Adenocarcinoma; Amides; Androgens; Breast Neoplasms; Colonic Neoplasms; Cyclophosphamide; Estrogens; Female; Fluorouracil; Glucocorticoids; Head; Head and Neck Neoplasms; Humans; Imidazoles; Lung Neoplasms; Male; Mechlorethamine; Melanoma; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Progesterone; Rectal Neoplasms; Sarcoma; Thiotepa; Triazenes | 1972 |
[Oral, florid papillomatosis].
Topics: Adrenal Cortex Hormones; Aged; Female; Fluorouracil; Humans; Injections, Intramuscular; Lip Neoplasms; Male; Methotrexate; Mouth Neoplasms; Neoplasm Recurrence, Local; Papilloma | 1973 |
Gynecologic oncology.
Topics: Alkylating Agents; Ascites; Biopsy; Dactinomycin; Endometrium; Female; Fluorouracil; Genital Neoplasms, Female; Humans; Methotrexate; Neoplasm Recurrence, Local; Ovarian Neoplasms; Pelvic Neoplasms; Pleural Effusion; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 1973 |
Chemoimmunotherapy for cancer of the head and neck.
Topics: Adult; Aged; BCG Vaccine; Carcinoma, Squamous Cell; Evaluation Studies as Topic; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Isoniazid; Jaw Neoplasms; Laryngeal Neoplasms; Lip Neoplasms; Male; Mandibular Neoplasms; Maxillary Neoplasms; Methotrexate; Middle Aged; Mouth Neoplasms; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Parotid Neoplasms; Salivary Gland Neoplasms; Tongue Neoplasms; Tonsillar Neoplasms | 1973 |
Treatment of basal cell carcinoma of the skin with curettage. II. A follow-up study.
Topics: Abdominal Neoplasms; Aged; Carcinoma, Basal Cell; Cheek; Curettage; Ear Neoplasms; Extremities; Facial Neoplasms; Female; Follow-Up Studies; Head; Head and Neck Neoplasms; Humans; Male; Methods; Methotrexate; Neoplasm Recurrence, Local; Nose Neoplasms; Skin Neoplasms; Time Factors | 1973 |
Burkitt's lymphoma in Ghana: clinical features and response to chemotherapy.
Topics: Abdominal Neoplasms; Adolescent; Allopurinol; Brain Neoplasms; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Female; Ghana; Humans; Jaw Neoplasms; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Neurologic Manifestations; Ovarian Neoplasms; Prognosis; Sex Factors; Time Factors; Vincristine | 1973 |
[Preliminary evaluation of intermittent polychemotherapy in high doses for prevention of recurrence after radical operation of lung cancer (author's transl)].
Topics: Bronchial Neoplasms; Carcinoma, Bronchogenic; Cyclophosphamide; Drug Therapy, Combination; Fructose; Humans; Injections, Intravenous; Lung Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Postoperative Complications; Time Factors; Vinblastine | 1973 |
Cutaneous reactivity in patients with cancer of the head and neck region.
Topics: Age Factors; Aged; Carcinoma, Squamous Cell; Croton Oil; Dinitrochlorobenzene; Drug Hypersensitivity; Head; Head and Neck Neoplasms; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Prognosis; Skin Tests | 1973 |
An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
Topics: Administration, Oral; Adult; Aged; Blood Cell Count; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fluorouracil; Humans; Injections, Intravenous; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prednisone; Remission, Spontaneous; Vincristine | 1974 |
Vulvar carcinoma treated successfully.
Topics: Administration, Oral; Carcinoma, Squamous Cell; Female; Humans; Injections, Intra-Arterial; Injections, Intravenous; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Vulvar Neoplasms | 1974 |
Prolonged survival in malignant melanoma of the nose.
Topics: Electrocoagulation; Female; Humans; Melanoma; Methotrexate; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Nose Neoplasms; Time Factors | 1974 |
Leukoencephalopathy following the administration of methotrexate into the cerebrospinal fluid in the treatment of primary brain tumors.
Topics: Adolescent; Autopsy; Brain Neoplasms; Cerebral Ventricles; Cerebrospinal Fluid Shunts; Child; Ependymoma; Female; Humans; Leukoencephalopathy, Progressive Multifocal; Male; Medulloblastoma; Methotrexate; Microscopy, Electron; Neoplasm Recurrence, Local; Neurologic Manifestations | 1974 |
Cyclical combination chemotherapy in advanced breast cancer.
Topics: Age Factors; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Hypophysectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Norethindrone; Vincristine | 1974 |
An ethmoidal tumour treated with methotrexate.
Topics: Adenocarcinoma; Ethmoid Sinus; Humans; Injections, Intra-Arterial; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paranasal Sinus Neoplasms; Radiotherapy, High-Energy | 1966 |
Systemic chemotherapy for carcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclophosphamide; Female; Fluorouracil; Humans; Hydroxyurea; Mechlorethamine; Melphalan; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Progestins; Thiotepa; Urea; Uterine Cervical Neoplasms | 1967 |
[Clinical picture of the so-called "oral florid papillomatosis" (Papillomatosis mucosae oris carcinoides)].
Topics: Aged; Basement Membrane; Chin; Female; Humans; Methotrexate; Mouth Mucosa; Mouth Neoplasms; Neoplasm Recurrence, Local; Papilloma; Skin; Terminology as Topic | 1972 |
Embryonal cell carcinoma of the ovary. Report of a case.
Topics: Abdominal Neoplasms; Adolescent; Age Factors; Black People; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Recurrence, Local; Ovarian Neoplasms; Teratoma; Vincristine | 1971 |
Urinary aminoimidazolecarboxamide levels in children with acute leukemia.
Topics: Blood Cell Count; Blood Cells; Blood Platelets; Bone Marrow Cells; Bone Marrow Examination; Child; Female; Humans; Imidazoles; Indicators and Reagents; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Methotrexate; Neoplasm Recurrence, Local | 1970 |
Intra-arterial chemotherapy for recurrent neoplasms.
Topics: Adult; Aged; Catheterization; Female; Fluorouracil; Humans; Infusions, Parenteral; Injections, Intra-Arterial; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis | 1967 |
[Intra- and peritracheal fibrosarcoma, surgically treated by the Gebauer technic].
Topics: Cobalt Isotopes; Fibrosarcoma; Humans; Male; Mercaptopurine; Methods; Methotrexate; Neoplasm Recurrence, Local; Thyroid Neoplasms; Tomography; Tracheal Neoplasms | 1969 |
Triple drug therapy in testicular tumors.
Topics: Adolescent; Adult; Chlorambucil; Choriocarcinoma; Dactinomycin; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Teratoma; Testicular Neoplasms | 1969 |
Case studies of squamous cell carcinoma of the nose and external auditory canal.
Topics: Adult; Carcinoma, Squamous Cell; Ear Neoplasms; Ear, External; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nose Neoplasms | 1969 |
Treatment of Burkitt's tumor with cyclophosphamide.
Topics: Abdominal Neoplasms; Adult; Brain Neoplasms; Burkitt Lymphoma; Child; Cranial Nerves; Cyclophosphamide; Cytarabine; Facial Neoplasms; Female; Humans; Injections, Spinal; Male; Mandibular Neoplasms; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Uganda; Vincristine | 1970 |
Five years' experience with the prevention of trophoblastic tumors by the prophylactic use of chemotherapy in patients with molar pregnancy.
Topics: Abortion, Induced; Chorionic Gonadotropin; Dactinomycin; Female; Humans; Hydatidiform Mole; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Placental Lactogen; Pregnancy; Pregnancy Complications | 1970 |
The rationale and development of a method of regional chemotherapy in cancer of the head and neck.
Topics: Carotid Arteries; Facial Neoplasms; Head and Neck Neoplasms; Hemiplegia; Humans; Infusions, Parenteral; Methotrexate; Mouth Neoplasms; Neoplasm Recurrence, Local | 1968 |
[The possibility of selective chemotherapy of progressive recurring ovarian carcinoma with the aid of cytodiagnosis and incorporation of tagged idoxuridine].
Topics: Aged; Antineoplastic Agents; Ascites; Cyclophosphamide; Cytodiagnosis; Female; Humans; Idoxuridine; Iodine Isotopes; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Ovarian Neoplasms; Time Factors | 1969 |
[Methotrexate as an adjuvant in radiotherapy of squamous cell carcinoma of the throat nose-ear-area].
Topics: Carcinoma, Squamous Cell; Ear Neoplasms; Humans; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nose Neoplasms; Pharyngeal Neoplasms; Prospective Studies; Time Factors | 1969 |
Keratoacanthoma. Association with basal and squamous cell carcinoma.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Keratoacanthoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nose Neoplasms; Tetracycline | 1969 |